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ABSTRACT
Cigarette smoking remains a major global public health issue. This is partially
due to the chronic and relapsing nature of tobacco use, which contributes to the ap-
proximately 90% quit attempt failure rate. The recent rise in mobile technologies
has led to an increased ability to frequently measure smoking behaviors and related
constructs over time, i.e., obtain intensive longitudinal data (ILD). Dynamical sys-
tems modeling and system identification methods from engineering o↵er a means to
leverage ILD in order to better model dynamic smoking behaviors. In this disserta-
tion, two sets of dynamical systems models are estimated using ILD from a smoking
cessation clinical trial: one set describes cessation as a craving-mediated process; a
second set was reverse-engineered and describes a psychological self-regulation pro-
cess in which smoking activity regulates craving levels. The estimated expressions
suggest that self-regulation more accurately describes cessation behavior change, and
that the psychological self-regulator resembles a proportional-with-filter controller.
In contrast to current clinical practice, adaptive smoking cessation interventions seek
to personalize cessation treatment over time. An intervention of this nature generally
reflects a control system with feedback and feedforward components, suggesting its
design could benefit from a control systems engineering perspective. An adaptive
intervention is designed in this dissertation in the form of a Hybrid Model Predictive
Control (HMPC) decision algorithm. This algorithm assigns counseling, bupropion,
and nicotine lozenges each day to promote tracking of target smoking and craving
levels. Demonstrated through a diverse series of simulations, this HMPC-based in-
tervention can aid a successful cessation attempt. Objective function weights and
three-degree-of-freedom tuning parameters can be sensibly selected to achieve inter-
vention performance goals despite strict clinical and operational constraints. Such
tuning largely a↵ects the rate at which peak bupropion and lozenge dosages are as-
i
signed; total post-quit smoking levels, craving o↵set, and other performance metrics
are consequently a↵ected. Overall, the interconnected nature of the smoking and
craving controlled variables facilitate the controller’s robust decision-making capa-
bilities, even despite the presence of noise or plant-model mismatch. Altogether,
this dissertation lays the conceptual and computational groundwork for future e↵orts
to utilize engineering concepts to further study smoking behaviors and to optimize
smoking cessation interventions.
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Chapter 1
INTRODUCTION
1.1 Motivation
Unhealthy behaviors, such as substance abuse, poor diet, and lack of physical
activity, remain among the leading causes of preventable death globally (Danaei
et al., 2009; Lopez et al., 2006). They also play prominent roles in the development
and severity of chronic diseases such as heart disease, chronic obstructive pulmonary
disease, diabetes, and more (World Health Organization, 2014; U.S. Department of
Health and Human Services and Centers for Disease Control and Prevention, 2014).
Through factors including losses in productivity, the cost of prevention programs, and
treatment expenses, these deleterious health behaviors have an economic e↵ect on the
order of trillions of dollars (World Health Organization, 2005).
Traditionally, preventative or therapeutic interventions intended to promote healthy
behaviors are fixed. In fixed interventions, all participants receiving the intervention
are assigned the same dosage of a treatment component for the entire duration of the
intervention (Collins et al., 2004; Rivera et al., 2007). Recently, adaptive interven-
tions have emerged as a means to explicitly address the chronic and relapsing nature
of many behavioral health disorders, such as substance use dependence (Collins et al.,
2004). Part of a growing interest in increasing therapeutic e ciencies through treat-
ment personalization (Fraser et al., 2014; Hamburg and Collins, 2010; Personalized
Medicine Coalition, 2014), adaptive interventions generally seek to adjust the com-
ponents and/or dosages of an intervention over time based on measurements of the
patient’s circumstances and changing needs (Collins et al., 2004).
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Adaptive interventions consist of closed-loop feedback systems, often with feed-
forward components (Rivera et al., 2007). This suggests that design of adaptive
behavioral interventions can benefit from a control systems engineering perspective.
Recent work suggests that well-established controller frameworks such as model-based
control and receding-horizon predictive control o↵er appealing approaches for the de-
sign of adaptive behavioral interventions (Deshpande et al., 2014; Dong et al., 2013,
2012; Rivera, 2012; Rivera et al., 2007; Savage et al., in press; Timms et al., 2014d).
Given the gravity of tobacco use as a major global public health issue (Centers
for Disease Control and Prevention, 2012; Dube et al., 2010; Erhardt, 2009; Killeen,
2011), this dissertation presents an engineering approach to better understand the
process of cigarette smoking behavior change, and proposes an initial framework for
an optimized adaptive smoking intervention. Initially, a secondary analysis of data
from a smoking cessation clinical trial (McCarthy et al., 2008b) is presented in order
to develop dynamic models of the cessation process. The connection between this
clinical trial data and engineering modeling methods is made via psychological theory.
The conceptual and computational groundwork is then established for a frequently-
adapting smoking cessation intervention in the form of a Hybrid Model Predictive
control algorithm. This intervention algorithm determines how dosages of counseling
and two medications should be varied over time in order to optimally promote a
successful cessation attempt for an individual patient.
1.2 Cigarette Smoking: A Persistent Global Public Health Issue
Cigarette smoking is the leading cause of preventable death in the United States,
where approximately 440,000 premature deaths and $157B in economic loss are at-
tributed to smoking annually (Dube et al., 2010; Erhardt, 2009; Killeen, 2011).
Decades of decreases in U.S. smoking rates have recently stagnated, with approxi-
2
mately 20% of adults actively smoking (Centers for Disease Control and Prevention,
2012). Globally, smoking is a growing concern and is expected to cause 5 million
annual deaths by 2020 (Dube et al., 2010). Cigarette smoking’s continued status as
a major public health concern is due in part to the chronic and relapsing nature of
tobacco dependence (Tobacco Use and Dependence Guideline Panel, 2008; Steinberg
et al., 2010; U.S. Department of Health and Human Services and Centers for Dis-
ease Control and Prevention, 2014). The fact that over 88% of quit attempts fail
(American Cancer Society, 2012) speaks to this assertion.
As quitting smoking is among the single greatest actions an individual can take
in order to improve their health (Pipe et al., 2010; U.S. Department of Health and
Human Services and Centers for Disease Control and Prevention, 2014), significant
resources have been dedicated to designing and evaluating smoking cessation inter-
ventions. Such interventions can be behavioral, pharmacological, or community-based
(e.g., a public health campaign) in nature (Rivera et al., 2007; Tobacco Use and De-
pendence Guideline Panel, 2008; U.S. Department of Health and Human Services and
Centers for Disease Control and Prevention, 2014). For example, individual counsel-
ing that focuses on garnering the ability to cope with cravings or on problem solving
skills related to identifying and managing “danger situations” (events or scenarios
that may normally lead a person to smoke, e.g., a particular stressor) are particularly
e↵ective behavioral therapies (Tobacco Use and Dependence Guideline Panel, 2008).
Seven medications have been approved as first line pharmacological tobacco use in-
terventions. Five are nicotine replacement therapies (NRTs), which deliver low doses
of nicotine in gum, lozenge, patch, nasal spray, or inhaler form (Rennard et al., 2014;
Tobacco Use and Dependence Guideline Panel, 2008). The non-NRT medications
are bupropion (WellbutrinR , ZybanR ) and varenicline (ChantixR ; Tobacco Use and
Dependence Guideline Panel, 2008). Bupropion is an anti-depressant thought to in-
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terfere with nicotine addiction mechanisms and reduce craving (Horst and Preskorn,
1998; Warner and Shoaib, 2005). Varenicline is an antagonist for a nicotinic cholin-
ergic receptor and was designed to reduce withdrawal symptoms and minimize the
rewarding e↵ect of cigarettes (Benowitz, 2009; West et al., 2008). Evidenced-based
clinical practice calls for use of these treatments in combination therapies (except
varenicline; Loh et al., 2012; McCarthy et al., 2008b; Piper et al., 2009; Tobacco Use
and Dependence Guideline Panel, 2008), such as in a combined bupropion and coun-
seling intervention (Tobacco Use and Dependence Guideline Panel, 2008; McCarthy
et al., 2008b; Piper et al., 2009). However, even the most e↵ective combination of
pharmacotherapies have 6-month cessation rates below 35% (Tobacco Use and De-
pendence Guideline Panel, 2008; Piper et al., 2009). Even these modest e cacies are
brought into question when considering time periods beyond one year (Irvin et al.,
2003; Irvin and Brandon, 2000).
Despite the chronic, relapsing nature of tobacco dependence, current clinical prac-
tice generally employs these treatment components in fixed interventions. Further-
more, the U.S. Department of Health and Human services notes that these treatments
are used without a well-accepted framework for optimally assigning intervention com-
ponents to an individual (Tobacco Use and Dependence Guideline Panel, 2008). Al-
together, the need for improved smoking cessation interventions is clear.
1.3 Personalizing Behavioral Interventions
The term “personalized medicine” encompasses a broad array of approaches in
which treatment is tailored to a specific patient with the general goal of improving
treatment outcomes with minimal resource waste. Often, research on personalized
interventions focuses on identifying subgroups of patients for whom a specific thera-
peutic protocol would be most appropriate (Hamburg and Collins, 2010; Personalized
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Medicine Coalition, 2014). For example, Bergen et al. (2013) examines which medi-
cations may be most appropriate for patients with genetic variants related to nicotine
receptor sites and neuronal activation.
However, systematic personalization of behavioral interventions remains limited
(Collins et al., 2004; Riley et al., 2011; Tobacco Use and Dependence Guideline Panel,
2008). This is due in part to challenges associated with precise identification of causal
relationships and quantification of treatment e↵ects. Intuitively, this likely arises from
inter-individual variability (Hamburg and Collins, 2010), which may enter at the
genetic, biomedical (e.g., co-morbidity), psychological or cognitive, environmental,
and socioeconomic levels. The time-varying nature of the cessation process (Chandra
et al., 2011; Gwaltney et al., 2005; Rivera, 2012; Timms et al., 2014a,c, 2013; Trail
et al., 2014; Velicer and Fava, 2003; Velicer et al., 1992; Walls and Rivera, 2009) makes
research on systematic treatment personalization more di cult.
As adaptive interventions attempt to explicitly address the chronic, relapsing na-
ture of disorders, they o↵er a promising approach for treating behavioral health issues.
Such interventions seek to personalize an intervention to a specific patient’s circum-
stances, varying the treatment over time in order to meet the changing needs of
individual patients. Specifically, these interventions take the form of decisions rules,
which systematically assign the components and/or dosages of an intervention based
on the levels of the patient’s tailoring variables (Collins et al., 2004). For example,
Kasari et al. (2014) considers a two-stage adaptive intervention in which minimally
verbal children with autism have a developmental/behavioral intervention that can
be augmented at a later point with a speech-generating device, depending on the
child’s early outcomes.
Recently, the design of adaptive behavioral interventions has been cast as a control
systems engineering problem (Bekiroglu et al., 2013; Deshpande et al., 2014; Dong
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et al., 2012, 2013, 2014; Nandola and Rivera, 2013; Noble, 2014; Rivera et al., 2007;
Savage et al., in press; Timms et al., 2013, 2014d). This approach proposes that
decision rules take the form of a control algorithm, with feedback and feedforward
signals acting as tailoring variables (Dong et al., 2012, 2013; Riley et al., 2011; Rivera
et al., 2007; Timms et al., 2014d). As will be discussed in detail in subsequent sec-
tions, employing a control systems paradigm in the design of adaptive behavioral
interventions is particularly appealing due to controller functionality related to cohe-
sive handling of multiple manipulated variables and objectives, tunability to influence
performance, robustness considerations, and constraint-handling abilities (Morari and
Zafiriou, 1989; Nandola and Rivera, 2013; Ogunnaike and Ray, 1994; Rivera et al.,
2007). Although ideas related to optimization and control theory have appeared in
psychological literature in the past—see Carver and Scheier (1998), Hyland (1987),
and Molenaar (1987) for examples—they remain absent from the landscape of current
clinical practice when it comes to tobacco use interventions.
1.4 Optimizing Smoking Cessation Interventions: An Engineering Approach
1.4.1 Overview
Although historically applied within traditional engineering settings (Ogunnaike
and Ray, 1994), control systems engineering principles have recently been employed
within non-traditional contexts including pharmacology (Fraser Health, 2014; Desh-
pande et al., 2014; Zurakowski and Teel, 2006), environmental engineering (e.g., Brdys
et al., 2008; Wang and Garnier, 2012), supply chain management (Nandola and
Rivera, 2013; Schwartz and Rivera, 2010), management of anemia (Gaweda et al.,
2008), and behavioral health (Dong et al., 2012, 2013; Bekiroglu et al., 2013; Nandola
and Rivera, 2013; Noble, 2014; Rivera, 2012; Rivera et al., 2007; Timms et al., 2014d).
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Patient care environments have also seen a rise in automation in recent years. Ex-
amples of automation ideas being introduced clinically include a clinical trial where a
PID controller is used to automate deliver anesthetics (Fraser Health, 2014; Soltesz,
2013), a clinical trial employing fuzzy control for cardiac intensive care patients (De-
nai et al., 2009; Ross et al., 2009), and a multitude of clinical analyses on artificial
pancreas systems drawing from PID and predictive control architectures (Doyle et al.,
2014).
Developing an engineering-based smoking cessation intervention draws from a
translation of the clinical demands of an intervention into control systems compo-
nents: treatment goals (e.g., smoking abstinence) correspond to controlled variable
set points and targets; tailoring variables correspond to measured outcomes and mea-
sured disturbances that act as feedback and feedforward signals, respectively; treat-
ment component dosages correspond to manipulated variables; clinical and pragmatic
limits on dosage levels and dosage adjustments correspond to manipulated variable
bounds and move size constraints; dose-responses, disturbance-responses, and uncer-
tainties are captured in nominal models; and an individual patient being treated is
the “plant” (Rivera et al., 2007; Timms et al., 2014d).
Noted previously, the goal of this research is to lay the computational and concep-
tual groundwork for an engineering-based adaptive smoking cessation intervention.
Toward this goal, two major areas of research are pursued: (1) estimation of dynam-
ical systems models describing the process of behavior change during a quit attempt
and (2) formulation, tuning, and analysis of an Hybrid Model Predictive Control
(HMPC)-based smoking cessation intervention.
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1.4.2 Dynamical Systems Modeling
Behavioral science has a rich history of quantifying the relationship between mea-
sured behaviors and related constructs using static modeling methods (Riley et al.,
2011), such as structural equation modeling (SEM; Bollen, 1989). This resulted
in part from early challenges related to cost-e↵ective and precise measurement of
behaviors frequently over time (Collins, 2006; Riley et al., 2011). Largely due to
the rise of computerized technologies, behavioral intensive longitudinal data (ILD)—
measurements of behaviors or related constructs recorded frequently over time, up
to continuous-time measurement—are becoming increasingly available (Riley et al.,
2011; Timms et al., 2014a; Walls and Schafer, 2006). Mobile and wearable technolo-
gies are particularly appealing as platforms for collecting ILD via ecological momen-
tary assessments (EMA), which collect such data in an individual’s natural environ-
ments (i.e., not clinical or laboratory environments) often in real time (Moskowitz
and Young, 2006; Shi↵man et al., 2008).
ILD o↵ers an opportunity to estimate dynamical systems models that parsimo-
niously represent changing behaviors as processes of change in the form of ordinary
di↵erential equations (ODEs; Rivera, 2012; Timms et al., 2014a). The estimation of
these dynamic models initially relies on well-established system identification meth-
ods resulting in rich, comprehensive, and quantitative descriptions of the dynamic
characteristics of time-varying behaviors (Ljung, 1999). These nomothetic or idio-
graphic models result in clinically-meaningful parameter estimates, insight into the
mechanisms of behavior change, can elucidate novel degrees-of-freedom on which to
potentially intervention, can facilitate potentially expanded analyses through simu-
lation, and more (Mart´ın et al., 2014; Rivera, 2012; Timms et al., 2013, 2014a,c).
Ultimately, though, modeling cessation with this analytical approach benefits most
8
significantly from its connection to control systems engineering, where estimated dy-
namical models can act as the basis for design of control systems-based interventions
(Ogunnaike and Ray, 1994; Rivera, 2012; Rivera et al., 2007; Timms et al., 2014a).
As behavioral interventions are often based on hypothesized mechanisms of be-
havior change, which have historically been described from a static perspective (Riley
et al., 2011), recent work has focused on developing dynamical systems models to de-
scribe behavior change according to well-known, theorized psychological mechanisms
(Dong et al., 2013; Mart´ın et al., 2014; Navarro-Barrientos et al., 2011; Rivera, 2012;
Rivera et al., 2007; Timms et al., 2014a,c). To better understand the process of
smoking cessation behavior change, dynamical systems models have been developed
to describe behavior change thought to occur according to two mechanisms of change:
mediation and self-regulation. Specifically, continuous-time dynamical systems mod-
els are estimated to examine the role of these mechanisms in cessation drawing from
ILD collected in the smoking cessation clinical trial described by McCarthy et al.
(2008b); Timms et al. (2014a,c).
Described in detail in Chapters 2 and 3, the models examined in this dissertation
primarily consider Craving, patient-reported average daily craving levels, and CPD,
the total number of cigarettes smoked per day (as recorded nightly from subjects via
personal digital assistant [PDA]; McCarthy et al., 2008b). Fig. 1.1 depicts Craving
and CPD ILD for two group averages, one that received active bupropion and coun-
seling (“AC” group) and another that received placebo medication and no counseling
(“PNc” group), and for single subject examples from these groups. In Fig. 1.1, the
target quit date (TQD) is day 8. Visual inspection of these data makes the case
for the utility of an engineering modeling method as Craving clearly features inverse
response on average and CPD features dynamics on two di↵erent time scales.
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Figure 1.1: Craving and CPD Signals for the AC Group Average, PNc Group
Average, One Subject from the AC Group, and One Subject from the PNc group;
ILD Collected in the McCarthy et al. (2008b) Study. TQD is Day 8.
Dynamic Mediation Models
Statistical mediation is a central tenant within the social and behavioral sciences.
It describes a multivariate relationship in which an independent variable, X, is said
to exert its influence on an outcome variable, Y , via changes in a mediator variable,
M—which directly a↵ects Y—and a non-mediated path. Statistical mediation is most
commonly characterized using static, structural equation modeling (SEM; MacKin-
non, 2008; Baron and Kenny, 1986). Navarro-Barrientos et al. (2011) illustrates
how path diagrams in SEM correspond to steady-state process models of production-
inventory systems. Drawing from the connection between SEM and fluid analogies
from production-inventory systems (Navarro-Barrientos et al., 2011), a general engi-
neering accounting principle (e.g., conservation of mass) is employed here to describe
behavior change as a mediational process (Timms et al., 2014a). Generally, these
models describe how M responds over time to changes in X, responding according to
some dynamic process represented as Pa; the level of Y responds over time to changes
10
in the independent variable directly according to some dynamic process represented
by Pc0 , as well as through changes in M according to some subprocess represented
by Pb. Altogether, from a dynamical systems perspective, mediation consists of a
parallel cascade process structure (Timms et al., 2014a).
An initial set of dynamic mediation models were estimated that consider initiation
of a quit attempt (represented by Quit, a unit step on TQD) as X, Craving as M ,
and CPD as Y (Timms et al., 2014a). Employing a prediction-error approach (Ljung,
1999), continuous-time transfer functions Pa(s), Pb(s), and Pc0(s) were estimated
for each treatment group average and the two single subjects. The group average
models accounted for up to 87.77% of the variance in the Craving signal, and up to
91.49% of the variance in the CPD signal. The structures and parameters of these
estimated models reflect the major dynamic features observed in each group, such
as the inverse response in Craving, dramatic reduction in CPD on TQD, and slow
and small resumption of smoking after TQD. Comparing the parameter estimates
across the groups suggests both bupropion and counseling a↵ect cessation dynamics.
For example, the parameter estimates indicate the relative degree to which Craving
increases on the TQD before ultimately decreasing is smallest for the AC treatment
condition and greatest for the PNc treatment condition.
A second set of mediation models were estimated using the group average data
in which Quit was the independent variable, CPD the mediator, and Craving the
outcome. These estimated models resulted similarly high goodness-of-fit values. This
suggests that the relationship between Craving and CPD cannot be fully explained
by statistical mediation alone (Timms et al., 2014a).
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Dynamic Self-Regulation Models
The concept of self-regulation has historically been of interest as a potential mech-
anism of behavior change (Carver and Scheier, 1998; Solomon, 1977; Solomon and
Corbit, 1974; Velicer et al., 1992; Walls and Rivera, 2009), although data collection
challenges in the pre-personal computing era made preceise modeling of this psycho-
logical phenomenon di cult (Collins, 2006; Riley et al., 2011). Craving and CPD
ILD a↵ords the opportunity to examine a self-regulatory relationship between these
constructs (Collins, 2006; Rivera, 2012; Timms et al., 2014a,c; Walls and Rivera,
2009). Furthermore, analysis of such a relationship significantly benefits from a con-
trol systems engineering perspective, given this field’s emphasis on understanding and
manipulating closed-loop processes (Ahmed and Koob, 1998; Dong et al., 2012, 2013;
Ogunnaike and Ray, 1994; Timms et al., 2014a,c).
Closed-loop models were developed describing cessation as the process depicted
in Fig. 1.2. In this mechanism, Craving acts as the primary outcome, the level of
which is directly a result of smoking, i.e., the level of CPD. Changes in CPD are the
result of a disturbance path and a feedback path: Quit is the disturbance that acts
as an independent, exogenous influence on CPD ; changes in CPD due to the latter
path result from a psychological or biological self-regulator, which promotes or deters
smoking in order to track a Craving set point (rcrav; Timms et al., 2014a,c). For
each set of group average ILD from the McCarthy et al. (2008b) clinical trial, three
continuous-time ODEs were estimated using a prediction-error approach (Ljung, 1999,
2011; Timms et al., 2014a). The closed-loop identification problem consists of a two
step estimation procedure (as is also required when estimating dynamic mediation
models): one transfer function, P (s), is estimated as part of a single-input single-
output (SISO) problem in which CPD is the input signal and Craving the output;
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Figure 1.2: Block Diagram Describing the Process of Smoking Cessation Behavior
Change as a Self-Regulated System (Timms et al., 2014a,c).
two transfer-functions, Pd(s) and C(s), are simultaneously estimated as part of a
two-input one-output problem where Quit and the di↵erence between Craving and
rcrav are the inputs, respectively, with CPD as the output. The appropriate rcrav
value was empirically determined to be the average pre-TQD Craving level (Timms
et al., 2014a).
As with the mediation models, high goodness-of-fit values were obtained for the
group averages—up to 87.44% fit for Craving and 91.44% for CPD—which are ob-
tained with low-order transfer function structures. Notably, P (s) is adequately rep-
resented with a first order with zero transfer function. Further analysis indicates this
function accounts for sum of two parallel subprocesses; one corresponds to the imme-
diate increase observed in Craving on TQD and the second is an opposing subprocess
that brings Craving down to net lower values as time goes on. The Pd(s) function
captures the drop in CPD on TQD. C(s) was found to be represented by a first order
continuous-time transfer function (Timms et al., 2014a). This suggests that on av-
erage, the self-regulator behaves as a proportional-with-filter controller (Morari and
Zafiriou, 1989; Timms et al., 2014a, 2013).
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1.4.3 Control Systems Engineering for Smoking Interventions
The smoking cessation decision framework detailed in the following involves inten-
sive measurement and intensive adaptation—both primarily on a daily basis. Con-
sequently, this constitutes a highly personalized intervention. Fig. 1.3 visually de-
picts the general location such an intervention takes in the “intervention optimiza-
tion space.” As seen in Fig. 1.3, this type of intervention contrasts a typical nicotine
patch intervention protocol; patch dosage is typically determined by whether a patient
smokes at least 10 or 15 cigarettes per day, and that daily patch dosage is generally
maintained from TQD throughout the duration of the intervention (Tobacco Use
and Dependence Guideline Panel, 2008; Rennard et al., 2014). It should be noted
that each area in this space features various opportunities, advantages, and clinical
challenges.
This dissertation proposes an adaptive smoking intervention algorithm that sys-
tematically determines daily adjustments to treatment components based on known
intervention targets, feedback and feedforward signals, and an understanding of the
cessation process and clinical constraints. Hybrid Model Predictive Control (HMPC)
o↵ers a distinctly appropriate framework for such an intervention:
• Control action is determined by minimizing a quantified optimality criterion
(Camacho and Bordons, 1999; Goodwin et al., 2005; Nandola and Rivera, 2013;
Rossiter, 2003), which is conductive to an optimized personalized intervention
(Nandola and Rivera, 2013; Rivera et al., 2007; Timms et al., 2014d).
• HMPC considers a dynamical system with logical and/or discrete components
and constraints (Bemporad and Morari, 1999). Optimal dosing assignments
can therefore be determined despite the fact that the manipulated variables,
i.e., the treatment components, can only assume pre-determined, discrete levels
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Figure 1.3: Conceptual Depiction of the Intervention Optimization Space, Including
the Approximate Locations of a Typical Nicotine Patch Protocol and the HMPC-
Based Adaptive Intervention Formulated in this Document. The Origin Corresponds
to an Intervention that is Not Personalized to Any Degree, Involves no Formal Mea-
surement, and is Not Varied Over Time.
(Deshpande et al., 2012; Dong et al., 2013; Nandola and Rivera, 2013; Timms
et al., 2014d). This means that an HMPC-based intervention algorithm can
only assign bupropion in 150 mg doses, for example (Lexicomp, 2014; Timms
et al., 2014d; Tobacco Use and Dependence Guideline Panel, 2008).
• Combined feedback and feedforward action means dosage assignment is based
on measurements of a patient’s changing needs (Nandola and Rivera, 2013;
Rivera et al., 2007; Timms et al., 2014d), which is the fundamental motivation
for use of adaptive interventions in behavioral health (Collins et al., 2004).
• The feedback and feedforward features help facilitate e↵ective dosing despite
unmeasured disturbances and potentially significant patient-to-patient variabil-
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ity (i.e., plant-model mismatch; Camacho and Bordons, 1999; Goodwin et al.,
2005; Nandola and Rivera, 2013; Rossiter, 2003). In other words, the abil-
ity to tune for robust performance supports the clinical-relevance of such an
engineering-based intervention.
• The ability to tune an HMPC formulation—particularly one with three-degree-
of-freedom features—can allow a clinician to flexibly balance outcome goals
with dosing demands (Dong et al., 2013; Deshpande et al., 2014; Nandola and
Rivera, 2013).
• The feedback, feedforward, and predictive nature of HMPC (and Model Pre-
dictive Control [MPC] more generally; Camacho and Bordons, 1999; Goodwin
et al., 2005; Nandola and Rivera, 2013; Rossiter, 2003) means dosing decisions
are made with a patient’s past, present, and future needs in mind (Deshpande
et al., 2014; Dong et al., 2013; Nandola and Rivera, 2013; Rivera et al., 2007;
Timms et al., 2014d). Therefore, an intervention of this nature is conducive to
“just-in-time” decision making (Timms et al., 2014d), which means that dosage
adjustments can be assigned in order to avoid future conditions that may lead
to deviations from treatment targets (Intille et al., 2003; Kumar et al., 2013;
Riley et al., 2011).
• HMPC is well-suited for multi-input multi-output (MIMO) systems (Camacho
and Bordons, 1999; Goodwin et al., 2005; Nandola and Rivera, 2013; Rossiter,
2003), which is conducive to systematic adaptation of interventions featuring
multiple treatment components and multiple objectives. This is critical, given
the push for combination therapies (Tobacco Use and Dependence Guideline
Panel, 2008) and the fact that a variety of risk factors are thought to promote
smoking relapse (Cui et al., 2006; Shi↵man, 2005; Timms et al., 2014d; Tobacco
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Use and Dependence Guideline Panel, 2008; Yasin et al., 2012).
• HMPC explicitly considers hard constraints while determining manipulated
variable adjustments (Camacho and Bordons, 1999; Goodwin et al., 2005; Nan-
dola and Rivera, 2013; Rossiter, 2003) implying dosing decisions can adhere
to clinically-necessitated restrictions (e.g., medication toxicity levels) as well
as implementation considerations (e.g., resource limitations determined by a
patient’s health insurance policy).
• Because solutions to the optimization problem within HMPC computations
involve well-established routines (Goodwin et al., 2005; Holmstrom et al., 2009;
The MathWorks, 2014d; Nandola and Rivera, 2013; Rossiter, 2003), calculation
of dosing decisions is computationally tractable and can be implemented within
existing technological infrastructure (potentially even a mobile phone). These
solutions take the form of a quadratic program (QP) or mixed integer quadratic
program (MIQP) (Holmstrom et al., 2009; Nandola and Rivera, 2013).
Altogether, these factors suggest that design of an frequently-adapting smoking cessa-
tion intervention from intensively sampled data can be pursued as a controller design
problem.
Primary Intervention Architecture
The controller design problem presented in this dissertation primarily considers the
structure depicted in Fig. 1.4. The controlled variables are CPD and Craving, con-
sidered to be self-reported via a smart phone application. The target levels of both
outcomes are 0 as of TQD. Consequently, CPD and Craving act as feedback signals,
while Quit and Stress (average daily patient-reported stress level) are feedforward
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Figure 1.4: Block Diagram of the General Decision Framework for an Adaptive,
Smoking Cessation Intervention that Employs an HMPC Algorithmic Structure to
Determine Daily Dosages of Counseling (uc), Bupropion (ub), and Nicotine Lozenges
(ul). CPD and Craving are Controlled Variables, Quit and Stress are Measured and
Anticipated Disturbance Variables, and dum Represents an Unmeasured Disturbance.
signals that are measured and anticipated. The intervention algorithm assigns daily
dosages of counseling, bupropion, and nicotine lozenges.
As described in Chapter 3, the intervention formulation involves the following.
The nominal models that act as the basis for the controller reflect the open-loop
dynamics for a representative yet hypothetical patient who unable to quit smok-
ing on their own. The open-loop CPD and Craving responses to initiation of a
quit attempt are patterned after dynamic self-regulation models estimated for the
previously-alluded-to subject from the PNc group in the McCarthy et al. (2008b)
study. These models reflect the fact that the Quit disturbance initially moves CPD
toward the intervention goal and simultaneously moves Craving further from its tar-
get, as depicted with the dotted red data in Fig. 1.1. These signals reflect an intuitive
CPD-Craving interrelationship. The patient is initially able to reduce smoking just
after the quit attempt, but doing so corresponds to an increase in Craving. However,
this patient is unable to sustain the initial abstinence, with CPD gradually increasing
to approximately pre-TQD levels as Craving simultaneously settles to pre-TQD levels
(Timms et al., 2014a). The open-loop dose-response and Stress-response models are
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informed by data, literature, and simulation.
As the manipulated variables can only be assigned in pre-determined, discrete-
valued levels, the behavior change dynamical process and constraints are represented
as a mixed logical dynamical structure (Bemporad and Morari, 1999; Nandola and
Rivera, 2013). Continuous and discrete auxiliary variables translate the descrete
dosage levels into linear inequality constraints (Bemporad and Morari, 1999), enforc-
ing that counseling can only be assigned as 0 or 1 sessions per day, bupropion as 0, 1,
or 2 150 mg doses per day (Lexicomp, 2014; Tobacco Use and Dependence Guideline
Panel, 2008), and integer values between 0 and 20 lozenges per day (Rennard et al.,
2014). Daily decision-making is done in the context of a number of constraints in
order to adhere to clinical requirements and practical considerations. For example,
a bupropion move size constraint is defined to allow only unit increases in bupro-
pion dosage at a time, reflective of the on-label use of bupropion and current clinical
recommendations (Lexicomp, 2014; Tobacco Use and Dependence Guideline Panel,
2008).
As TQD is typically pre-determined (Tobacco Use and Dependence Guideline
Panel, 2008; Lexicomp, 2014), the set points changes and Quit disturbance are an-
ticipated during each decision point. With a multi-week prediction horizon, these
changes are anticipated from the first decision period. Stress is also anticipated in
this formulation, where Stress is assumed to take on the most recent measured value
for the duration of the prediction horizon. Here, Stress is represented as an stochastic,
auto-correlated signal (DeLongis et al., 1988; Shi↵man and Waters, 2004).
As a simple illustration of the detailed analyses in Chapter 4, Fig. 1.5 depicts
the disturbance signals, dosing decisions as determined by the controller, and the
corresponding CPD and Craving responses (predicted through simulation) when the
patient receiving the intervention is that around whom the intervention was designed
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Figure 1.5: Craving and CPD Responses to Quit and the Corresponding Set Point
Changes (Solid Black), the Stochastic Stress Disturbance (Dashed Red), and the
Depicted Counseling (Magenta), Bupropion (Green), and Lozenge (Brown) Dosing,
which is Determined by the HMPC-Based Intervention. (The Objective Function
Penalty Weight for the CPD Target Equals 10, and that for the Craving Target
Equals 1.)
(i.e., negligible to no plant-model mismatch). This scenario considers two weeks pre-
TQD (i.e., TQD is day 15) through the first five weeks of the quit attempt. Here, the
controller employs an 8 day move horizon and a 30 day prediction horizon, and the
objective function penalty weight for CPD target tracking is an order of magnitude
larger than that for the Craving target.
Fig. 1.5 indicates that under these conditions, both intervention targets are ul-
timately tracked to a successful degree. Dosing is initially more hesitant than most
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current treatment protocols, with minimal dosing around TQD. This reflects the fact
that the patient is briefly able to abstain to a relatively successful degree on their
own. The aggressive bupropion and lozenge dosing implemented within the first week
of the quit attempt serves to suppress the full relapse that would otherwise occur,
and to bring down Craving to approximately target levels within 10 days of TQD.
Visual inspection of Fig. 1.5 indicates that the lozenge treatment, which has an im-
mediate e↵ect, as does Stress (both sets of open-loop transfer function models are
semi-proper), has high variance after day 20 in order to reject the stochastic Stress
disturbance. Overall, some lapses may occur, but the quit attempt remains relatively
successful: less than 15 cigarettes are smoked in the five weeks after TQD, nearly
three of those weeks are smoke-free (non-consecutively), and the maximum lapse is
less than three cigarettes.
Fig. 1.5 corresponds to a relatively straightforward formulation and a minimally-
tuned scenario. Chapter 3 incorporates and evaluates the e↵ect of additional com-
plexity to enhance the formulation in a clinically-meaningful manner. For example,
the objective function penalizes o↵set for a third set point in order mitigate overly-
aggressive dosing demands. Three-degree-of-freedom tuning functionality is also inte-
grated into the HMPC architecture which facilitates more intuitive tuning. Analysis
of nominal performance of the intervention for various tuning scenarios first demon-
strates the flexibility of this treatment strategy for obtaining dosing that promotes
smoking abstinence and feature various treatment schedule characteristics; as will be
shown, the inter-related nature of Craving and CPD supports relatively good and
consistent abstinence outcomes even with significant detuning meant to influence the
trade o↵ between daily dosing peaks and treatment adjustment intensity. Robust per-
formance is also evaluated when CPD and Craving feature measurement noise and
plant-model mismatch in the form of both parametric uncertainty and non-parametric
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uncertainty in which the patient receiving the intervention is modeled after a subject
in the McCarthy et al. (2008b) study who is not the nominal patient.
1.5 Contributions of This Research
This dissertation documents two closely-related areas of research: (1) use of dy-
namical systems modeling and system identification techniques to better understand
behavior change during smoking cessation; (2) development and evaluation of an
HMPC-based decision system for an optimized, adaptive smoking intervention. Some
of the model development and identification research entails the following.
• Development of dynamical systems representations of psychological theories.
Dynamical systems models describing hypothesized mechanisms of change that
are prominent within social science, behavioral science, and substance use literature—
statistical mediation and self-regulation—are developed that can o↵er novel in-
sight into these hypothesized mechanisms.
• An illustration of what linear, continuous-time dynamical systems models and
system identification methods can o↵er in terms of better understanding health
behaviors, particularly tobacco-use behaviors.
• Application of an engineering approach to describe statistical mediation as a
time-varying process of behavior change, which can be examined in the context
of a traditional, cross-sectional behavioral science experiment. Secondary anal-
ysis of clinical trial data (McCarthy et al., 2008b) is used in a case study of
dynamic mediation modeling.
• The use of a control systems engineering perspective to understand the role
of self-regulation within day-to-day changes in smoking and craving levels dur-
ing an attempt to quit smoking. In secondary analysis of the McCarthy et al.
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(2008b) study, a closed-loop identification problem is pursued, resulting in es-
timated models that benefit from a PID-control interpretation.
• Brief demonstration of how these engineering modeling techniques can be used
to provide insight into the manner in which mediated and self-regulatory be-
havior change is a↵ected by treatment conditions (through nomothetic model
estimation), as well as to provide insight into intra-individual e↵ects (through
idiographic model estimation).
The intervention-design aspect of this research consists of a controller design prob-
lem that acts as a proof-of-concept for the potential clinical utility of an engineering-
based adaptive smoking intervention. The nature of the smoking cessation problem
necessitates an engineering-based treatment strategy with a unique combination of
demands and features compared to similar controller design e↵orts in alternate behav-
ioral health interventions. For example, the cessation intervention revolves around a
central event—initiation of the quit attempt. The TQD can be anticipated weeks in
advance, and the quit attempt acts as a measured and anticipated step disturbance
which directly corresponds to step changes in the intervention targets. This distur-
bance initially moves CPD toward its target, and the CPD target distinctly switches
from smoking “on” to smoking fully “o↵.” Because of such considerations, major
components of this research include the following.
• A set of requirements for an HMPC-based smoking intervention is determined
such that the intervention proposed here closely matches clinical reality, while
managing pragmatic challenges associated with clinical implementation.
• A clinically-relevant adaptive intervention architecture (e.g., Fig. 1.4) is pro-
posed that employs a control systems paradigm to determine day-to-day adjust-
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ments to treatment component dosages in order to optimally meet the changing
needs of a patient.
• An intervention algorithm is formulated employing an HMPC structure. This
formulation translates the requirements of an intensive adaptive cessation inter-
vention (alluded to previously) into a state-space representation of the system
that adheres to a mixed logical dynamical framework, linear inequality con-
straints, and an objective function. Computation of control action takes the
form of a MIQP (Holmstrom et al., 2009; Nandola and Rivera, 2013).
• The closed-loop intervention is evaluated through simulation. A tuning strat-
egy is developed by analyzing the nominal and robust performance of the inter-
vention algorithm in both the absence and presence of three-degree-of-freedom
(3DoF) tuning capabilities. Ultimately, the case is made for the potential clin-
ical utility of this intervention approach, which features significant flexibility
in order to obtain various clinically-meaningful dosing demands and controlled
variable performance.
Details on future e↵orts that could move this approach toward clinical implemen-
tation are also provided, and the overall findings from this research are summarized.
1.6 Outline
This chapter provided an introduction to the problem setting and motivation for
this research. The approach, methods, and findings presented in detail in the following
chapters were also briefly outlined.
Chapter 2 further motivates and generally describes the utility of dynamical sys-
tems modeling and system identification methods for understanding health behaviors.
The nature of ILD and its role in understanding smoking behavior change are out-
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lined. Details on a continuous-time system identification approach for estimating and
interpreting mediation and self-regulation models are presented; estimation draws
from ILD collected nightly in the McCarthy et al. (2008b) study. This model de-
velopment e↵ort is presented here largely through incorporation of the Timms et al.
(2014a) manuscript, which cohesively summarizes the modeling and estimation meth-
ods and findings. Extensions of the concepts and opportunities presented in Timms
et al. (2014a) are also provided, including an illustration of opportunities for ex-
ploring therapeutic mechanisms through simulation and investigation of the role of
self-regulation on a within-day level.
Chapter 3 formulates the HMPC-based intervention. First, connections between
the clinical demands of a cessation intervention and control systems engineering ideas
are established. Details on the nominal patient models, hybrid linear models of the
overall system, control action computations, and the 3DoF structure are presented.
Chapter 4 evaluates the performance of the proposed HMPC-based intervention
through diverse simulations. Nominal performance is first considered. For this, the
e↵ects of adjusting the objective function penalty weights and 3DoF tuning parame-
ters on the character of dosing demands and post-TQD Craving and CPD responses
are evaluated. Robust performance is then considered when noise and plant-model
mismatch in the form of parametric uncertainty and alternate patient models from
the McCarthy et al. (2008b) study are introduced.
Chapter 5 summarizes summarizes the contribution and overall findings of this
research.
1.6.1 Publications
Much of the material presented in this dissertation has also been incorporated
into a series of publications. The following primarily describe modeling aspects of
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this research:
• K.P. Timms, D.E. Rivera, L.M. Collins, and M.E. Piper, “System identification
modeling of a smoking cessation intervention”, Proceedings of the 16th IFAC
Symposium on System Identification pp. 786-791 (2012).
• K.P. Timms, D.E. Rivera, L.M. Collins, and M.E. Piper, “Control systems
engineering for understanding and optimizing smoking cessation interventions”,
Proceedings of the 2013 American Control Conference pp. 1967-1972 (2013).
• K.P. Timms, D.E. Rivera, L.M. Collins, and M.E. Piper, “Continuous-time
system identification of a smoking cessation intervention”, International Journal
of Control 87, 7, 1423-1437 (2014).
• K.P. Timms, D.E. Rivera, L.M. Collins, and M.E. Piper, “A dynamical sys-
tems approach to understanding self-regulation in smoking cessation behavior
change”, Nicotine and Tobacco Research 16, Suppl. 2, S159-S168 (2014).
• K.P. Timms, C.A. Mart´ın, D.E. Rivera, E.B. Hekler, and W. Riley, “Leveraging
intensive longitudinal data to better understand health behaviors”, Proceedings
of the 36th Annual IEEE EMBS Conference pp. 6888-6891 (2014).
• K.P. Timms, D.E. Rivera, L.M. Collins, and M.E. Piper, “Dynamic modeling
and system identification of mediated behavior change with a smoking cessation
case study”, Multivariate Behavioral Research (Submitted).
An early version of the HMPC-based controller is briefly developed and evaluated in:
• K.P. Timms, D.E. Rivera, M.E. Piper, and L.M. Collins, “A Hybrid Model
Predictive Control strategy for optimizing a smoking cessation intervention”,
Proceedings of the 2014 American Control Conference pp. 2389-2394 (2014).
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Most of the analyses in Chapter 4 have not yet been incorporated into manuscript
form; anticipated publication venues for this work include Control Engineering Prac-
tice and the Journal of Consulting and Clinical Psychology.
27
Chapter 2
DYNAMICAL SYSTEMS MODELING FOR BETTER UNDERSTANDING
TIME-VARYING HEALTH BEHAVIORS
2.1 Overview
Historically, the study of dynamic behavior relied on experiments in tightly-
controlled laboratory environments, epidemiological correlation analyses, and ran-
domized, cross-sectional (e.g., factorial), placebo-controlled clinical trials (Hekler
et al., 2013a; Shadish et al., 2002). The prominence of these experimental approaches
was due in part to challenges with cost-e↵ective data collection in non-controlled set-
tings and frequently over time. Relatedly, methodological and analytical e↵orts fo-
cused on research questions that could be answered with relatively few, non-repeating
observations (Walls and Schafer, 2006).
The personal computing era has led to a rapid rise in the availability of intensive
longitudinal data (ILD; Collins, 2006; Riley et al., 2011; Walls and Schafer, 2006).
The increased ability to collect data sets with such intensive measurements has largely
outpaced development of analytical methods optimally suited to characterize the ex-
tensive phenomena captured within these data (Walls and Schafer, 2006). The inten-
sive nature of these data o↵er an opportunity for introduction engineering modeling
methods into social and behavioral science research settings. This chapter illustrates
how valuable insight into the dynamic nature of health behaviors can be elucidated
using dynamical systems modeling and system identification methods, which are com-
monly used within engineering settings to model dynamic processes.
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2.2 ILD: Collection & Data Types
The term intensive longitudinal data is used to describe data sets where observa-
tions are “recorded at more than a handful of time points,” up to continuous-time
measurement of events. The nature of these intensive measurements can vary widely:
ILD may be quantitative or qualitative in nature, measured at consistent or irregular
intervals, involve fixed or random measurement, and more. Simple examples of ILD
include number of steps per day as recorded by a pedometer and surveys of emotional
states completed by individuals within a single day (Walls and Schafer, 2006)
Generally, ILD o↵ers an opportunity to study dynamic behavioral phenomena
(Collins, 2006; Walls and Schafer, 2006). In doing so, one of the greatest opportuni-
ties a↵orded by ILD is the study of intra-individual variability (Collins, 2006; Mole-
naar, 2004). This is generally a departure from traditional behavioral science analy-
ses, which has historically examined cross-sectional intervention data sets primarily
(Collins, 2006). More generally, ILD facilitates a time-varying analytical perspective
when comparing groups. For example, Timms et al. (2014c) develops separate models
of a single dynamic process as it is observed in two di↵erent treatment groups. Also,
ILD have largely facilitated the rise of a research paradigm focusing on single subjects
(Molenaar and Campbell, 2009; Molenaar, 2004). Altogether, the rise in the use and
availability of ILD has opened up a number of opportunities for more comprehensive
modeling and understanding of health behaviors.
Ecological momentary assessment (EMA) encompasses a range of experimen-
tal approaches in which ILD is collected in the context of an individual’s natural
environment—i.e., not a laboratory or clinical environment (Shi↵man et al., 2008).
For example, patient self-reports of withdrawal symptoms as collected via a smart-
phone application from subjects trying to quit smoking constitute EMA (McCarthy
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et al., 2008b, 2006; Shi↵man et al., 2008). EMA now plays a larger role in the study of
behavior due in part to the recent rise in advanced mobile and wearable technologies
(Hekler et al., 2013b). Furthermore, the appeal of ecological momentary interventions
with “just-in-time” decision-making motivates greater focus on EMA: measurement
of behaviors and related constructs in a patient’s natural environment can directly
inform adaptation of an intervention such that it can most e↵ectively address a pa-
tient’s ecological and situational circumstances at that moment (Heron and Smyth,
2010).
2.3 Dynamic Modeling & System Identification for Studying Health Behaviors
2.3.1 Overview
The rate at which methods for modeling ILD have been developed has lagged
behind the rate at which such data has become available (Walls and Schafer, 2006).
In a departure from a long tradition of static modeling methods frequently employed
by quantitative psychologists (e.g., structural equation modeling; Bollen, 1989), at-
tention is increasingly given to development of modeling methods that extract the
additional information captured in ILD. Many of which are based in systems science
ideas, some of these emerging approaches are described in Boker (2012), Boker and
Nesselroade (2002), Ginexi et al. (2014), Riley et al. (2011), Rivera (2012), Tan et al.
(2012), Trail et al. (2014), and Timms et al. (2014a).
Dynamical systems modeling and system identification methods from engineering
o↵er a means to more comprehensively characterize the behavioral dynamics at play
during an attempt to quit smoking (Timms et al., 2014a,c). In fact, the maturity
and flexibility of these principles—and ultimately their connection to the design of
closed-loop interventions—has resulted in their recent use in answering important
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questions outside of traditional engineering settings. Examples include modeling dy-
namic cellular processes (Ahn et al., 2006), the e↵ects of rainfall (Garnier and Young,
2014), supply chains (Schwartz and Rivera, 2010), climate change (McGu e and
Henderson-Sellers, 2005), economics (Franksen, 1969), and crowd control (Schwager,
2008).
Incorporating engineering ideas and perspectives into the study of psychological
phenomena is not limited to recent work (Carver and Scheier, 1998; Hyland, 1987;
Molenaar, 1987). For example, McCleary and Hay (1980) and McDowall et al. (1980)
describe how time-series models can represent dynamic phenomena observed in data
from an “interrupted time series;” an interrupted time series consists of sampled
data from before and after introduction of an intervention or stimuli that has in-
duced a change in the dependent variable; this type of study is considered to be a
“quasi-experiment” in behavioral science settings (Shadish et al., 2002). Specifically,
McCleary and Hay (1980) discusses an “ARX with intervention” model in which an
intervention is represented as an exogenous input; if the coe cient(s) for these inter-
vention terms are statistically significant, the case is made for the causal e↵ect of the
intervention on the dependent variable dynamics. A more recent e↵ort documented
in Khuder et al. (2007) employs an ARX with intervention model to characterize how
a clean air ordinance in Bowling Green, Ohio, a↵ected local rates of coronary heart
disease.
2.3.2 Dynamical Systems Modeling
Dynamical systems models mathematically represent processes of change. Specif-
ically, they represent how an output variable in a system (y) responds over time to
changes in an input variable (u) or a disturbance variable (d); u is typically known
and controlled, while d can be a measured or unmeasured exogenous factor (Ljung,
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1999; Ogunnaike and Ray, 1994). In behavioral science contexts, u correspond to
independent or predictor variables and y are dependent variables that correspond to
outcomes of interest (Timms et al., 2014c).
Dynamical systems modeling encompasses a broad array mathematical represen-
tations; these expressions may be continuous or discrete, lumped or distributed pa-
rameter, deterministic or stochastic, linear or nonlinear, and so on (Ljung, 1999). The
di↵erent general characteristics of the models determine the form of these mathemati-
cal functions. For example, lumped parameter representations “lump” all process dy-
namics into a single variable, t, and are represented by ordinary di↵erential equations
(ODEs). Distributed parameter models account for spatial and temporal dynamics
separately and are represented by partial di↵erential equations (Ogunnaike and Ray,
1994). Continuous-time models are written in the time or frequency domains; mod-
els of the latter case are often dealt with in transfer function form. Alternatively,
discrete-time models often take the form of transfer functions in the z domain, as ob-
tained via the Z-transform, i.e., the discrete-time equivalent of the Laplace-transform;
these models are also frequently written in the time-domain as a sampled, di↵erence
equation in which the output at time k, y(k), is written as a function of y at previous
time instances (y(k   1), ..., y(k   ny)), and of the value of the input at current or
previous time instances (u(k), ..., u(k   nu); Franklin et al., 1998; Ljung, 1999).
The general approach to modeling can also vary. Black-box models represent
input-output dynamics in a way that is agnostic of the exact mechanisms by which
changes in input variables lead to changes in output variables. Models derived from
first principles describe processes according to the physical laws in which the process
is based. Of these two approaches, the former is a purely data-driven approach, while
the latter is theory-driven (Ljung and Glad, 1994).
Frequently, dynamic models fall within the extreme bounds of fully black-box or
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first principles. A common starting point for dynamic model development relies on a
general accounting principle:
Accumulation = In Out (2.1)
In physical systems such as unit operations in engineering settings, equation 2.1 gener-
ally corresponds to conservation of mass and energy equations (Felder and Rousseau,
2004; Ljung, 1999; Ogunnaike and Ray, 1994). However, this general principle has also
guided model development in settings related to supply chain management (Schwartz
and Rivera, 2010; Nandola and Rivera, 2013), pain management (Deshpande et al.,
2014; dos Santos et al., 2013), physiology (Dong et al., 2013; Hall et al., 2012; Hekler
et al., 2013a), economics (Franksen, 1969), climate change (McGu e and Henderson-
Sellers, 2005), social science (Ionides et al., 2006), crowd control (Schwager, 2008)
and more.
Ultimately, choice of the model form and modeling approach are determined by
the needs of the modeler. This decision frequently depends on data availability,
tractability of model estimation and management, and the planned end use of the
model. From a control systems engineering perspective, the modeling task should
identify the simplest model of the process that is “good enough” to inform e↵ective
control action (Rossiter, 2003).
2.3.3 Dynamic Models for a Smoking Cessation Intervention
This dissertation primarily models the cessation process using ILD from the Mc-
Carthy et al. (2008b) clinical trial. This was briefly introduced in Chapter 1 and
is further described in this chapter. More specifically, ILD was collected through
EMA using personal digital assistants, in which participants self-reported withdrawal
symptoms, cravings, and a↵ect variables on 10-point Likert scales: 1-11, No!! ... Yes!!
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(McCarthy et al., 2008b). Intuitively, self-reported data is often noisy and subject to
potential data quality issues, such as recall bias or cognitive and situational influences
(Raphael, 1987; Brener et al., 2003). A natural question is therefore whether self-
reported data is appropriate for studying cessation dynamics and intervention e↵ects.
Although details on the field of psychometrics is outside the scope of this dissertation
(see Rust and Golmbok, 1999 and Urbina, 2011), analysis of self-reported data in this
work is motivated by the following: self-reports have been shown to be informative
and representative of actual psychological and physiological processes (Brener et al.,
2003; Patrick et al., 1994). Haley et al. (1983), for example, demonstrated that self-
reported smoking behavior strongly correlated with biochemical markers of smoking
activity. Furthermore, the surveys in the McCarthy et al. (2008b) study drew from the
Wisconsin Smoking Withdrawal Scale (WSWS; Welsch et al., 1999) and the Positive
and Negative A↵ect Schedule (PANAS; Watson et al., 1988; Watson and Clark, 1999).
These are well-established measures that have been rigorously evaluated for their rel-
evance in assessing withdrawal and emotional constructs. Castro et al. (2011), for
example, examines the predictive ability of the WSWS. Similarly, Watson and Clark
(1999) details the construct validity (whether the survey appropriately measures the
psychological factors it claims to measure) and external validity (generalizability of
the data collected with this measure) of the PANAS (Shadish et al., 2002; Watson
and Clark, 1999). These considerations suggest models estimated from self-reported
behaviors and related constructs can describe psychological phenomena.
Furthermore, more objective metrics of smoking activity are not necessarily the
most appropriate variables to consider in this work. Notably, biochemical measure-
ments of nicotine metabolites are poor indicators of smoking activity if the patient
is being treated with nicotine-based therapies. As five of the seven first-line tobacco
dependence pharmacotherapies involve low dose nicotine delivery (Tobacco Use and
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Dependence Guideline Panel, 2008; Rennard et al., 2014), serum nicotine level or sim-
ilar indicators are impractical behavioral metrics. Similarly, carbon monoxide levels
in expired air varies significantly over time and can be a function of environmental
circumstances unrelated to cigarette smoking (Fortmann et al., 1984), and is similarly
an impractical measurement of cessation-induced behavioral dynamics.
Estimating dynamic models with self-reported CPD, Craving, and Stress levels
is further motivated by the intervention design component of this work. A smoker
smokes based on an implicit or explicitly-acknowledged desire to do so. Therefore,
estimating dynamic models estimated using self-reported data on this level is more
in line with the “simplest useful model” aspect of designing a predictive controller
(Rossiter, 2003). In other words, modeling smoking behavior change with a first-
principles approach is suboptimal, given that these behaviors are the result of a
confluence of biochemical, physiological, learned habitual factors, and more.
2.3.4 System Identification
System identification encompasses a set of principles and techniques to obtain
estimated dynamical systems models that are useful in many end-use applications. A
formal system identification procedure involves four components:
1. Design and implementation of an experiment to study a dynamic system of
interest under various operating conditions. The result should be an informative
data set conducive to estimation of high-fidelity dynamical systems models.
2. Data pre-processing to remove drifts and trends, address high-frequency distur-
bances above the frequency of interest, and deal with anomalies and missing
data. The resulting data set then informs model structure selection.
3. Parameter estimation for a user-defined equation structure.
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Figure 2.1: Flow Chart of the Iterative System Identification Process (Ljung, 1999).
4. Model validation. This can be broad-based (e.g., white residuals) or focused on
a particular model end-use (e.g., control-relevant identification).
These steps should actually be components of an iterative procedure, as depicted in
the flow chart in Fig. 2.1 (Ljung, 1999).
Detailed later in this chapter, Model estimation in this dissertation primarily
involves secondary data analysis of ILD collected in the McCarthy et al. (2008b)
clinical trial, as will be detailed later in this chapter. Consequently, this work relies
most heavily on the parameter estimation aspects of system identification. More
specifically, a prediction-error estimation approach is primarily employed to estimate
continuous-time models from sampled data. The remainder of this subsection provides
details on this approach.
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Estimating Continuous-Time Models with Prediction-Error Methods
Continuous-time dynamic models o↵er a number of distinct advantages generally
(Garnier et al., 2008b; Garnier and Young, 2014) and in this behavioral science con-
text specifically (Timms et al., 2014a). This work primarily estimates continuous-time
transfer functions with a two-step indirect approach: first, a discrete-time model
is estimated from sampled data; next, the discrete-time model is transformed into
continuous-time form. Indirect continuous-time identification benefits from the reli-
ability and statistical e ciency of discrete-time model estimation methods (Garnier
et al., 2008b). Direct continuous-time model identification techniques are detailed
in Garnier et al. (2008b) and Young et al. (2008), but lie outside the scope of this
dissertation. The general estimation method is described in the following.
Consider an AutoRegressive with eXternal input (ARX) discrete-time model of
the general form:
A(q 1,✓)y(t) = B(q 1,✓)u(t) + e(t) (2.2)
where t represents a specific instance in time (a sample) and q 1 is the time-domain
backshift operator, i.e., q 1u(t) = u(t 1). A(q 1,✓) is the autoregressive polynomial
of order na and B(q 1,✓) is the external input polynomial of order nb:
A(q 1,✓) = 1 + a1q 1 + a2q 2 + · · ·+ anaq na (2.3)
B(q 1,✓) = b1q 1 + b2q 2 + · · ·+ bnbq nb (2.4)
Equation 2.2 can be rewritten as,
y(t) = 'T (t)✓ + e(t) (2.5)
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where the regressor and vector of parameters are, respectively,
'(t) = [ y(t  1) . . .   y(t  na) u(t  1) . . . u(t  nb)]T (2.6)
✓ = [a1 . . . ana b1 . . . bnb ]
T (2.7)
A classical least squares regression problem would analytically estimate ✓ according
to the expression in equation 2.8:
✓ˆLS =
 
1
N
NX
t=1
'(t)'T (t)
! 1
1
N
NX
t=1
'(t)y(t) (2.8)
However, ✓ˆLS may be inconsistently estimated when the elements in '(t) are mea-
surements that are contaminated by noise—when e(t) in equation 2.5 is not white
noise—as is the typical case (Garnier et al., 2008b). To manage this, the least squares
approach is modified according to instrumental variables methods (where the normal
equations associated with the least squares estimate are altered) or prediction error
methods (PEM; Ljung, 1999). The latter set of methods are employed in this work.
Generally, PEM seeks to model the noise in the measured samples as well. In other
words, the model outputs are considered to be stochastic, as opposed to deterministic
(Ljung, 1999). PEM encompasses a family of estimation approaches that generally
seek to estimate ✓ˆ by minimizing a weighted norm of the prediction error:
✓ˆ = argmin
✓
VN(✓) (2.9)
where VN is a cost function that is a scalar value (Garnier et al., 2008b; Ljung, 1999;
The MathWorks, 2014e):
VN(✓) =
1
N
NX
t=1
`(L(q 1)"(t,✓)) (2.10)
" is the vector of prediction errors. Specifically, " is the di↵erence between the ob-
served data, y(t), and the model predictions, yˆ(t|t  1,✓) at each sample, t:
"(t,✓) = y(t)  yˆ(t|t  1,✓), t = 1, . . . , N (2.11)
38
`(·) in equation 2.10 denotes a scalar-valued function that measures the size or norm
of the expression it encloses (Garnier et al., 2008b; Ljung, 1999); L(q 1) is a linear
filter that can weigh certain properties of the model (e.g., filter out high-frequency
disturbance e↵ects; Ljung, 1999).
With the task in equation 2.9 in mind, consider the general model structure:
y(t) = G(q 1,✓)u(t) +H(q 1,✓)e(t) (2.12)
where G(q 1,✓) is the u to y transfer function and H(q 1,✓) is the e to y transfer
function. Equating e(t) and "(t) and substituting e(t) into equation 2.23 gives:
y(t) = G(q 1,✓)u(t) +H(q 1,✓)(y(t)  yˆ(t|t  1,✓)) (2.13)
Solving for yˆ(t|t  1,✓) and rearranging gives the optimal mean square predictor:
yˆ(t|t  1,✓) = H 1(q 1,✓)G(q 1,✓)u(t) + (I  H 1(q 1,✓))y(t) (2.14)
If equation 2.14 is a linear function with respect to the unknown parameters, and
equation 2.10 consists of a relatively simple cost function, a closed form solution can
be obtained. For example, when equation 2.14 can be written as,
yˆ(t|t  1,✓) = 'T (t)✓ (2.15)
and VN is quadratic,
VN(✓) =
1
N
NX
t=1
"2(t,✓) =
1
N
NX
t=1
(y(t) 'T (t)✓)2 (2.16)
estimation of ✓ˆ can follow computations from classical regression procedures, notably,
equation 2.8 (Garnier et al., 2008b; Ljung, 1999). For more complex cost functions or
when nonlinearities are present in equation 2.14, estimation of ✓ˆ relies on a numerical
search algorithm (Ljung, 1999). Common numerical search algorithms include sub-
space Gauss-Newton approach, Levenberg-Marquart method, and steepest-descent
gradient method (Ljung, 1999; The MathWorks, 2014f).
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2.4 Understanding Statistical Mediation & Self-Regulation Within Smoking
Behavior Change
The remainder of this section is a copy of the Timms et al. (2014a) publication.
This manuscript details development of behavior change models of statistical medi-
ation and self-regulation in a dynamical systems sense. (Note, Timms et al. (2014a)
refers to the CPD signal as Cigsmked.) Timms et al. (2014c) and Timms et al.
(2014b) o↵er a more tutorial explanation of the mediation and self-regulation model-
ing methodology. Extensions of the modeling ideas described in Timms et al. (2014a),
Timms et al. (2014b), and Timms et al. (2014c) are documented in Section 2.5.
2.4.1 Continuous-Time System Identification of a Smoking Cessation Intervention
Cigarette smoking is a major global public health issue. Approximately 10 mil-
lion annual global deaths are expected to result from smoking by 2020 (Fish and
Bartholomew, 2007), and the global smoking population is expected to surpass 1.7
billion by 2025 (Erhardt, 2009). In the U.S., cigarette smoking is the leading cause
of premature death and $157B in economic loss is attributed to tobacco use annually
(Centers for Disease Control and Prevention, 2010; Killeen, 2011). 40 years of de-
creases in smoking rates have recently stalled in the U.S., where one in five adults is
an active smoker (Centers for Disease Control and Prevention, 2012). This smoking
rate persists despite the fact that nearly 70% of smokers have expressed a desire to
quit (Center for Disease Control and Prevention, 2011). Largely due to the chronic,
relapsing nature of cigarette smoking (Tobacco Use and Dependence Guideline Panel,
2008), over 88% of attempts to quit smoking fail (American Cancer Society, 2012).
Interventions play an important role in smoking prevention and cessation. Gener-
ally speaking, interventions for behavioral health disorders seek to reduce unhealthy
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behaviors and promote healthy ones through prevention or treatment, and are used to
address many public health concerns in addition to smoking such as other substance
abuse, obesity, sexually transmitted infections, and cancer screening, and can be phar-
macological or behavioral in nature (Collins, 2012; Baker et al., 2011). Traditionally,
these interventions are “fixed,” meaning they are not systematically operationalized,
and the composition and dosage of an intervention component is given to all indi-
viduals receiving the intervention and do not vary over time (Collins et al., 2004).
The e↵ectiveness of existing fixed smoking cessation interventions is limited. Coun-
seling alone, for example, has a reported success rate below 15% (Tobacco Use and
Dependence Guideline Panel, 2008; Fish and Bartholomew, 2007). Pharmacological
interventions (e.g., nicotine replacement therapies such as Nicorette R ) have individ-
ual one-year abstinence rates below 35% (Fish and Bartholomew, 2007), which may
be lower at longer term follow-up (Irvin and Brandon, 2000; Irvin et al., 2003). Such
low success rates are particularly troubling given the gravity of cigarette smoking as
a public health issue.
To address the limitations of fixed interventions, recent e↵orts in behavioral health
have centered around development of so-called “adaptive” interventions, where treat-
ment components and dosage vary according to participant response (Collins et al.,
2004). These interventions consist of closed-loop dynamical systems and may be more
e↵ective behavioral health interventions as they essentially seek to optimally adapt
to the changing needs of a patient (Rivera et al., 2007; Nandola and Rivera, 2013).
Control systems engineering principles o↵er an appealing framework for developing
algorithms that implement these optimized, time-varying smoking cessation interven-
tions. However, the impact of using control engineering concepts in the design of
time-varying smoking cessation interventions is tied to the reliability of the smoking
behavior change models upon which the algorithms are based (Nandola and Rivera,
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2013; Rivera, 2012; Riley et al., 2011).
The development of reliable models has been greatly enhanced by increased ac-
cess to intensive longitudinal data (ILD). ILD in behavioral settings is loosely defined
as quantitative or qualitative measurements recorded frequently over time, and is
more readily available due to increasing use of mobile and computerized technologies
in behavioral trials (Walls and Schafer, 2006). ILD facilitates the dynamic model-
ing of behavior, and generally provides a means for improved analysis of inter- and
intra-individual variability (Collins, 2006). In the context of cigarette smoking, ILD
o↵ers an opportunity to study the dynamics of smoking behavior change (e.g., daily
smoking rate, average craving level) during a quit attempt. Whereas traditional
quantitative modeling methodologies from behavioral science (e.g., structural equa-
tion models, SEMs) are static in nature (Bollen, 1989), dynamical systems modeling
and system identification o↵er a framework for more comprehensive characterization
of dynamic behavioral relationships and how smoking cessation interventions a↵ect
these dynamics (Timms et al., 2012). Recently, similar models have been used for
improved evaluation of gestational weight gain and fibromyalgia interventions; these
models also o↵er an appealing basis for development of optimized, time-varying in-
terventions that draw from control systems engineering principles (Dong et al., 2013;
Nandola and Rivera, 2013; Rivera, 2012; Deshpande et al., 2011). In terms of smoking
cessation, an intervention based in controller design methods could feature feedback
in order to systematically assign medication dosages based on patient reports of with-
drawal symptoms, for example (Timms et al., 2013). Given the gravity of cigarette
smoking as a public health issue and the modest e↵ectiveness of even the most e -
cacious treatments available, an improved ability to inform and evaluate behavioral
health interventions warrants development of dynamic models of smoking cessation.
In this article, smoking cessation is described as a process of behavior change, and
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this process is represented via continuous-time models. A continuous-time approach is
particularly appealing in behavioral health settings (Timms et al., 2012; Rivera, 2012).
Notably, for low order dynamics (which appears to be the case for many dynamic be-
haviors; Timms et al. 2012, 2014c; Deshpande et al. 2011; Rivera 2012), continuous-
time models estimated from discrete-time data result in parsimonious expressions
through which important dynamic features are more easily discerned. Consequently,
insight into behavioral phenomena and intervention e↵ects may be more easily in-
terpretable with continuous-time models. As will be demonstrated, continuous-time
models that capture inverse response in craving during a quit attempt can be easily
identified with a right half plane zero term, the estimated value of which may shed
light on underlying dynamic phenomena (Timms et al., 2012, 2013). Similarly, the
parameters in continuous-time models are more meaningful in terms of understand-
ing a process, as such models more transparently describe the continuous nature of
actual physical systems of interest. An a priori understanding of a system can also
be more easily preserved with continuous-time models, whereas discrete-time models
of a second order system, for example, may introduce additional parameters due to
sampling. Furthermore, discrete-time models estimated at fixed sampling rates may
not be representative of process dynamics observed under di↵erent sampling rates
(Garnier et al., 2008b). This may be an important consideration given the range
of time scales of interest to behavioral scientists (e.g., short term, long term, non-
standard time periods such as pubertal time scales; Collins et al. 2004). Additionally,
missing data and irregular sampling intervals are characteristic of self-reported be-
havioral health experiments, whether intentional or not; this supports the appeal
of a continuous-time modeling approach, which will not have parameters that are a
function of the sampling time, and therefore inherently manage the issue of non-ideal
data measurement. Consequently, continuous-time models of discrete data collected
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at a su ciently fast sampling rate can produce models that accurately represent the
overall dynamics of behavioral phenomena, while avoiding challenges associated with
missing data and inconsistent sampling intervals in discrete-time modeling (Garnier
et al., 2008b).
Behavioral scientists often rely on behavior change theories to guide intervention
design, evaluation, and delivery (Riley et al., 2011). In the context of cigarette smok-
ing, the concepts of statistical mediation and self-regulation have been of particular
interest (Timms et al., 2012, 2014c; McCarthy et al., 2008a; Piper et al., 2008; Velicer
et al., 1992; Walls and Rivera, 2009). Statistical mediation is a modeling paradigm
central to the social and behavioral sciences, describing a multivariate causal rela-
tionship in which an independent variable a↵ects a mediator variable and an outcome
variable, with the mediator also a↵ecting the outcome (MacKinnon, 2008). Self-
regulation theory within smoking considers a process in which nicotine levels, behav-
ioral state, or emotional state set points are regulated by smoking activity (Velicer
et al., 1992; Walls and Rivera, 2009; Solomon and Corbit, 1974; Timms et al., 2013,
2014c). However, the utility of models that describe these behavior change theories
for the purposes of development of optimized, time-varying interventions has been
limited; this is largely a consequence of the static nature of traditional behavioral
science models and the di culties historically associated with intensive collection of
behavioral data (Riley et al., 2011). This article employs a modeling framework that
leverages ILD and continuous-time system identification in order to describe smoking
cessation as a mediational and self-regulatory process.
This section is organized as follows. First, a clinical trial of bupropion and coun-
seling as aids to smoking cessation is outlined; this study was conducted at the Uni-
versity of Wisconsin Center for Tobacco Research and Intervention (UW-CTRI) and
funded by the Transdisciplinary Tobacco Use Research Centers (TTURC; McCarthy
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et al. 2008b). Behavioral signals for treatment group averages and two single subject
examples from the clinical trial are then presented. The features of the signals of
interest in this article—Craving, average daily craving level, and Cigsmked, total
daily smoking—are discussed in general terms. Statistical mediation is first presented
in conceptual terms and the connection to dynamic model development is then out-
lined. The iterative procedure used for model estimation is then described and the
resulting empirical dynamic mediation models are discussed. Next, self-regulatory
smoking cessation models are presented, estimated, and compared. In examination
of both the mediation and self-regulation models, parameter estimates and model
simulations are analyzed for treatment group averages. Following this, examples of
single subject models are briefly discussed. Finally, conclusions and recommendations
are presented.
Smoking Cessation Intervention Overview
Dynamic models are obtained in a secondary analysis of a TTURC-funded study
conducted by the UW-CTRI. In this double-blinded, placebo-controlled, randomized
clinical trial, 101 subjects received both active bupropion and counseling as treat-
ment (the “AC” group), 101 received active bupropion and no counseling (“ANc”),
100 received a placebo and counseling (“PC”), and 101 received a placebo and no
counseling (“PNc”). Participants receiving bupropion took 150 mg per day starting
one week prior to the quit date and 300 mg per day from four days prior to quit to
eight weeks post-quit. Bupropion SR (Zyban SR) is commonly prescribed as a smok-
ing cessation treatment (Fish and Bartholomew, 2007; Tobacco Use and Dependence
Guideline Panel, 2008), although the exact mechanism that makes it an e↵ective
smoking treatment is debated (Horst and Preskorn, 1998; Warner and Shoaib, 2005).
Generally, bupropion is thought to interfere with nicotine dependence mechanisms
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(Warner and Shoaib, 2005), and has been shown to alleviate withdrawal symptoms,
including craving (McCarthy et al., 2008b). In lieu of active bupropion, the PC
and PNc groups took placebo medication. Subjects receiving counseling completed
two pre-quit counseling sessions, one quit-date session, and five sessions over the fol-
lowing four weeks post-quit. Sessions focused on preparation, coping, motivation,
and relapse prevention. In lieu of counseling, the ANc and PNc groups spoke with
sta↵ about medication use adherence and received general encouragement (McCarthy
et al., 2008b).
For the two weeks prior to and four weeks immediately following the target quit
date, participants were instructed to complete assessments through personal digital
assistants (PDAs) each day immediately after waking up, before going to bed, and
four to seven times throughout the day as prompted by the PDA at pseudo-random
intervals. These self-reports generally collected data on smoking frequency and with-
drawal symptoms. Although data from each set of reports or a combination of reports
could be used to model the smoking process, the Evening Report (ER) is the focus
of this article’s e↵orts. The ER featured questions on a 10 point Likert scale cov-
ering topics such as withdrawal symptoms (McCarthy et al., 2008b), positive a↵ect
(generally, the degree to which an individual feels enthusiastic and alert), negative
a↵ect (generally, the degree to which an individual feels anger, disgust, guilt, fear,
and nervousness; Watson et al. 1988), and motivation to abstain. Table 2.1 provides
a selection of items from the ER (McCarthy et al., 2008b). The relationship between
Craving and Cigsmked variables is the focus of this article, as was done in a statis-
tical study of the same ILD by McCarthy et al. (2008a). Craving is defined as the
sum of Urge, Cigonmind, Thinksmk, and Bother. Cigsmked is the total number
of cigarettes smoked per day.
Both nomothetic (group level) and idiographic (single participant) models are of
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Table 2.1: Representative Subset of Questions from the Evening Report.
Code Question Scale
Urge Since last ER on average—Bothered by urges? 1-11, No!!...Yes!!
Cigonmind Since last ER on average—Cigarettes on my mind? 1-11, No!!...Yes!!
Thinksmk Since last ER on average—Thinking about smoking a lot? 1-11, No!!...Yes!!
Bother Since last ER on average—Bothered by desire to smoke? 1-11, No!!...Yes!!
Enthus Since last ER on average—Enthusiastic? 1-11, No!!...Yes!!
Tense Since last ER on average—Tense or anxious? 1-11, No!!...Yes!!
Sad Since last ER on average—Sad or depressed? 1-11, No!!...Yes!!
Anger Since last ER on average—Bothered by anger/irritability? 1-11, No!!...Yes!!
Excellent Since last ER on average—Concentration was excellent? 1-11, No!!...Yes!!
Happy Since last ER on average—Happy and content? 1-11, No!!...Yes!!
Food Since last ER on average—Thinking about food a lot? 1-11, No!!...Yes!!
Confidence Since last ER on average—Confidence in ability to quit? 1-11, Low!!...High!!
Motive Since last ER on average—Motivation to quit/stay quit? 1-11, Low!!...High!!
Cigsmked Total number of cigarettes smoked since the last ER? 0-99
general interest to behavioral scientists. In this section, treatment group average
models are the primary focus. To produce the group average signal, each report item
was averaged across all members in a group for each relative day over the week prior to
and four weeks immediately following the target quit date. This filtering that occurs
by averaging the data across all single subject data points in a group, and putting the
time series in deviation variable form, was the only data pre-processing done prior to
group average model estimation. While the continuous-time approach employed here
can e↵ectively model data with missing samples or non-constant sampling, missing
ER data for the two single subject examples was interpolated for straightforward
use of standard MATLAB estimation routines. Interpolation consisted of averaging
adjacent measured values or extending the adjacent measured value to the appropriate
boundary. For the single subject example from the AC group, eight days of data
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Figure 2.2: Plots of Two group Average (Solid Blue, AC; Dashed Green, PNc) and
Two Single Subject (Dash-Dot Magenta, AC; Dotted Red, PNc) Data Sets.
points were imputed. Seven days of data points were imputed for the single subject
example from the PNc group. Although single subject data sets are often noisier
than corresponding group average data, no filtering was done on these data prior
to idiographic model estimation. Fig. 2.2 depicts the Craving and Cigsmked ILD
for two group averages (solid blue, AC; dashed green, PNc) and two single subject
examples (dash-dot magenta, AC; dotted red, PNc).
As seen in Fig. 2.2, the group average Craving signals feature quit-induced inverse
response. With a continuous-time modeling approach, a priori knowledge that the
groups’ Craving signals features a right half plane zero is more easily preserved
(Garnier et al., 2008b). The group average Cigsmked signals feature a dramatic
quit-day drop, followed by a relatively small and slow resumption of smoking. The
single subject data sets display greater variability. In Fig. 2.2, the PNc single subject
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does not feature a net reduction in craving. The AC subject has little resumption
in smoking—reflecting a successful quit attempt—while the PNc subject features
significant resumption to approximately pre-quit levels.
Statistical Mediation Modeling
The concept of statistical mediation is a prominent model of change in the social and
behavioral sciences. As previously described, mediation defines a causal relationship
in which an independent variable, X, a↵ects a mediator,M , and an outcome, Y , with
M also contributing to Y (MacKinnon, 2008). Behavioral scientists use path diagrams
to depict this type of process (MacKinnon, 2008; Bollen, 1989). A mediational model
path diagram—not to be confused with a block diagram—is depicted in Fig. 2.3(a): a,
b, and c0 represent gains for the X to M , M to Y , and X to Y pathways, respectively
(MacKinnon, 2008). Structural Equation Model (SEM) representations of mediation
are found in Equations 2.17 and 2.18.
M =  01 + a X + e1 (2.17)
Y =  02 + c
0 X + b M + e2 (2.18)
Historically, Equations 2.17 and 2.18 have characterized mediation thought to be cap-
tured within cross-sectional studies; X typically codes the presence or absence of an
intervention andM and Y data are collected at a small number of time points (MacK-
innon, 2008). A dynamical framework is developed in this manuscript according to a
more general definition of mediation described in Collins et al. (1998). Collins et al.
(1998) underscores a temporal relationship between X, M , and Y , where a change
in an independent variable at some time is said to result in lagged changes in the
mediator and outcome (Collins et al., 1998). The SEMs in Equations 2.17 and 2.18
still apply under the Collins et al. (1998) definition, but the variables are a function
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(a) Path Diagram, Used in Structural Equation Modeling (SEM) to Describe the Relation-
ship Between Variables, for a Classic Mediational Model.
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(b) Fluid Analogy for Mediated Behavior Change Developed from Production Inventory
Management Models in Supply Chains.
Figure 2.3: Path Diagram Describing Statistical Mediation and an Initial Fluid
Analogy.
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of specific, discrete times.
Prior work by Navarro-Barrientos et al. (2011) established how path diagrams
in SEM correspond to steady-state process models; from these, fluid analogies can
be constructed which lead to dynamical systems amenable to estimation via system
identification methods. Drawing from techniques used in production inventory man-
agement in supply chains, fluid analogies describe dynamic behaviors according to a
structural relationship defined by a behavioral model (Schwartz et al., 2006). The
fluid analogy in Fig. 2.3(b) depicts a physical system analogous to behavior change
according to a mediational mechanism. Here, the independent variable corresponds
to the exogenous input to the system, and the endogenous quantities in the path
diagram (M and Y in Fig. 2.3(a)) are represented as inventories. Dynamic, mediated
behavior change models are obtained when each inventory is considered in the context
of a general conservation principle:
Accumulation = Sum of Inflows   Sum of Outflows (2.19)
A system of basic, first order di↵erential equations results from the application of
Equation 2.19 to Fig. 2.3(b):
⌧1
dM
dt
= aX(t  ✓1) M(t) + e1(t) (2.20)
⌧2
dY
dt
= c0X(t  ✓2) + bM(t  ✓3)  Y (t) + e2(t) (2.21)
where the derivative terms describe the changing levels of the inventory, a, b, and c0
are the system gains, ⌧1 and ⌧2 are the inventory time constants, and ✓1, ✓2, and ✓3
are the time delays. It can be shown that at steady-state, Equations 2.20 and 2.21
simplify to the structural models in Equations 2.17 and 2.18.
Higher order di↵erential equations could be used to describe more complex dy-
namic behavior while still adhering to relationships depicted in Fig. 2.3(b). While
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this simple fluid analogy reflects structural relationships defined by Equations 2.17
and 2.18, the resulting di↵erential equations are relatively restrictive. Specifically, the
outcome inventory dynamics are bound by a single time constant, despite the fact that
the inventory accepts contributions from both the independent variable input and the
mediator inventory outlet. This restriction is not necessary in a behavioral setting.
Fig. 2.4(a) is a less restrictive fluid analogy that describes mediated behavior change.
In this analogy, each pathway from Fig. 2.3(a) is represented by an inventory, each
with its own characteristic dynamics. Fig. 2.4(b) is the corresponding block diagram
and highlights the fact that Y is the result of two processes, where YD accounts for the
outcome change that is a direct result of the input variable change, and YI accounts
for the outcome change that is an indirect result of the input variable change via the
mediator variable change. Fig. 2.4(b) also highlights the parallel-cascade nature of
time-varying behaviors in a mediational relationship. Equations 2.22 and 2.23 are the
corresponding Laplace-domain models:
M(s) = Pa(s) X(s) + d1(s) (2.22)
Y (s) = Pc0(s) X(s) + Pb(s)M(s) + d2(s) (2.23)
In accordance with McCarthy et al. (2008a), this section primarily treats Craving
and Cigsmked as the mediator and outcome, respectively. The independent variable
input, Quit, is modeled as a unit step occurring on the quit date and corresponds to
a transition from not attempting to quit smoking to attempting to quit. d1 and d2 in
Equations 2.22 and 2.23 represent process disturbances, as opposed to measurement
noise. In this framework, they represent un-modeled factors that influence the medi-
ator and outcome. In this context, d1 represents factors other than the initiation of
a quit attempt that contribute to, or mitigate, Craving, such as negative or positive
life events (i.e., changes in Stress); d2 represents factors other than the initiation of a
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quit attempt or changing Craving levels that influence Cigsmked, such as the acces-
sibility or inaccessibility of cigarettes. If these process disturbances are measured and
uncorrelated with the inputs to Pa(s), Pb(s), and Pc0(s), they could be explicitly mod-
eled (Ljung, 1999). In behavioral health settings, explicitly modeling disturbances is
challenging, as additional influences that are truly independent and exogenous are
often not obvious. Consequently, accurate measurement and estimation of reliable
models presents significant practical and related estimation issues. In the following,
it is assumed that process disturbances are uncorrelated with the inputs and not of
significant influence. The group averaging likely e↵ectively filters out un-controlled
disturbances, suggesting these assumptions are reasonable. Ultimately, reliable iden-
tification and characterization of possible process disturbances would require novel
identification experiments. With novel clinical trial data, measurements of hypothe-
sized disturbances could be included in estimation of Equations 2.22 and 2.23 and val-
idated (e.g., through cross-validation); future validation of a time-varying disturbance
could significantly contribute to development of an improved—engineering-based or
otherwise—smoking intervention, as it would ultimately o↵er tobacco treatment prac-
titioners an additional degree-of-freedom on which to intervene.
In fitting the Laplace-domain models in Equations 2.22 and 2.23 to the Craving
and Cigsmked signals, a prediction-error approach is used to estimate continuous-
time linear models from sampled data (Ljung, 2009). Model estimation initially
employed the lowest order equation structure possible (a gain), as preliminary visual
inspection of the data indicated low order dynamic phenomena; transfer function
structures with gradually increased complexity were evaluated as necessary according
to the following iterative estimation and validation procedure:
(1) Estimation of Pa(s) as a single-input single-output (SISO) system with Quit as
the input and Craving as the output according to a given low order transfer
53
!"#
$##%
#%
d1(t)
YI(t)
YD(t)
d2(t)
(1  b)M(t)
$##%
#%
$##%
#%
&'()*'++,*
-.
-.
&'()*'++,*
!"#$
%"#$
&'"#$
bM(t  ✓2)
&'()*'++,*
-.
-. !"#"$%&'()*+,--"'
.,/"
.0+/
1"*,*-()2"
3($#"
aX(t  ✓1)
c0X(t  ✓3)
Y(t)
(a) Generalized Fluid Analogy for a Mediated Behavioral Intervention Developed from
Production Inventory Management Models in Supply Chains.
!"#$ !"#$%&'
!
!
!($%&' !)$%&'
%"#$
&'"#$
!
! &()"#$
&"#$
*!
!
!
*"
(b) Block diagram of statistical mediation.
Figure 2.4: Generalized Fluid Analogy and Block Diagram Describing Dynamic
Mediation. 54
function structure.
(2) Simultaneous estimation of Pb(s) and Pc0(s) as a multi-input single-output
(MISO) system with Craving and Quit as the inputs and Cigsmked as the
output according to given low order transfer function structures for Pb(s) and
Pc0(s).
(3) Simulation of the Craving and Cigsmked responses to Quit according to the
estimated Pa(s), Pb(s) and Pc0(s) expressions.
(4) Evaluation of Craving and Cigsmked goodness-of-fit on a 0 to 100% scale,
calculated according to the following criterion:
Fit [%] = 100
✓
1  ||y(t)  y˜(t)||2||y(t)  y¯||2
◆
(2.24)
where y(t) is the data to which the model is fit, y˜(t) is the simulated output,
and y¯ is the average of all y values.
This procedure was implemented in MATLAB through a custom graphical user in-
terface (GUI) built for flexible model estimation (see Fig. A.1). Using the GUI, the
four steps were repeated for di↵erent combinations of Pa(s), Pb(s), and Pc0(s) transfer
function structures with parameter estimation relying on the pem command from the
System Identification Toolbox in MATLAB. To use this routine, the input and output
data was defined as an iddata object and the structure of the model to be estimated
was defined as an idproc model object. For specification of the idproc model struc-
ture, the process models notation was used in which a single-output continuous-time
model transfer function structure is specified and can feature one to three poles, an
integrator, a zero, and a time-delay (Ljung and Singh, 2012). The idproc and pro-
cess models functionality employs an indirect continuous-time estimation approach
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in which discrete-time estimation methods are first used before the resulting discrete-
time representation is transformed into the equivalent continuous-time model. This
two-step approach has the advantage of drawing from established discrete-time esti-
mation methods to produce consistent and statistically e cient parameter estimates,
and still results in continuous-time models that parsimoniously represent complex
behaviors and can more easily be interpreted (Garnier et al., 2008b). In the iterative
four step procedure used here, a set of model estimates were ultimately identified as
appropriate representations of the behavioral dynamics for each group average and
the single subject examples according to goodness-of-fit values, a concern for model
parsimony, evaluation of parameter realizability, and through simulation.
Table 2.2 contains the parameter estimates, settling times (in days), and goodness-
of-fit values for the mediation models; ILD and model outputs are shown in Figures 2.5
and 2.6. The iterative estimation procedure’s employment of low order structures
where complexity was increased only as necessary, the associated high goodness-
of-fit values, and the corresponding simulations, which appear to accurately model
the dynamic features observed in the ILD, suggest the following transfer function
structures adequately represent cessation as a Craving-mediated process:
Pa(s) =
a (⌧as+ 1)
(⌧1s+ 1)
(2.25)
Pb(s) =
b
(⌧3s+ 1)
(2.26)
Pc0(s) = c
0 (2.27)
The estimated models feature high fit percentages according to Equation 2.24 for
the group averages. The low order of the structures indicate that over-parameterization
is not taking place. In general, the high signal-to-noise ratios of the group average
data sets are conducive to model estimation with high goodness-of-fit values, regard-
less of the transfer function structure. The lower mediator fit value for the PNc group
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Figure 2.5: Craving and Cigsmked Data and Models for AC and PNc Group
Averages (Solid Blue, AC Data; Dashed Light Green, AC Mediation Model; Dash-
Dot Magenta, AC Self-Regulation Model; Dash-Dot Red, PNc Data; Dotted Brown,
PNc Mediation Model; Dashed Dark Green, PNc Self-Regulation Model).
supports this assertion, as this group’s Craving appears to have a lower signal-to-
noise ratio than its counterparts.
The net decrease in Craving is greatest in the AC group, smallest in the PNc
group, and follows a logical relationship to treatment condition (a is -11.10 for AC,
-8.38 for ANc, -7.12 for PC, and -3.90 for PNc). As indicated by the negative system
zeroes, the group average craving signals feature pronounced inverse response. It is
known that a zero term in a dynamical systems model can result from two lower-order
subprocesses in parallel. Because inverse response in Craving results from a unit step
(Quit), it can be deduced that Pa(s) reflects parallel subprocesses in competition with
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Figure 2.6: Craving and Cigsmked Data and Models for AC and PNc Single
Subject Examples (Solid Blue, AC Data; Dashed Light Green, AC Mediation Model;
Dash-Dot Magenta, AC Self-Regulation Model; Dash-Dot Red, PNc Data; Dotted
Brown, PNc Mediation Model; Dashed Dark Green, PNc Self-Regulation Model).
each other. The first subprocess has a positive gain and faster speed of response than
the second, negative-gained subprocess. The positive-gained subprocess corresponds
to the immediate, quit-induced increase in Craving while the negative-gained subpro-
cess corresponds to the post-quit settling of Craving to below baseline levels. For the
case that Pa(s) is described by the di↵erential equation structure in Equation 2.25,
Pa(s) = Pa1(s) + Pa2(s); Pa1(s) = Ka1 and Pa2(s) = Ka2/(⌧1s + 1), where the time
constant is equal to that for the overall Pa(s) function. It follows that Ka1 =  a⌧a/⌧1
and Ka2 = a   Ka1 , where a is the Pa(s) gain, ⌧a is the Pa(s) zero, and ⌧1 is the
Pa(s) time constant. This notion of competing parallel processes within the overall
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Table 2.2: Mediation Model Parameter Estimates and Goodness-of-Fit Values.
Treatment AC ANc PC PNc AC PNc
Data Set Avg Avg Avg Avg Sgl Sgl
Mediator Fit [%] 87.77 78.88 77.80 64.72 69.44 44.80
Outcome Fit [%] 89.17 83.06 91.49 84.38 77.09 58.98
ab 0.94 1.96 1.45 1.17 -0.24 19.34
ab+ c0 -14.07 -11.17 -12.05 -9.07 -13.29 3.55
Mediator Settling Time [Days] 35.69 35.91 35.82 35.90 26.34 33.87
Outcome Settling Time [Days] 34.56 35.26 35.60 35.29 10.64 33.86
a -11.10 -8.38 -7.12 -3.90 -20.38 3.10
⌧a -2.28 -4.60 -14.18 -24.21 -4.23 100.00
⌧1 7.74 10.99 18.34 17.13 6.01 16.47
b -0.08 -0.23 -0.20 -0.30 0.01 6.25
⌧3 4.59 2.89 0.42 1.89 1.29 95.53
c0 -15.10 -13.13 -13.50 -10.42 -13.05 -15.99
smoking cessation process agrees with the observation that quitting smoking involves
delayed and immediate gratification motives (executive and impulsive neurological
processes, respectively) that compete during a quit attempt (Bickel et al., 2007).
Such insight into the nature of these underlying subprocesses highlights the utility
of a continuous-time system identification approach, as the implications of the Pa(s)
transfer function’s first order with zero structure were easily identified.
For the group average Cigsmked models, there is a dramatic quit-date drop in
smoking followed by a relatively small and slow resumption. This dramatic quit-date
smoking reduction is modeled by Pc0(s). Considering the treatment group averages,
the magnitude of the initial drop is largest for the AC group, a 15.01 cigarette per
day decrease, and smallest for the PNc group, a 10.42 cigarette per day decrease.
For each model corresponding to the parameter estimates in Table 2.2, the direct
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contribution of the quit attempt to Cigsmked is immediate, and the YD signal in
Fig. 2.4 acts as a step of magnitude c0. The resumption of smoking is modeled by the
mediated pathway, specifically Pb(s). For the group averages, the speed of resumption
is small, as the Pb(s) time constant, ⌧3, is under five days for the groups. The
speed of resumption of smoking does not strictly adhere to an expected relationship
with respect to treatment condition: the AC group features the largest ⌧3 and the
PC group has the smallest. The magnitude of resumption during a quit attempt is
quantified with ab, and is relatively small for the groups. Comparing ab and ab + c0
values, the mediated pathway and net outcome gains, respectively, it is apparent
that the mediated pathway’s contribution to the net e↵ect of the quit attempt is
consistently small for all of the group averages. Interestingly, the mediated pathways’
relative contribution to the outcome does not follow a natural progression in terms
of relationship to treatment; the mediated pathway’s contribution to the outcome is
6.3% for the AC group, 14.9% for ANc, 10.7% for PC, and 13.0% for PNc.
As seen in Fig. 2.6, the AC single subject example appears to successfully quit
smoking. The estimated mediation model for this subject is consistent with this
observation. Specifically, the magnitude of resumption is near zero (ab equal to -
0.24), and the speed at which quit success is achieved is significantly faster than
that of the group average counterparts, as the outcome settling time is 10.64 days.
Conversely, the PNc single subject example appears to fully relapse (comparatively
large b estimate) and does not feature inverse response (positive values for both the
a and ⌧a values).
The estimated single subject models are generally less accurate, particularly the
PNc subject models. This can be attributed to greater variance in the single subject
data. The greater degree of variance is evident in Fig. 2.2: both subjects’ baseline
signals are very noisy, feature Craving signals with lower signal-to-noise ratios, and
60
the PNc subject’s resumption also shows greater variance. These data quality issues
are typical when considering single subject data and consequently pose a significant
challenge to optimization of smoking interventions given that patient-specific mod-
els would ideally act as the basis for development of personalized smoking cessation
treatments. As parameters in continuous-time models are not a function of the sam-
pling time, a continuous-time system identification approach is appealing in terms
of managing data quality issues such as missing data and non-constant measurement
intervals—both common characteristics of self-reported behavioral data (McCarthy
et al., 2008b; Timms et al., 2012). Discussed in more detail in Chapter 5, future
estimation of reliable single subject smoking cessation models may benefit from data
collected in clinical trials designed with system identification in mind (Ljung, 1999;
Deshpande et al., 2012; Rivera, 2012).
Using an iterative estimation procedure similar to that previously described, mod-
els for the “reverse” mediation scenario were also estimated, where Cigsmked was the
mediator and Craving the outcome (models not shown). This similarly resulted in
models with high goodness-of-fit values and corresponding simulations that appeared
to accurately represent the Craving and Cigsmked dynamics. This suggests that
a Craving-Cigsmked interrelationship captured in the clinical trial ILD is not fully
described by a single mediation model. This significantly motivated identification
of an alternative description of the smoking cessation process that accounts for this
interrelationship in a parsimonious manner.
Self-Regulation Model
One of the greatest opportunities a↵orded by ILD is the ability to study self-regulating
and self-exciting phenomena (negative and positive feedback, respectively) within be-
havior change processes (Collins, 2006). Regulatory behaviors have historically been
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of significant interest in terms of characterizing addiction generally and smoking be-
haviors specifically (Carver and Scheier, 1998; Solomon, 1977; Solomon and Corbit,
1974; Velicer et al., 1992). The Nicotine Regulation Model, for example, proposes
that smoking is done in an attempt to maintain a smoker’s blood nicotine set point,
where deviations from this set point are the result of environmental conditions (e.g.,
cigarettes not readily available; Velicer et al. 1992). More complicated but concep-
tually similar mechanisms propose that cigarettes are smoked in order to regulate
emotional states or an Urge set point (Velicer et al., 1992; Solomon, 1977; Solomon
and Corbit, 1974; Walls and Rivera, 2009; Timms et al., 2013, 2014c); these emo-
tional states may be directly a↵ected by environmental factors unrelated to the act of
smoking (Velicer et al., 1992). However, the ability of such theories to inform e↵ective
treatment strategies, such as time-varying adaptive interventions, has been limited.
This is largely due to the historically significant challenges associated with e↵ective
measurement and mathematical modeling of behavioral dynamics (Riley et al., 2011).
Fig. 2.7 depicts a block diagram of the smoking cessation process that features
self-regulation. Generally, Fig. 2.7 suggests that cigarette smoking is done in order
to maintain a Craving set point and an attempt to quit smoking is a disturbance on
this self-regulatory relationship. Essentially, this block diagram reflects an intuitive
process: over time, an increasing desire to smoke leads to smoking activity, which then
reduces that desire in the short-term. Specifically, Fig. 2.7 describes a feedback loop
in which a biochemical or psychological controller, C(s), responds to the deviation,
e, between a craving set point, rcrav, and the actual measured craving signal (e =
rcrav   Craving). Cigsmked is a sum of the outputs from C(s), the craving self-
regulator, and Pd(s), the e↵ect of the quit attempt; Cigsmked then acts as an input to
62
Quit
Cigsmked
Pd (s)
Craving+
- C(s)
rcrav
e
P2(s)
P1(s)
P(s)
+
+ +
+
Figure 2.7: Block Diagram Depicting a Smoking Cessation Self-Regulation Model
Relating Craving and Cigsmked.
P (s), producing Craving. The associated closed-loop transfer function structures are:
Craving =
✓
PC
1 + PC
◆
rcrav +
✓
PPd
1 + PC
◆
Quit (2.28)
Cigsmked =
✓
C
1 + PC
◆
rcrav +
✓
Pd
1 + PC
◆
Quit (2.29)
As the output of P (s) is Craving, this function will require a system zero, which
stems from the sum of two subprocesses in parallel. Fig. 2.7 depicts these underlying,
competing processes. Mapping the self-regulatory relationship in Fig. 2.7 to a gener-
alized description of self-regulating behaviors described in Carver and Scheier (1998),
P (s) and C(s) correspond to “E↵ect on Environment” and “Behavior” processes,
respectively.
As in the case of the mediation models, estimating the self-regulation models
employed a prediction-error approach to obtain continuous-time linear models from
sampled data (Ljung, 2009). The system identification procedure is similar to that
previously described:
(1) Estimation of P (s) as a single-input single-output (SISO) system with Cigsmked
as the input and Craving as the output according to a given low order transfer
function structure.
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(2) Simultaneous estimation of C(s) and Pd(s) as a multi-input single-output (MISO)
system with e = rcrav   Craving and Quit as the inputs and Cigsmked as the
output according to given low order transfer function structures for C(s) and
Pd(s).
(3) Simulation of the Craving and Cigsmked responses to Quit according to the
estimated P (s), C(s) and Pd(s) expressions.
(4) Calculation of Craving and Cigsmked goodness-of-fit according to the criterion
in Equation 2.24.
This procedure was implemented in MATLAB through the previously described cus-
tom GUI that relied on the pem routine, an idproc model object, and the process
models notation for estimation (Ljung and Singh, 2012). The four steps were repeated
for di↵erent combinations of transfer function structures, beginning with the lowest or-
der (gain-only) equation structure, with structural complexity increased as necessary.
Similarly, various craving set points were examined: baseline Craving level, a lin-
early decreasing Craving function, and absolute Craving equal to zero. In assessing
the group average and single subject candidate model estimates for goodness-of-fit,
model parsimony, parameter realizability, and through simulation, the appropriate
rcrav value was found to equal the baseline Craving level, and the following trans-
fer function structures were found to appropriately represent the observed cessation
dynamics:
P (s) =
K1 (⌧as+ 1)
(⌧1s+ 1)
(2.30)
Pd(s) = Kd (2.31)
C(s) =
Kc
(⌧cs+ 1)
(2.32)
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Table 2.3: Self-Regulation Model Parameter Estimates and Goodness-of-Fit Values.
Treatment AC ANc PC PNc AC PNc
Data Set Avg Avg Avg Avg Sgl Sgl
Craving Fit [%] 87.33 77.65 77.51 62.25 66.90 57.59
Cigsmked Fit [%] 89.16 83.03 91.44 84.12 77.09 62.99
P (s) K1 0.77 0.74 0.50 0.52 1.57 -2.21
P (s) ⌧a -1.99 -3.76 -14.34 -21.90 -3.05 3.45
P (s) ⌧1 8.22 14.23 18.70 26.75 6.88 10.76
C(s) Kc 0.08 0.23 0.20 0.30 -0.01 -6.25
C(s) ⌧c 4.59 2.89 0.42 1.89 1.29 95.53
Pd(s) Kd -15.01 -13.13 -13.50 -10.24 -13.05 -15.99
The parameter estimates and goodness-of-fit percentages are tabulated for the treat-
ment group averages and the single subjects in Table 2.3. The corresponding model
outputs are depicted in Figures 2.5 and 2.6.
As evident in Table 2.3 and Figures 2.5 and 2.6, high goodness-of-fit values and
high fidelity simulations are obtained with low order transfer function structures.
As before, the negative system zero, ⌧a, indicates P (s) represents the sum of two
competing subprocesses in parallel. Whereas the group average mediation models
suggest the subprocess with the faster speed of response is positive-gained, it is now
the negative-gained subprocess that has an immediate speed of response (P1(s) = Kp1 ,
where Kp1 < 0); conversely, it is the positive-gained function that has the slower
speed of response (P2(s) = Kp2/(⌧p2s + 1), where Kp2 > 0 and ⌧p2 equals ⌧1 from
Equation 2.30 and Table 2.3). The negative value of Kp1 corresponds to the initial
increase in Craving that results from the quit-induced, step-like initial decrease in
Cigsmked. The positive value of Kp2 corresponds to the settling of Craving to
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below baseline levels that results from the dramatic reduction in the group average
Cigsmked signals. As the group average estimates in Table 2.3 for K1 are positive,
it follows that the magnitude of Kp2 is greater than that of Kp1 . As previously
described, the sum of two subprocesses agrees with the concept of dual impulsive and
executive neurological processes that compete during a quit attempt (Bickel et al.,
2007). Altogether, the craving reduction per unit decrease in daily cigarettes smoked
is larger for the active drug groups versus the placebo groups: K1 equal to 0.77 for
the AC group, 0.74 for ANc, 0.50 for PC, and 0.52 for PNc.
The Pd(s) model corresponds to the initial quit-day reduction in Cigsmked, and
the magnitude of this drop is largest for the AC group (Kd = -15.01) and smallest for
the PNc group (Kd = -10.24). As the C(s) function models the post-quit smoking
resumption for all of the estimated expressions, it follows that the feedback pathway
is responsible for relapse. A distinct advantage of the continuous-time modeling ap-
proach is that the nature of the craving self-regulator can be reverse-engineered, as
interpretation of the estimated continuous-time C(s) function is straightforward. Ev-
ident in Equation 2.32, C(s) is described by a first order di↵erential equation for both
the group average and single subject models. Consequently, the craving self-regulator
can be classified as a proportional-with-filter controller. This is significant, as such
a controller allows o↵set, and therefore C(s) does not necessarily track the set point
(pre-quit baseline Craving levels), e↵ectively allowing the model to capture possible
quit attempt success as well as failure. The filter component, 1/(⌧cs + 1), serves to
attenuate the influence of frequent changes in e on resumption, and suggests that
the influence of unmeasured disturbances that lead to the apparent noise in e is sup-
pressed on average. This may support the notion in behavioral science that Craving
dynamics induced by abstaining from smoking is the dominant factor in determining
relapse versus cessation success (McCarthy et al., 2008a; Piper et al., 2008). In gen-
66
eral, the connection between a fundamental control paradigm (PID control) and a
mechanism of change central to behavioral science (self-regulating smoking behavior)
makes a case for the potential utility of system identification techniques to behavioral
health settings in the future (Ogunnaike and Ray, 1994; Carver and Scheier, 1998;
Solomon and Corbit, 1974; Solomon, 1977; Velicer et al., 1992; Timms et al., 2014c).
Comparing Kc and ⌧c estimates in Table 2.3 for the group average models, the craving
self-regulator appears to provide a relatively small and slow contribution to the net
change in Cigsmked. Interestingly, the overall influence of the feedback pathway on
cessation dynamics may be diminished by the combined active drug and counseling
treatment, as Kc is approximately 63% smaller for the AC group compared to the
ANc and PC groups, and is approximately 73% smaller compared to the PNc group.
The single subject self-regulation models generally have lower goodness-of fit val-
ues as compared to the group average models. This was expected, as the ILD from
which both mediation and self-regulation models were estimated feature significant
variance. (Experimental design options that can mitigate the data quality issue typi-
cal of single subject behavioral data is discussed in Chapter 5.) Interestingly, the PNc
single subject’s Craving and Cigsmked goodness-of-fit values are approximately 10%
greater for the self-regulation model compared to the mediation model. This supports
the case for self-regulation as a better description of the smoking process.
Focusing on the single subject model estimates specifically, the successful quit
attempt for the AC single subject is appropriately represented by the self-regulation
model. Although the PNc subject’s P (s), Pd(s), and C(s) dynamics are adequately
described by the same low order di↵erential equation structures as the group average
models, the characteristics of the corresponding parameter estimates contrast those
of the group averages. This is due to the subject’s failed quit attempt, which is
characterized by a full resumption in Cigsmked and a lack of inverse response in
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Craving. Whereas the group average model estimates feature Kc estimates that
are positive and small in magnitude, the PNc subject’s Kc equals -6.25. This large,
negative value reflects the significant resumption evident in the subject’s Cigsmked
signal, which is the response to e, the input to C(s) that is essentially the inverted
Craving signal (e = rcrav  Craving, where rcrav is the baseline Craving level). The
PNc subject’s K1 estimate is also negative, contrasting the other models’ K1 values;
this estimated P (s) model reflects the subject’s increase in Craving that results from
the initial drop in smoking and the subsequent settling to approximately pre-quit
levels that results from the apparent relapse. In terms of the underlying subprocesses,
where P (s) = P1(s) + P2(s) with P1(s) = Kp1 (Kp1 < 0) and P2(s) = Kp2/(⌧p2s+ 1)
(Kp2 also negative and ⌧p2 = ⌧1 = 10.76 days, per Table 2.3). The relative signs of
these subprocess gains are a departure from the relationship inferred for the other
models examined.
The feedback nature of the self-regulation model suggests that Craving and
Cigsmked are fundamentally related and a change in one variable results in a change
in the other. In other words, the self-regulation models describe a Craving-Cigsmked
interrelationship that cannot be accounted for by classic mediation. This is significant
as a Craving-Cigsmked interrelationship was originally suggested by the fact that
both the mediation models presented and the reverse mediation models (not shown)
have high goodness-of-fit values and high fidelity simulations. Altogether, smoking
cessation behavior change is more appropriately and parsimoniously represented as a
self-regulatory process as opposed to a mediational relationship. Furthermore, very
poor models result from estimation of reverse self-regulation models, where P (s) is
said to accept Craving as the input, producing Cigsmked as the output, etc. This
supports the case that Fig. 2.7 is a more appropriate representation of the Craving
and Cigsmked relationship (i.e., Craving is the variable being regulated).
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Conclusions and Recommendations
Drawing from intensive longitudinal data collected from a clinical trial of bupropion
and counseling as aids to smoking cessation, system identification models were de-
veloped to describe smoking cessation as mediational and self-regulatory processes.
Ultimately, these models di↵er in how they each describe the resumption of smoking:
for mediation, resumption is the result of daily changes in Craving (via Pb(s)); for self-
regulation, resumption is the result of a craving self-regulator. Analysis of both sets
of models highlight the utility of continuous-time system identification in behavioral
health settings. Specifically, continuous-time system identification facilitates estima-
tion of parsimonious expressions that accurately represent complex dynamic features
within the smoking cessation process. Furthermore, these continuous-time expressions
are conducive to straightforward identification and interpretation of the dynamics—in
this section, shedding light on the nature of the two competing subprocesses that to-
gether form Craving, and that the craving self-regulator is a proportional-with-filter
controller on average. Altogether, the models developed suggest that self-regulation
more appropriately describes the process of smoking cessation. Regardless of struc-
ture, parameter values estimated from the group average data, which are signals with
high signal-to-noise ratios, suggest both bupropion and counseling have some e↵ect
on craving and reduction of smoking behavior.
This section has e↵ectively shown that system identification is useful in analysis
of smoking cessation interventions and for comprehensively describing the process
of smoking cessation. The dynamical modeling strategy used here could be further
applied to the clinical trial data examined here in order to study alternate signal
relationships and behavioral mechanisms. Notably, participants in the UW-CTRI
clinical trial completed up to seven self-reports at pseudo-random intervals through-
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out the day (McCarthy et al., 2008b). These reports assessed environmental factors
as well as behavioral states as experienced by the participant at the time the re-
port was completed (whereas the ER focused on a participant’s average behavioral
state over the previous 24 hours). Behavioral data collected in this fashion is said to
reflect the influence of an individual’s natural environment, and may measure such
influences. Continuous-time models estimated using data from these reports could
provide some insight into environmental sources of inter-individual variability, and
consequently may act as the basis for more reliable idiographic model estimation.
However, the generalizability of such models would still be limited due to the sec-
ondary nature of the analysis. In the future, more informative single subject data
sets—and ultimately more reliable patient-specific smoking cessation models—could
be obtained through a novel smoking cessation clinical trial that draws from experi-
mental design techniques in system identification. Such a trial may vary intervention
dosage over time (e.g., bupropion dose, counseling frequency), use self-reports more
conducive to measurement of nuanced behavioral dynamics (e.g., Craving assessed
on a 0 to 100 point scale), or feature a longer self-reporting protocol. However, the
medical, practical, and ethical concerns associated with human subjects would also
have to be addressed simultaneously. A smoking cessation clinical trial designed to
produce more informative single subject data sets would involve experimental de-
sign strategies similar to those described in Deshpande et al. (2012) and Deshpande
and Rivera (2013). Specifically, Deshpande et al. (2012) and Deshpande and Rivera
(2013) propose optimization-based approaches for the design of periodic, determinis-
tic input signals that facilitate cross-validation, constraint handling, and altogether
“patient-friendly” operation.
Ultimately, self-regulatory models similar to those estimated here could inform
novel treatment strategies (Timms et al., 2013; Rivera, 2012; Nandola and Rivera,
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2013; Riley et al., 2011). Although accurate models of patient-specific behavioral
dynamics would ideally be used to personalize interventions, a more practical in-
tervention design approach may rely on a self-regulatory model described in the
block diagram in Fig. 2.7, but is parameterized to reflect a representative failed quit
attempt—full resumption in Cigsmked, inverse-free Craving, and no net change in
Cigsmked or Craving. A representative model of a failed quit attempt could be
similar to the PNc single subject model examined here. Timms et al. (2013) presents
such an example of a representative model of quit attempt failure. For designing an
adaptive smoking cessation intervention, such a representative model could be used
in conjunction with controller design principles to develop an algorithm that defines
intervention adjustment (e.g., medication dosage increases), based on a patient’s base-
line conditions, self-reported smoking and withdrawal symptoms (e.g., daily Craving
and Cigsmked reports), and environmental or other disturbances (e.g., Stress). A
Hybrid Model Predictive Control approach is appealing as it can simultaneously man-
age manipulated variables that are on discrete scales (e.g., discrete medication dosage)
and constraints (e.g., medication toxicity levels) in an optimal manner (Nandola and
Rivera, 2013; Rivera, 2012; Timms et al., 2013). Fig. 2.8 depicts the general form
of this control scheme. An optimized, adaptive smoking intervention designed in an
HMPC framework could also include features of other well-known control approaches.
For example, variables that are e↵ectively non-time-varying but may be relevant to
the cessation process, such as the presence of a genetic variant in a patient’s nico-
tine metabolism genes (Chen et al., 2012), could act as scheduling variables in an
intervention featuring gain-scheduled Model Predictive Control (Chisci et al., 2003).
Finally, event-based control o↵ers controller capabilities that may be appropriate for
intervention design. Specifically, event-based control concepts o↵er a way to mitigate
relapse that may otherwise result from time-varying cues to smoke (e.g., proximity
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Figure 2.8: Block Diagram of a Hybrid Model Predictive Control Approach to
Design of an Optimal, Adaptive Smoking Cessation Intervention.
to smokers) or other disturbances (Pawlowski et al., 2012), and would be particularly
appealing for interventions that draw from models of cessation dynamics on shorter
time scales (e.g., within-day dynamic models).
2.5 Additional Modeling Considerations
The flexibility of dynamic modeling and system identification techniques suggests
they can be useful for investigating a variety of questions in this problem setting. This
section outlines some additional opportunities for employing an engineering modeling
approach to study smoking behaviors and tobacco interventions.
2.5.1 Characterizing Confounding Influences
The presence of confounding factors are a major concern to behavioral scientists
when estimating models of causal mechanisms (Li et al., 2007; Shadish et al., 2002).
In dynamical systems terms, confounding variables are exogenous disturbances that
may or may not be measured (Timms et al., 2014c,b). Confounders are generally
not, or cannot be, controlled for experimentally, and may be static or time-varying.
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Even when measured, confounders can increase the complexity of the modeling prob-
lem, particularly when considering multivariate causal relationships; for example, Li
et al. (2007) describes 19 di↵erent ways a single confounder can a↵ect a mediational
relationship.
The dynamic mediation or self-regulation models developed in the previous section
can be adjusted in a straightforward manner in order to characterize the e↵ect of a
confounding variable. Consider the confounded mediational relationship depicted in
the path diagram in Fig. 2.9; in this example, a confounding variable, Z, influences the
levels of both the mediator and outcome variables (Li et al., 2007). The magnitudes
of these net e↵ects are represented by  and !, respectively. It can be shown that
the structural relationship in Fig. 2.9 can be cast as a dynamical system described
by the following:
M(s) = Pa(s)X(s) + P (s)Z(s) + d1(s) (2.33)
Y (s) = Pc0(s)X(s) + Pb(s)M(s) + P!(s)Z(s) + d2(s) (2.34)
where P (s) and P!(s) are the transfer functions representing how Z(s) a↵ects M(s)
and Y (s), respectively. With ILD for Z, P (s) and P!(s) can be estimated in addition
to Pa(s), Pb(s), and Pc0(s). If the resulting set of five estimated functions account
for more variance in the observed M and Y signals, as compared to models of the
standard three-variable dynamic mediation models (equations 2.22 and 2.23), the case
is made that Z is a significant exogenous e↵ects. Ultimately, modeling e↵orts of this
sort are limited by the availability and quality of ILD.
2.5.2 Conceptualizing Mechanisms of Treatment E↵ects
The group average dynamic self-regulation models presented in Timms et al.
(2014a) account for the e↵ects of bupropion and counseling within the di↵erent param-
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Figure 2.9: Path Diagram Depicting One Manner by which a Single Confounding
Variable can A↵ect a Mediational Relationship (Li et al., 2007).
eter estimates in Table 2.3. Ultimately, dynamic self-regulation models that would be
most informative to designing novel treatment regimens would explicitly treat inter-
vention components as independent, exogenous inputs to the psychological feedback
system. Future e↵orts may be able to delineate the treatment e↵ects in this manner.
As will be briefly discussed in Chapter 5, ILD from a novel clinical trial designed
with system identification principles in mind could facilitate estimation of high fi-
delity models of this type. However, the models described in previous sections are
conducive to general, informal analyses of therapeutic mechanisms.
For example, inspection of Fig. 2.7 suggests there are three clear degrees-of-
freedom on which to intervene: rcrav, Craving, and CPD directly. The seven
first-line tobacco dependence medications are all thought to directly reduce Craving
(Benowitz, 2009; Tobacco Use and Dependence Guideline Panel, 2008; Lexicomp,
2014; Rennard et al., 2014). Several aspects of counseling likely act most directly
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on CPD; for example, counseling may lead a person to reduce their own access
to cigarettes (e.g., where they throw away their cigarettes pre-TQD). Bupropion
is thought to interfere with nicotine addiction mechanisms (Benowitz, 2009; West
et al., 2008); this e↵ect could be modeled as a disturbance on rcrav, the psycholog-
ical Craving set point. As engineers commonly run simulations to explore how to
augment a system or alter its operation in order to obtain more favorable outputs,
Fig. 2.7 and equations 2.35 and 2.36 can facilitate similar e↵orts in the context of
cessation interventions (Timms et al., 2014c, 2013). Timms et al. (2013) provides an
example of this opportunity. Here, the self-regulatory process depicted in Fig. 2.7 is
considered, but for a hypothetical subject unable to quit smoking on their own. This
subject is patterned after the single subject from the PNc group modeled in Timms
et al. (2014a). Timms et al. (2013) then posits that a hypothetical pharmacotherapy
acts as a disturbance on the psychological CPD-Craving feedback process featuring
dual modes of therapeutic action: (1) directly altering rcrav and (2) directly altering
Craving. Fig. 2.10 depicts this sort of mechanism of e↵ectiveness. The corresponding
closed-loop transfer functions are:
Craving =
✓
PIc + PIrPC
1 + PC
◆
uI +
✓
PPd
1 + PC
◆
Quit (2.35)
CPD =
✓
(PIr   PIc)C
1 + PC
◆
uI +
✓
Pd
1 + PC
◆
Quit (2.36)
where uI denotes whether the hypothetical medication is active (uI = 1) or not
(uI = 0), PIc is the dose-response model representing how uI a↵ects Craving over
time, and PIr is the dose-response model representing how uI a↵ects rcrav over time.
Primarily through simulation, Timms et al. (2013) then identifies a combination of
first order transfer functions for PIc and PIr that together promote successful cessa-
tion and decreased Craving values, when uI is implemented in simulation as a fixed
intervention that becomes fully e↵ective on TQD. Simulations of this sort could help
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Figure 2.10: Block Diagram Depicting the Mechanism of Action for a Hypothetical
Cessation Medication (Timms et al., 2013).
evaluate the most e↵ective mechanisms by which novel therapies should intervene.
2.5.3 Getting a Sense for Parameter Sensitivity
Assuming rcrav = 0 and P (s), C(s), and Pd(s) adhere to the structures in equa-
tions 2.30 through 2.32, the closed-loop transfer functions in equations 2.35 and 2.36
can be rewritten as:
Craving =
⇣
K1Kd
1+K1Kc
⌘
(⌧as+ 1)(⌧cs+ 1)⇣
⌧1⌧c
1+K1Kc
⌘
s2 +
⇣
⌧1+⌧c+K1Kc⌧c
1+K1Kc
⌘
s+ 1
(2.37)
CPD =
Kd
1+K1Kc
(⌧1s+ 1)(⌧cs+ 1)⇣
⌧1⌧c
1+K1Kc
⌘
s2 +
⇣
⌧1+⌧c+K1Kc⌧c
1+K1Kc
⌘
s+ 1
(2.38)
Clearly, uncertainty in any single or combination of parameters in the P (s), C(s), and
Pd(s) transfer functions can have complex e↵ects on Craving and CPD dynamics.
This raises a question of how uncertainties in the various parameters will a↵ect the
character of the responses. A formal sensitivity analysis lies outside the scope of
this dissertation. However, simulation o↵ers a straightforward means for rapidly and
informally getting a sense for the e↵ects of small amounts of parameter uncertainty.
For this, the value of each parameter estimate for the PNc single subject self-
regulation model (see Table 2.3) was independently increased or decreased by 10%.
The responses of Craving and CPD to Quit were then simulated in MATLAB. The
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Table 2.4: Percent Change in the Characteristics of the CPD and Craving Re-
sponses to a Step in QuitWhen the Model Parameters are Adjusted by 10%, Relative
to the Metrics for the Nominal Case of the Single PNc Subject Estimated Model with
No Parameter Uncertainty (See Table 2.3).
Output: Craving Craving Craving Craving CPD CPD CPD
Parameter Uncertainty level Net change Settling time Peak magnitude Peak time Net change Settling time Peak magnitude
P (s), K1 -10 -2.5 5.6 -7.0 16.1 7.6 5.7 0
P (s), K1 +10 1.5 -4.9 6.9 -3.0 -6.6 -5.0 0
P (s), ⌧1 -10 -1.6 -5.7 4.1 -9.4 -4.3 -5.0 0
P (s), ⌧1 +10 1.3 5.1 -3.3 22.9 2.3 4.5 0
P (s), ⌧a -10 1.2 0.7 -0.4 16.1 1.9 0.3 0
P (s), ⌧a +10 -1.7 -0.9 0.9 -3.0 -2.4 -0.4 0
C(s), Kc -10 8.3 5.6 3.4 16.1 7.6 5.7 0
C(s), Kc +10 -7.7 -4.9 -2.8 -3.0 -6.6 -5.0 0
C(s), ⌧c -10 0.4 -5.6 -3.1 -4.0 0.9 -5.8 0
C(s), ⌧c +10 -0.6 5.3 3 16.5 -1.2 5.5 0
Pd(s), Kd -10 -10 0 -10 0 -10 0 -10
Pd(s), Kd +10 10 0 10 0 10 0 10
net change, settling time, peak magnitude, and time of the peak for both outcome
responses were then determined (The MathWorks, 2014h). Table 2.4 documents
the percent di↵erence of the responses with parameter uncertainty, relative to the
simulated response with no uncertainty.
Per Table 2.4, the time at which the Craving peak is reached is generally very
sensitive to small perturbations in model parameters in terms of the relative amount
of change in that time point. Small amounts of uncertainty in the K1 and Kc pa-
rameters have relatively broad e↵ects, inducing changes of approximately 5% or more
in several of the step response characteristics. This agrees with visual inspection of
equations 2.37 and 2.38, as the gains, time constants, and damping coe cients in
these closed-loop transfer functions are all a function of K1 and Kc. The net changes
in Craving and CPD induced by a quit attempt, and the peak magnitudes of these
signals are also sensitive to small perturbations in Kd. The character of the dynamic
responses appear to be relatively robust to uncertainty in ⌧a and ⌧c. Given that ⌧c
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corresponds to the frequency of signals the self-regulator filters out, and these simula-
tions do not incorporate a stochastic disturbance, the limited e↵ect of ⌧c perturbations
is intuitive.
2.5.4 Within-Day Smoking Dynamics
Analysis of the self-regulation process in Timms et al. (2014a) and Timms et al.
(2014c) raises the question, “does a similar phenomenon occur on a within-day level?”
Interest in this type of question is ongoing in smoking research settings (Chandra
et al., 2011; Shi↵man, 2005; Todd, 2004). For example, Chandra et al. (2011) char-
acterizes a reciprocal relationship between craving and smoking levels within a day.
This is part of a general interest in dynamics on a finer level, where specific deter-
minants of specific instances of smoking could be studied more precisely. However,
modeling within-day dynamics may incur a number of additional challenges. Intu-
itively, complex sets of biological, psychological, habitual, environmental, situational,
and other types of time-varying disturbances may be more prominent at this level.
Consequently, measuring and unentangling these influences may demand significantly
more complex models. For example, the e↵ect of stress-management counseling is will
be a function of the presence of a stressor at a given time, implying a linear time-
invariant model of counseling e↵ects may not be su cient.
To briefly explore the question of self-regulation on a within-day level, dynamic
models were estimated using ILD collected through EMA protocols for approximately
324 subjects in the clinical trial described in Shi↵man et al. (2006). Although the
general relationship depicted in the block diagram in Fig. 2.7 is being considered
here, the ILD used in this subsection’s modeling work is di↵erent from that used in
Timms et al. (2014a) and Timms et al. (2014c), so the craving and smoking signals are
represented as b cravin and cigs here (per the notation used in alternative statistical
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analyses of this data). In deviation variable form, b cravin ranges from approximately
-10 to 7; cigs was reported for each observation and represents instances of smoking,
e.g., a whole cigarette was smoked.
Fig. 2.11 depicts b cravin and cigs data for one subject in this study (in deviation
variable form). This figure depicts the subject’s data as a single time series, where the
time scale is minutes since the first self-report was recorded, spanning from minute 0
to minute 79,720. The irregular sampling intervals suggest this modeling e↵ort could
benefit from a continuous-time estimation approach (Garnier et al., 2008b; Timms
et al., 2014a). However, early e↵orts indicated that models could not be consistently
estimated using routines from the CONtinuous-Time System IDentification (CON-
TSID) toolbox, a well-established toolbox for estimating continuous-time dynamic
models (Garnier et al., 2009, 2008a). Specifically, parameters could only be reliably
estimated when a filter was employed with a cuto↵ frequency that filters out dynamics
with time constants around approximately 12 hours.
The limitations of CONTSID and the secondary nature of these analyses moti-
vated estimation of discrete-time models to describe within-day b cravin and cigs dy-
namics. However, discrete-time model estimation routines have di culty with irreg-
ularly sampled data (Garnier et al., 2008b; Ljung, 1999). In order to take advantage
of well-established parameter estimation methods and tools such as the System Iden-
tification Toolbox (Ljung, 2011), ILD for the approximately 324 subjects is “binned”
and averaged. Specifically, a single day is split into seven two hour time intervals, i.e.,
seven bins: bin 1 corresponds to 7:00 AM to 8:59 AM, bin 2 corresponds to 9:00 AM
to 10:59 AM, and so on, through bin 7 that corresponds to 7:00 PM to 8:59 PM. As
the clinical trial focused on a six week time period, two weeks pre-quit to four weeks
post-quit, each of the 42 days in this time period consists of seven bins. The day
relative to TQD was then determined for each observation. Each b cravin and cigs
79
0 1 2 3 4 5 6 7 8
x 104
0
0.5
1
cigs
0 1 2 3 4 5 6 7 8
x 104
0
5
10
b_cravin
0 1 2 3 4 5 6 7 8
x 104
0
1
Minutes since first observation
Quit
Figure 2.11: Raw cigs and b cravin Data for One Subject from the Clinical Trial
Described in Shi↵man et al. (2006).
observation was assigned to the appropriate bin based on the time during the day the
report was recorded. The data in each bin for each day relative to TQD was then av-
eraged. The result is 42 sets of time series data, with each time series containing seven
data points. Fig. 2.12 depicts binned and averaged time series for several days. As
before, there are two identification tasks to be conducted in parallel: (1) estimation of
a SISO system where cigs is the input and b cravin is the output, and (2) estimation
of a two-input single-output (2ISO) problem where Quit and ecrav = rcrav   b cravin
are the inputs and cigs is the output. Here, it is assumed that rcrav = 0, as was the
case for the corresponding day-to-day models. The quit input signal is constant for
each time series, equal to 0 for days pre-TQD and 1 for TQD and after. To leverage
the parameter estimation methods in MATLAB’s System Identification Toolbox, two
iddata objects are defined for each of the 42 days of data: one corresponding to the
SISO problem and a second corresponding to the 2ISO problem. The availability of
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Figure 2.12: Four Days of Binned and Averaged cigs and b cravin Time-Series Data
from the Study Described in Shi↵man et al. (2006).
42 time series data sets means there is an opportunity for cross-validation. Here, ev-
ery other time series is assigned to the estimation data set, and the remaining to the
validation data set. Each data set is consequently composed of iddata objects for 21
days. For each identification problem, iddata objects in the estimation data set are
merged into a single object containing 21 “experiments” (The MathWorks, 2014c).
This means data for all 21 time series are considered together during the parameter
estimation step (Ljung, 2011), as opposed to individual models being estimated for
each day.
Discrete-time ARX models in the form of equation 2.2 were then estimated; t
in equation 2.2 denotes the current bin. Several combinations of autoregressive and
external input polynomial orders were examined (see equations 2.3 and 2.4); model
structures with integrators were also considered. Each candidate estimated model
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was compared to each of the 21 time series in the validation data set through visual
inspection and calculation of a goodness-of-fit percentage.
For the SISO problem, models with fourth order autoregressive polynomials gen-
erally did significantly better than models with lower order polynomials. The greatest
case was made for an ARX-[4 1 1] model:
b cravin(k) =  0.09 b cravin(k   1)  0.5 b cravin(k   2)  0.3 b cravin(k   3)
  0.3 b cravin(k   4)  1.5 cigs(k   1) + e(k) (2.39)
Of the structures examined, equation 2.39 corresponds to the highest goodness-of-fit
value found for a single validation time series, 81%. Furthermore, of the stable models,
equation 2.39 corresponds to the highest goodness-of-fit on average, 46%. While the
46% goodness-of-fit average is below the goodness-of-fit values in Table 2.3, this is
encouraging as cross-validation is a more rigorous validation method.
Fig. 2.13 features step and impulse responses for equation 2.39, where the respec-
tive unit input changes occur at bin 0. The step response indicates that going from
0 cigarettes per bin to 1 per bin for the entire day leads to a relatively large reduc-
tion in b cravin initially, but that a unit cigarette smoked during each bin essentially
becomes less satisfying as the time since the step change increases. The impulse re-
sponse suggests smoking a single cigarette quickly leads to a relatively large reduction
in b cravin; however, that single cigarette leads to higher b cravin levels four to eight
hours later, which seems to follow addiction theory.
The resulting model for the 2ISO problem is:
cigs(k) = 0.7 cigs(k   1) + 0.25 cigs(k   2)  0.35 cigs(k   3) + 0.1 cigs(k   4)
+ 0.3 cigs(k   5)  0.02 ecrav(k   1) + 0.02 ecrav(k   2) + e(k) (2.40)
As with the model in equation 2.39, equation 2.40 corresponds to the highest goodness-
of-fit on average of the low order structures considered, 51%. It also corresponds to
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Figure 2.13: Response of b cravin to a Unit Change in cigs.
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goodness-of-fits greater than 80% for five of the days in the validation data set, with
a 90% fit for one of these days. Note, equation 2.40 attributes no dynamics to the
quit path.
The step response in Fig 2.14a suggests that a sustained unit increase in ecrav =
rcrav   b cravin leads to a decrease in the number of cigarettes smoked throughout
the same day, as would be expected. Fig. 2.14b suggests that a unit decrease in the
di↵erence between rcrav and b cravin at time 0 initially leads to a decrease in the
amount of smoking, but the overall e↵ect quickly diminishes.
Whereas initiation of the quit attempt acts to excite the CPD and Craving dy-
namics on a day-to-day scale (see the models in Fig. 2.5 and Fig. 2.6), equation 2.40
suggests initiation of a quit attempt does not excite cigs or b cravin. The fact that
Quit(k) in this model has a constant e↵ect is intuitive though: Quit represents a
within-day concept, and conceptually, the transition from not trying to quit smoking
to trying to quit occurs sometime between the end of bin 7 on day =TQD-1 and
the beginning of bin 1 on day =TQD. However, one might have expected that Quit
contributes to equation 2.40 in a way that scales cigs(k) down from pre-TQD baseline
levels of cigs to approximately 0 cigs, as Pd(s) in equation 2.31 served to do. Future
model estimation e↵orts drawing from novel clinical trial data may provide greater
insight into this unintuitive result. Furthermore, such future experimentation amy be
able to shed light on the excitation source that induces cigs and b cravin dynamics,
as seen in Fig. 2.12. It has been documented that there is a natural evolution of
craving and smoking levels throughout the day in smokers not trying to quit (Chan-
dra et al., 2011); this may be an appropriate starting point for future experimen-
tation and modeling e↵orts. Such e↵orts to essentially estimate cigs(z 1)/uday(z 1)
and b cravin(z 1)/uday(z 1)—where uday(z 1) is an impulse defining the beginning
of a new day—were briefly explored using data from the McCarthy et al. (2008b)
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85
study. However, early analyses indicated that data quality issues prohibit estimation
of meaningful models of this sort.
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Chapter 3
FORMULATION OF AN HMPC-BASED SMOKING CESSATION
INTERVENTION
3.1 Overview
Control systems engineering is playing an increasing role in clinical environments
with the goal of automating high quality care, increasing the e ciency of treatments,
or treating patients in remote areas or developing nations through telehealth technolo-
gies (Doyle et al., 2011). Fraser Health (2014) and Soltesz (2013) use a PID control
algorithm to automate delivery of anesthesia; Denai et al. (2009) and Ross et al.
(2009) employ a fuzzy logic controller to automate delivery of medication to cardiac
intensive care patients; a predictive control approach to designing treatment regimens
for pharmacological HIV therapies is presented in Zurakowski and Teel (2006); Doyle
et al. (2014) surveys the current landscape of control approaches for use within ar-
tificial pancreas technology; and Brier et al. (2010) and Gaweda et al. (2008) take a
Model Predictive Control (MPC) approach to treating anemia.
Recently, predictive control concepts have been introduced into behavioral health
settings by casting the task of developing adaptive, behavioral intervention decision
rules as a control systems engineering problem (Deshpande et al., 2014, in press; Dong
et al., 2012, 2013, 2014; Noble, 2014; Rivera, 2012; Rivera et al., 2007; Savage et al.,
in press; Timms et al., 2014d). Accomplishing this draws from a number of clear
parallels between adaptive behavioral interventions and control systems engineering
principles. Table 3.1 summarizes these conceptual connections.
Briefly described in Section 1.4.3, decision systems based on MPC and Hybrid
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Table 3.1: Conceptual Connections Between Adaptive Interventions in Behavioral
Health and Control Systems Engineering Principles.
Adaptive behavioral intervention component Control systems engineering equivalent
Intervention outcomes Controlled variables, associated variables
Intervention goals Set points, controlled variable targets
Tailoring variables Measured outputs, disturbances, and scheduling
parameters (feedback and feedforward signals)
Treatment components (e.g., medication) Manipulated variables
Clinical use guidelines and restrictions Constraints
Decision rules Controller
Behavior change process Open-loop dynamical systems models
MPC (HMPC) o↵er distinct advantages in terms of frameworks for adaptive behav-
ioral interventions. Some of these advantageous features include the following: control
action is determined by minimization of an objective function (Camacho and Bor-
dons, 1999; Goodwin et al., 2005; Ogunnaike and Ray, 1994; Rossiter, 2003), which is
conducive to optimized, personalized dosing (Nandola and Rivera, 2013; Rivera et al.,
2007; Timms et al., 2014d); HMPC specifically can manage the pre-determined and
discrete-valued nature of treatment component dosages when determining optimal
dosing regimens (Bemporad and Morari, 1999; Deshpande et al., 2014; Dong et al.,
2013; Nandola and Rivera, 2013; Timms et al., 2014d); the predictive and receding-
horizon nature of MPC means dosing decisions can be made with a patient’s past,
present, and future needs in mind (Deshpande et al., 2014; Dong et al., 2013; Nandola
and Rivera, 2013; Timms et al., 2014d), which facilitates “just-in-time” decision mak-
ing (Intille et al., 2003; Kumar et al., 2013; Riley et al., 2011; Timms et al., 2014d);
predictive control can systematically manage multi-input, multi-output (MIMO) sys-
tems; and constraints are explicitly considered at each decision point (Camacho and
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Bordons, 1999; Goodwin et al., 2005; Nandola and Rivera, 2013; Rossiter, 2003).
In this chapter, an HMPC-based adaptive smoking cessation intervention algo-
rithm is designed with three general tasks in mind:
• Tracking intervention targets: The controller assigns adjustments to treat-
ment component dosages in order to take measured treatment outcomes toward
target levels.
• Managing measured disturbances: The intervention controller seeks to
reject measured disturbances that may otherwise move the measured outcomes
away from target levels or, more generally, negatively influence performance.
• Rejection of unmeasured disturbances: The intervention controller will
manipulate treatment component dosages in order to manage the risks posed
by unmeasured factors, such as exogenous unmeasured and unmodeled distur-
bances and plant-model mismatch (which are managed by the controller in
a similar manner). The ability of the controller to mitigate the potentially
negative e↵ects of such disturbances is critical, given the significant patient-to-
patient variability present in this problem setting.
More specifically, this chapter lays the conceptual and computational groundwork for
a control engineering-based decision system that personalizes treatment over time in
order to meet the changing needs of a smoker trying to quit. An HMPC-based algo-
rithm is derived where CPD and Craving are the primary controlled variables and
Quit and Stress are measured and anticipated disturbances. The HMPC algorithm
primarily assigns day-to-day adjustments to dosages of treatment components that
are both pharmacological and behavioral in nature. Altogether, the MIMO controller
formulation is developed to take CPD and Craving to target levels of zero each day.
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It should be noted that Timms et al. (2014d) proposed an initial framework for an
engineering-based smoking cessation intervention algorithm. The decision framework
developed in this chapter significantly builds upon, and refines the basic ideas dis-
cussed in Timms et al. (2014d). Chapter 4 similarly provides a much more thorough
analysis of intervention performance and a study of intervention robustness.
This chapter is organized as follows: Section 3.2 outlines the general requirements,
components, and structure of the controller designed in this dissertation; Section 3.3
o↵ers details on the open-loop dynamical systems models that act as the basis for
design of the controller; Section 3.4 details the decision-making procedure and com-
putations; and Section 3.5 extends the fundamental HMPC framework to one that
features three-degree-of-freedom (3DoF) tuning capabilities.
3.2 General Structure, Components, and Requirements of the Intervention
This controller design problem must address a number of factors not seen in more
conventional engineering settings. This is largely due to the clinical setting in which
the controller will be implemented and the fact that the “plant” in the control loop
is a smoker trying to quit. In terms of control-based behavioral health interventions
in general, determination, implementation, and ultimately clinical validation of the
control actions defined by the controller must adhere to an array of medical, practical
(largely logistical), and ethical restrictions. However, smoking interventions involve a
number of controller design considerations not present within other behavioral health
problem settings (Deshpande et al., 2012; Dong et al., 2012, 2013; Rivera et al., 2007;
Rivera, 2012). These factors include the fact that the cessation intervention revolves
around a central event—initiation of the quit attempt on a pre-determined target quit
date—in which the goal is to support the transition of a behavior from fully “on” to
fully “o↵”. This quit process moves CPD toward the cessation goal initially while
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simultaneously moving Craving further from the intervention goals (Timms et al.,
2014a,c). Furthermore, initiation of a quit attempt acts as an exogenous disturbance
on the system and also directly corresponds to set point changes on TQD; both of
which can be anticipated during every control decision, even for weeks prior to TQD.
Additionally, the set points are equal to physically realizable limits on the system
(e.g., CPD = 0) in this control problem, which may have implications for feasibility
of the optimization computations and dosing decision-making.
Altogether, the intervention algorithm derived in this chapter considers the clinical
requirements, concerns, and restrictions developed in the following subsection.
3.2.1 General Requirements
Table 3.1 describes the general parallels between an adaptive behavioral interven-
tion and a control loop with combined feedback-feedforward action. Translation of
the adaptive smoking cessation intervention concept into a control systems engineer-
ing setting must consider the following general clinical and practical aspects of the
cessation problem.
• The primary goal of smoking cessation intervention is to facilitate a patient’s
pursuit of a successful quit attempt. In order to directly support abstinence,
dosages should consider CPD (number of cigarettes smoked per day) as a con-
trolled variable. While quit attempt success does not necessarily require com-
plete abstinence for all times beginning on TQD, the primary intervention target
is CPD = 0, t   TQD.
• Although the most straightforward metric of quit attempt success is CPD, the
intervention should also seek to mitigate risk factors that could otherwise pro-
mote relapse. Notably, high craving and withdrawal levels that are sustained
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for long periods or experienced as acute episodic events during a quit attempt
are associated with greater rates of lapse and relapse (Allen et al., 2008; Baker
et al., 2012; Shi↵man et al., 2006). Furthermore, recent work described previ-
ously and in Timms et al. (2014a,c) notes an interrelationship between Craving
(average daily craving levels) and CPD during an attempt to quit smoking.
Consequently, Craving is a second controlled variable here. A secondary goal
of reducing Craving, specifically moving Craving = 0, t   TQD, is therefore
also considered.
• Many smokers attribute lapse events to stress (Marlatt and Gordon, 1980; Shi↵-
man and Waters, 2004; Shi↵man, 1982), and rapid changes in stress levels are
associated with lapse and relapse (Shi↵man and Waters, 2004). Consequently,
stress levels should be incorporated dosing decision-making.
• In pursuit of an intervention that is optimized in a personalized manner, as-
sessments of a patient’s changing needs should act as feedback and feedforward
signals. Specifically, CPD and Craving are the controlled variables (measure-
ments of which act as feedback signals) and Stress is a disturbance (measure-
ments of which act as a feedforward signal). These signals are considered to be
self-reported measurements assessed via a mobile phone application or similar
mHealth technology.
• It is common for TQD to be determined or assigned days to weeks in advance
(McCarthy et al., 2008b; Lexicomp, 2014). Given the significant influence ini-
tiation of a quit attempt has on CPD and Craving, and its ability to be
appropriately represented as an exogenous disturbance (Timms et al., 2014a,c),
Quit should be incorporated into the control architecture as a measured and
anticipated feedforward signal.
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• Given the expense of treatment components, potential side-e↵ects of pharma-
cotherapies (Tobacco Use and Dependence Guideline Panel, 2008; Lexicomp,
2014; Rennard et al., 2014), and a concern that excessive treatment beyond
that required for cessation success may ultimately prove counterproductive (es-
pecially in patients who are able to achieve relatively successful outcomes with-
out the aid of an intervention; Rivera et al., 2007), an intervention that could
explicitly address a concern for the total dosing demands over a given time
period would be desirable.
• A “just-in-time” intervention describes treatment in which anticipatory dosing
is implemented prior to a potential detrimental change in a patient’s needs
(Kumar et al., 2013; Timms et al., 2014d).
• The first line medications used for smoking cessation are only available and
prescribed in pre-determined, discrete dosages (Tobacco Use and Dependence
Guideline Panel, 2008; U.S. Department of Health and Human Services and
Centers for Disease Control and Prevention, 2014; Lexicomp, 2014; Rennard
et al., 2014). Similarly, cessation treatment components that are behavioral or
cognitive in nature can realistically only be delivered in discrete-valued dosages
(e.g., the patient does or does not participate in a counseling session in a given
day). A clinically-relevant predictive controller should be formulated for a hy-
brid linear dynamical system (Bemporad and Morari, 1999; Nandola and Rivera,
2013).
• Combination therapies generally have the most success in supporting smoking
abstinence (Tobacco Use and Dependence Guideline Panel, 2008; Piper et al.,
2009; U.S. Department of Health and Human Services and Centers for Dis-
ease Control and Prevention, 2014). Consequently, an intervention formulation
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should involve a multi-input system. This, combined with the dual objectives of
minimizing CPD and Craving, implies that the intervention formulation must
be designed around a MIMO system. Given its ability to account for multiple
control objectives and manage multiple manipulated variables, an intervention
employing an MPC structure should be able to manage the MIMO nature of the
system in a systematic manner (Camacho and Bordons, 1999; Goodwin et al.,
2005; Rossiter, 2003; Ogunnaike and Ray, 1994).
• Because of the clinical and human health context, “hard” constraints should
be explicitly incorporated into determination of the control action. This inter-
vention requirement furthers the case for MPC as the algorithmic framework
(Camacho and Bordons, 1999; Goodwin et al., 2005; Rossiter, 2003; Ogunnaike
and Ray, 1994).
• Ideally, the dosing schedules assigned by the HMPC-based intervention should
not deviate too significantly from current protocols associated with specific
treatments. Clinicians may be uncomfortable with such significant deviations
from current clinical practice and large degrees of “o↵ label” medication use,
likely resulting in challenges in terms of practitioner buy-in.
• The intervention algorithms employed within a clinical setting should feature
“clinician-friendly” tuning. As those implementing the intervention will be
healthcare practitioners as opposed to engineers, a tuning strategy should be
defined that focuses on a subset of tuning knobs and consists of straightforward
tuning heuristics.
While the points made above are not necessarily an exhaustive list of the requirements
and ideal features of a clinically-implementable adaptive smoking cessation interven-
tion, they reflect the major factors to be considered. Consequently, conceptual and
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computational development of an HMPC-based intervention that reflects these re-
quirements and concerns will o↵er an advanced starting point from which e↵orts to
experimentally assess the clinical utility of this approach can begin.
3.2.2 Treatment Components
The intervention components considered in this work are as follows:
1. Counseling, uc: Brief tobacco dependence treatment delivered in the form of
telephone counseling has been shown to be e↵ective (U.S. Department of Health
and Human Services and Centers for Disease Control and Prevention, 2014).
This treatment component would entail “practical counseling,” which includes
identification of a patient’s “danger situations” that may promote relapse, and
development of coping skills (Tobacco Use and Dependence Guideline Panel,
2008). The prominence of telephone quit lines within public health programs
(Centers for Disease Control and Prevention, 2014; U.S. Department of Health
and Human Services and Centers for Disease Control and Prevention, 2014)
suggests this may be an appealing venue through which such counseling could
be implemented. Recent e↵orts to allow an exchange of patient information
between quit lines and the servers on which electronic medical records are held
(Adsit et al. (2014); on which an intervention algorithm may also calculate
dosing decisions) may even allow quit line counselors to call patients for whom
the HMPC algorithm assigns counseling for a given day.
2. Bupropion, ub: One of the two non-nicotinic first line medications, sustained-
release bupropion has consistently been shown to help people quit smoking (U.S.
Department of Health and Human Services and Centers for Disease Control and
Prevention, 2014). Current bupropion dosing protocols consist of 150 mg once
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daily for three days, then increased to twice daily, with eight hours in between
doses. Evidence-based bupropion treatment regimens consist of 7-12 weeks
of 300 mg per day, with the protocol beginning at least one week pre-TQD
(Tobacco Use and Dependence Guideline Panel, 2008; Lexicomp, 2014).
3. Lozenges, ul: One of the five nicotine-based first line cessation medications
(Tobacco Use and Dependence Guideline Panel, 2008), nicotine replacement
lozenges deliver nicotine orally. Patients assessed to have a high nicotine de-
pendency (e.g., those who smoke within 30 minutes of waking) are directed to
take 4 mg lozenges as opposed to 2 mg lozenges. The typical dosing schedule
involves one lozenge every one to two hours, up to five lozenges every six hours
or 20 per day; one lozenge dissolves in the mouth in approximately 30 minutes
(Rennard et al., 2014). Patients typically report that lozenges are less satisfy-
ing than a cigarette. This is likely a reflection of the fact that nicotine delivery
via the blood stream (initially through tissues in the mouth) occurs on a much
longer time scale than nicotine delivered through smoking (Piper et al., 2009).
In summary, the HMPC algorithm must assign the manipulated variables according
to the following discrete-valued levels:
uc(k) 2 {0, 1} [sessions/day] (3.1)
ub(k) 2 {0, 1, 2} [150mg doses/day] (3.2)
ul(k) 2 {0, 1, 2, ..., 20} [lozenges/day] (3.3)
3.2.3 Constraints
As the system being intervened upon is human health, dosing decisions need to
adhere to a variety of constraints. These constraints reflect medical concerns (e.g.,
medication toxicity levels), resource-use limitations (e.g., restrictions on counseling
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availability as imposed by a patient’s health insurance policy), and practical and lo-
gistical considerations (e.g., manufacturer-determined bupropion dosage levels). The
intervention developed here considers the following constraints:
• Treatment component dosages can only be assigned in discrete levels, which are
pre-determined: uc can only be assigned as whole counseling sessions; bupropion
is only widely available in 150 mg doses (Lexicomp, 2014); and ul can only be
assigned as whole lozenges.
• A minimum number of zero doses of any of the treatment components can
be assigned each day. For practical and logistical reasons, a maximum of one
dose of counseling can be assigned each day. Dictated by medication safety
concerns, a maximum of two 150 mg bupropion doses can be assigned each
day (Lexicomp, 2014). To avoid nicotine toxicity symptoms, a patient can be
assigned a maximum of 20 lozenges per day (Tobacco Use and Dependence
Guideline Panel, 2008; Rennard et al., 2014).
• There is no limit to how much uc or ul can increase or decrease from one day to
another, other than the limits due to the availability of discrete-valued dosage
levels.
• Although up to two doses of 150 mg of bupropion can be assigned to a patient
per day, bupropion use protocols require that a patient take one 150 mg dose
per day for three days before a second daily dose can be assigned (Tobacco
Use and Dependence Guideline Panel, 2008; Lexicomp, 2014). There are no
medically-necessitated restrictions on the magnitude at which ub can decrease
from one day to another.
• Assigning unlimited counseling for the duration of an intervention is impractical.
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Similarly, a health insurance company will often cover only a certain number of
counseling sessions over a given quit attempt (Centers for Disease Control and
Prevention, 2006). Because of this, a maximum bound on the total amount of
counseling received by a patient over the intervention time period considered
should be enforced.
• Negative CPD and Craving values are not physically realizable or logical,
respectively. Therefore, the controller should adhere to a lower bound of zero
for both controlled variables.
• The results of the clinical trial documented in Piper et al. (2009) suggest a syn-
ergistic e↵ect when nicotine replacement therapy is combined with bupropion.
To maximize the e↵ect of both and reasonably assume a linear system despite
a potential non-linearity introduced by the interaction between these treatment
components, lozenges should only be assigned when bupropion is also being
assigned.
As will be shown in Section 3.4, these requirements will be incorporated into the
models representing the open-loop cessation process as a hybrid dynamical system,
and as upper and lower limits on the controlled variables, manipulated variables, and
move sizes.
3.2.4 Intervention Structure & Decision-Making Process
The closed-loop intervention is patterned after the conceptual structure depicted
in Fig. 3.1. Such an approach is particularly appealing given the emergence of tech-
nologies that o↵er cost-e↵ective platforms through which information on changing
patient needs can be collected, a decision support system may be operationalized,
and dosing decisions may be delivered (Adsit et al., 2014; Aveyard and Raw, 2012;
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Figure 3.1: Block Diagram of the General Decision Framework for an Adaptive,
Smoking Cessation Intervention that Employs an HMPC Algorithmic Structure to
Define Daily Dosages of Counseling, Bupropion, and Nicotine Replacement Lozenges.
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Figure 3.2: Flow Chart of the Decision-Making Process for the HMPC-Based Smok-
ing Cessation Intervention. p is the Prediction Horizon, m is the Move Horizon, and
J Denotes the Objective Function.
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Kumar et al., 2013; Riley et al., 2011; Tobacco Use and Dependence Guideline Panel,
2008). As alluded to previously, the intervention pursued here focuses on a daily time
scale and relies on an HMPC framework.
The decision-making process consists of the steps depicted in the flow chart in
Fig. 3.2. The open-loop behavior change models and intervention properties are spec-
ified prior to any decision-making. At each decision period, values of the controlled
(CPD, Craving) and measured disturbance variables (Quit, Stress) are obtained
through patient self-reports via a mobile phone application. The next p days (i.e.,
the length of the prediction horizon) of CPD and Craving o↵sets in the absence of
additional control action are predicted based on the measurements, nominal models,
and previous dosage assignments. The next m days of uc, ub, and ul values are de-
termined by minimizing J subject to constraints (where m is the move horizon and
J is the objective function). Only the first set of these treatment dosage levels are
assigned, before these steps are repeated on the next decision period. Details of the
HMPC formulation are described in the following subsections.
3.3 Open-Loop Dynamical Systems Models
3.3.1 Representative Patient Dynamics
Development of a model-based control algorithm requires a su cient understand-
ing of the relationship between controlled variables and both manipulated and non-
trivial disturbance variables. In this work, the HMPC decision framework that assigns
daily dosage adjustments considers the following general transfer function represen-
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tation of the system:
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375
264 Quit
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375 (3.4)
where Pcpdc(s), Pcpdb(s), and Pcpdl(s) represent the open-loop transfer functions de-
scribing how CPD responds to unit changes in the respective manipulated variable
dosages. Pcravc(s), Pcravb(s), and Pcravl(s) represent the open-loop transfer functions
describing how the patient-reported average daily craving level responds over time to
unit changes in the manipulated variables. Stress represents patient-reported levels
of average stress per day, which acts as a disturbance to the system. PcpdS(s) and
PcravS(s) are the corresponding disturbance models. Quit is a signal representing the
transition from not attempting to quit smoking to attempting to quit. Here, the Quit
signal is treated as the primary measured disturbance, the entire character of which
is known prior to any dosing. PcpdQ(s) and PcravQ(s) are the corresponding transfer
functions representing how a patient’s CPD and Craving levels would vary from
day-to-day when trying to quit smoking without the aid of any treatments.
Ideally, a patient-specific HMPC-based cessation intervention would be formulated
and implemented for each individual patient using open-loop models representative of
that smoker’s actual individual dynamics. However, estimating these models involves
significant experimental and logistical challenges (Deshpande, 2014; Deshpande and
Rivera, 2013). Instead, the smoking intervention is developed using nominal models
of a hypothetical, representative patient. This representative patient draws from
dynamics observed for one subject in the McCarthy et al. (2008b) clinical trial and
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modeled in Timms et al. (2014a). Prior to TQD, this hypothetical subject smokes 9.25
cigarettes per day and experiences an average daily craving level of 16.40. The quit
attempt dynamics, which describe an unsuccessful quit attempt, are represented by
the continuous-time transfer function structure in equation 3.5 and the corresponding
parameters in Table 3.2:
PyQ(s) =
KQ(⌧a1Qs+ 1)(⌧a2Qs+ 1)
⌧ 2Qs
2 + 2⌧Q⇣Qs+ 1
(3.5)
where y will be either CPD or Craving. These models correspond to simplified and
rearranged versions of equations 2.37 and 2.38 for the hypothetical patient.
This subject is initially able to quit smoking on TQD without the aid of any
intervention, but this also corresponds to an initial increase in Craving. However,
the patient gradually resumes smoking over time with a corresponding to a reduction
in Craving levels. Both outcomes ultimately settle to approximately pre-TQD levels.
These open-loop models reflect how initiation of a quit attempt initially brings CPD
levels toward the target of cessation, while conversely Craving is initially pushed
away from the target of reducing Craving.
The open-loop dose-response models for the hypothetical subject are represented
as low order continuous-time functions described below. These open-loop dose-
response and Stress-response models should ultimately be obtained by estimating
and validating models using data from novel clinical trials designed with system iden-
tification in mind. However, conducting trials of this nature would require significant
e↵ort, time, and funding. These considerations, and limitations associated with sec-
ondary analysis of the previously-described UW clinical trial (McCarthy et al., 2008b),
mean that the following dose-response and Stress-response models are primarily in-
formed by literature and analysis of step and impulse responses.
The continuous-time models representing how one 10-minute phone counseling
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session leads to changes in either controlled variable employ the transfer function
structure in equation 3.6 and the corresponding parameters in Table 3.2:
Pyc(s) =
Kyc
⌧ 2c s
2 + 2⌧yc⇣ycs+ 1
(3.6)
where y will be either CPD or Craving. These equations suggest a single counseling
session has a relatively modest e↵ect on the representative patient (Tobacco Use and
Dependence Guideline Panel, 2008; McCarthy et al., 2008b).
Table 3.2: Parameter Values of the Dose-, Quit-, and Stress-Response Open-Loop
Models in Continuous-Time Form for the Representative Patient.
Model Parameters Parameter Values
PcpdQ KQ, ⌧a1Q , ⌧a2Q , ⌧Q, ⇣Q -0.24, 90.53, 10.76, 5.07, 0.59
PcravQ KQ, ⌧a1Q , ⌧Q, ⇣Q -0.24, 90.53, 5.07, 0.59
Pcpdc Kc, ⌧c, ⇣c -30.00, 4.00, 1.50
Pcravc Kc, ⌧c, ⇣c -50.00, 3.75, 1.50
Pcpdb Kb, ⌧b, nb -1.28, 0.45, 3.00
Pcravb Kb, ⌧b, nb -1.16, 0.50, 3.00
Pcpdl Kl, ⌧al , ⌧l -0.50, -0.44, 0.88
Pcravl Kl, ⌧al , ⌧l -0.70, -0.44, 0.50
Pcpds Ks, ⌧as , ⌧s 1.65, 0.50, 0.80
Pcpds Ks, ⌧as , ⌧s 3.00, 0.60, 0.80
Bupropion is considered to have a relatively stable and uniform e↵ect when consis-
tently dosed, and has consistently been shown to be an e↵ective cessation aid. A unit
increase in daily bupropion dose—here, one 150 mg dose—is thought to take e↵ect
within three days (McCarthy et al., 2008b; Piper et al., 2009; Lexicomp, 2014; U.S.
Department of Health and Human Services and Centers for Disease Control and Pre-
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vention, 2014; Tobacco Use and Dependence Guideline Panel, 2008). Also informed
by observations of clinical trial data (McCarthy et al., 2008b), the continuous-time
open-loop bupropion dose for the representative subject employs the following struc-
ture and the corresponding parameters in Table 3.2:
Pyb(s) =
Kyb
(⌧bs+ 1)nb
(3.7)
Nicotine replacement gum and lozenges deliver nicotine through the bloodstream
via tissues in the mouth, which is a significantly slower delivery method compared to
actual cigarette smoking. This contributes to the observation reported by patients
that a nicotine replacement lozenge dose is less satisfying than one cigarette. How-
ever, compared to the daily time scale being considered here, a single dose of lozenge
lasts less than one hour generally (Lexicomp, 2014; Piper et al., 2009). Consequently,
the gain of the dose-response models to ul are relatively modest. Furthermore, the
continuous-time transfer functions are semi-proper, indicating that lozenges taken on
a given day are primarily e↵ective on that same day. Specifically, the models describ-
ing how one nicotine replacement lozenge a↵ects CPD and Craving levels employ
the continuous-time transfer function structure in equation 3.8 and the corresponding
parameters in Table 3.2:
Pyl(s) =
Kyl(⌧ayls+ 1)
(⌧yls+ 1)
(3.8)
Increased stress or bad mood levels for a given day are associated with relapse
on that same day, but not significantly on the following days (Shi↵man and Waters,
2004). To reflect this, the disturbance models associated with the exogenous Stress
disturbance employ the semi-proper transfer function structure in equation 3.9 and
relatively fast speeds of response, documented in Table 3.2:
PyS(s) =
KyS(⌧ayS s+ 1)
(⌧ySs+ 1)
(3.9)
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Figure 3.3: Step Responses for the Discrete-Time, Open-Loop Models Representing
the Dynamics for a Hypothetical Patient, in Deviation Variable Form (Solid) and
the Corresponding Nominal Model if Di↵erent than the Hypothetical Patient Model
(Dashed). The Unit Step Occurs at t = 0.
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Figure 3.4: Impulse Responses for the Discrete-Time, Open-Loop Models Repre-
senting the Dynamics for a Hypothetical Patient, in Deviation Variable Form (Solid)
and the Corresponding Nominal Model if Di↵erent than the Hypothetical Patient
Model (Dashed). The Unit Impulse Occurs at t = 0.
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3.3.2 Nominal Models
Section 3.3.1 represents the hypothetical, representative patient’s behavior change
processes in continuous-time model form. However, the nominal models used in com-
putation of the control action draw from discrete-time representations of these open-
loop models. The nominal models are obtained through discretization of equations 3.5
through 3.9 for a 1 day sampling time using the zero-order hold (ZOH) in equation 3.10
(Franklin et al., 1998; The MathWorks, 2014a):
G(z) = (1  z 1)Z
⇢
G(s)
s
 
(3.10)
whereG(z) is the ZOH-equivalent transfer function representation ofG(s), the frequency-
domain, continuous-time transfer function being discretized; Z {} indicates the trans-
formation from the continuous-time domain to the discrete-time domain; and z 1 in-
dicates a lagged sample (e.g., z 1y(z) in the z-domain is equivalent to q 1y(k) which
equals y(k   1) in the time-domain, where q 1 is the backshift operator; Franklin
et al., 1998; Ljung, 1999). Step or impulse responses for the z-domain versions of
the representative subject’s open-loop models are depicted with the solid lines in
Fig. 3.3 and Fig. 3.4 (step responses are shown for the models in which a step is
conceptually the appropriate input, and impulse responses are shown for the models
in which an impulse is conceptually the appropriate input). Simulations of the in-
tervention employ state-space versions of the semi-proper, discretized models as the
plant. The nominal models describing the response of CPD and Craving to uc and
ub are discretized versions of equations 3.6 and 3.7 in state-space form.
Discretization of equations 3.5, 3.8, and 3.9 similarly results in semi-proper func-
tions. Correspondingly, the discrete-time state-space form of these equations will
feature nonzero direct feedthrough terms. However, open-loop models featuring di-
rect feedthrough terms cannot be integrated into existing HMPC routines in this
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form: direct feedthrough terms mean the prediction step would require u(k + 1) to
compute y(k+1) and so on. Intuitively, this leads to an acausal scenario in the classi-
cal HMPC formulation as u(k+1) is itself determined using the predictions y(k+1).
Consequently, the controller formulation relies on adjusted versions of discretized
equations 3.5, 3.8, and 3.9.
As Quit represents a transition from not attempting to quit smoking to attempt-
ing to quit, and TQD is typically determined weeks prior to initiation of the attempt
(Tobacco Use and Dependence Guideline Panel, 2008; Lexicomp, 2014), this distur-
bance signal can be constructed a priori. Consequently, the Quit disturbance signal
observed by the controller is defined in equation 3.11:
Quit = 0, t < TQD  1
= 1, t   TQD  1 (3.11)
The Quit-response nominal models can now be appropriately represented by delayed
versions of discretized equation 3.5. In other words, as:
P˜cpdQ(z) = z
 1PcpdQ(z) (3.12)
P˜cravQ(z) = z
 1PcravQ(z) (3.13)
where PcpdQ(z) and PcravQ(z) are obtained via the transformation described by equa-
tion 3.10.
The nominal models for the controlled variables’ responses to ul and Stress are
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represented in discrete-time transfer function form as:
P˜cpdl(z) =
 0.228z 1 + 0.227z 2
1  1.359z 1 + 0.361z 2 + z
 1 0.085z
 1   0.085z 2
1  1.359z 1 + 0.361z 2 (3.14)
P˜cravl(z) =
 0.514z 1 + 0.510z 2
1  1.542z 1 + 0.542z 2 + z
 1 0.257z
 1   0.255z 2
1  1.542z 1 + 0.542z 2 (3.15)
P˜cpdS(z) =
0.894z 1   0.990z 2
1  1.570z 1 + 0.570z 2   z
 1 0.447z
 1   0.450z 2
1  1.570z 1 + 0.570z 2 (3.16)
P˜cravS(z) =
2.145z 1   1.773z 2
1  1.344z 1 + 0.431z 2   z
 1 1.072z
 1   0.887z 2
1  1.344z 1 + 0.431z 2 (3.17)
These models result from delayed versions of the continuous-time models transformed
into the z-domain, but have been adjusted such that the peak e↵ect of a unit impulse
in ul or Stress is not fully “expected” a full day after the impulse occurs, according
to the nominal model; furthermore, these models feature minimal mismatch in the
e↵ects of a unit impulse in ul and Stress for two or more days after the unit change.
The step and impulse responses for the nominal models are found in Fig. 3.3 and
Fig. 3.4.
3.3.3 Dosing Capacity
As described in Section 3.2, the decision framework should feature functionality
that systematically balances intervention targets with concerns of unnecessary or over-
dosing. Clinically, explicit consideration of total dosing demands may be motivated
by concerns for potential side-e↵ects, resource management, or whether a patient is
likely to adhere to aggressive dosing schedules.
In production-inventory control literature, a construct representing the quantity of
a manipulated variable assigned over a given time frame is referred to as a “capacity”
or “work-in-progress” (WIP ; Nandola and Rivera, 2013; Schwartz and Rivera, 2010).
The capacity for some manipulated variable u is generally represented as:
WIP (k + 1) =
✓ 1X
i=0
u(k   i) (3.18)
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where ✓ is the time delay between u(k) and y(k) and WIP (k+1) is the total amount
of u assigned by the controller between times k and k   ✓ + 1 (Nandola and Rivera,
2013).
In this context, the capacity construct representing the total amount treatment
doses assigned over a given time period is represented by equation 3.19.
WIPT (k + 1) =
nuX
j=1
nwipX
i=0
uj(k   i) (3.19)
where j indicates the jth manipulated variable, nu is the total number of manipulated
variables, and nwip is the number of samples in the time frame of interest for the
capacity construct.
A metric of the aggregate treatment used each day is defined. This metric of
aggregate dosing is calculated according to equation 3.19 where nu = 3, nwip = 1,
and the uj’s correspond to uc, ub, and ul. It can be shown that this treatment dosing
metric is equivalently represented by the discrete-time transfer function,
WIPT (z
 1) =
✓
z 1
1  z 1
◆
(uc(z
 1) + ub(z 1) + ul(z 1)) (3.20)
which is the summation of uc, ub, and ul dosages assigned for the previous day. For the
primary aim of penalizing over-dosing, equation 3.20, or more generally equation 3.19,
can be treated as a controlled variable with a set point, objective function penalty
weight, and/or constraints (as detailed later in this chapter). WIPT is assigned a
set point equal to 0 in lieu of penalties on each individual treatment component.
Such a set point and penalty weight ensures that total dosing demands would be
explicitly accounted for during minimization of the objective function while allowing
for flexibility in how the treatment components are assigned.
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3.4 Controller Development
3.4.1 Overview
Design of the smoking cessation intervention in this chapter draws from an im-
proved formulation of MPC for linear hybrid systems. The HMPC algorithm for-
mulated here considers the behavior change system in a mixed logical and dynamical
(MLD) framework to systematically manage the general goals of tracking intervention
targets, managing measured disturbances, and being robust to unmeasured influences
including noise and plant-model mismatch. Ultimately, 3DoF tuning capabilities are
incorporated into the decision system to allow more clinician-friendly adjustment to
the character of the dosing and outcomes. Details of the formulation are presented
below, and the intervention is evaluated through simulation in Chapter 4.
3.4.2 MLD Systems
Although advanced control approaches have largely emerged in the context of sys-
tems with smooth dynamics described by smooth transition functions, many systems
in which controllers can be incorporated have components that can be described by
logic, such as switched systems (Bemporad and Morari, 1999). The discrete-valued
nature of the manipulated variable levels in the cessation intervention means the open-
loop dynamical system can be represented as an MLD system. MLD systems can be
described by linear dynamic equations subject to linear mixed-integer inequalities;
these expressions are a function of both continuous and binary variables, with terms
for real or integer states, inputs, and constraints. Specifically, the linear hybrid be-
havior change process is represented as an MLD system in discrete-time, state-space
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form as:
x(k) = Ax(k   1) + B1u(k   1) + B2 (k   1) + B3z(k   1) + Bdd(k   1) (3.21)
y(k) = Cx(k) + d0(k) + ⌫(k) (3.22)
E5   E2 (k   1) + E3z(k   1)  E4y(k   1)  E1u(k   1) + Edd(k   1) (3.23)
where x and u represent discrete and continuous states and discrete and continuous
inputs, respectively; y is a vector of the outputs; d, d0, and ⌫ are the measured
disturbances, unmeasured disturbances, and noise, respectively, which are lumped
into the measurement equation (equation 3.22); and   (2 {0, 1}) and z are discrete and
continuous auxiliary variables, which facilitate conversion of logical/discrete decisions
into linear inequality constraints (equation 3.23; Bemporad and Morari, 1999).
To illustrate the conversion of logical/discrete decisions into linear inequality con-
straints via the auxiliary variables, recall equations 3.1 through 3.3. These expressions
noted that uc can only assume one of two possible levels, ub can only assume one of
three possible levels, and ul can only assume one of 21 possible levels. The discrete-
valued nature of counseling dosages can be represented logically:
 0(k) = 1 , z0(k) = 0
 1(k) = 1 , z1(k) = 1 (3.24)
1X
i=0
 i(k) = 1 (3.25)
uc(k) =
1X
i=0
zi(k) (3.26)
Equations 3.24 and 3.26 denote that  0 represents whether the 0 counseling dose level
is “on” and  1 represents whether the 1 counseling dose level is “on”. Equation 3.25
enforces that uc(k) must assume one and only one of its possible dosage levels at a
time. Similarly, the discrete-valued nature of the bupropion and lozenge dosages can
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be represented as equations 3.27 through 3.29 and 3.30 through 3.32, respectively.
 j(k) = 1 , zj(k) = j   2; j 2 {2, 3, 4} (3.27)
4X
j=2
 j(k) = 1 (3.28)
ub(k) =
4X
j=2
zj(k) (3.29)
 k(k) = 1 , zk(k) = k   5; k 2 {5, ..., 25} (3.30)
25X
k=5
 k(k) = 1 (3.31)
ul(k) =
25X
k=5
zk(k) (3.32)
These logical represents are incorporated into the decision-making process via the E⇤
matrices (where ⇤ is 1, 2, 3, 4, 5, and d) in equation 3.23.
Modeled as an exogenous e↵ect in the measurement equation (equation 3.22), the
unmeasured disturbance signal d0 is considered here to be a stochastic signal that is
described by equations 3.33 and 3.34,
xw(k) = Awxw(k   1) + Bww(k   1) (3.33)
d0(k) = Cwxw(k) (3.34)
where w(k   1) is a vector of integrated white noise; assuming d0 consists of uncor-
related components, Bw = Cw = I and Aw = 0 (for single-integrating disturbances,
i.e., Type I disturbances, as are considered here; Nandola and Rivera, 2013).
The prediction step of HMPC-based decision-making draws from an augmented
form of the state-space models in equations 3.21 and 3.22 to represent the system in
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di↵erence form:
X(k) = AX(k   1) + B1 u(k   1) + B2  (k   1)
+ B3 z(k   1) + Bd d(k   1) + Bw w(k   1) (3.35)
y(k) = CX(k) + ⌫(k) (3.36)
where
X(k) =
266664
 xT (k)
 xTw(k)
yT (k)
377775 =
266664
(x(k)  x(k   1))T
(xw(k)  xw(k   1))T
yT (k)
377775 (3.37)
A =
266664
A 0 0
0 Aw 0
CA Aw I
377775
Bi =
266664
Bi
0
CBi
377775 , i = 1, 2, 3, d ; Bw =
266664
0
I
I
377775
C = [0 0 I] (3.38)
 ⇤ denotes ⇤(k) ⇤(k 1) and  w(k) is a white noise sequence (Nandola and Rivera,
2013).
3.4.3 Prediction Step
The open-loop models in equations 3.35 and 3.36 and the constraints in equa-
tion 3.23 are used to predict the outcomes p steps into the future, Y(k + 1),
Y(k + 1) = ⇥yT (k + 1) yT (k + 2) · · · yT (k + p)⇤T (3.39)
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according to
Y(k + 1) =  X(k) +H1U(k) +H2 ¯(k) +H3Z(k) +HdD(k)
 H11u(k   1) H21 (k   1) H31z(k   1) Hd1dflt(k   1)
(3.40)
where the decision variables are represented in equations 3.41 through 3.43, and D(k)
is the externally-forecasted measured disturbance vector, per equation 3.44:
U(k) = ⇥uT (k) uT (k + 1) · · · uT (k +m  1)⇤T (3.41)
 ¯(k) =
⇥
 T (k)  T (k + 1) · · ·  T (k + p  1)⇤T (3.42)
Z(k) = ⇥zT (k) zT (k + 1) · · · zT (k + p  1)⇤T (3.43)
D(k) = ⇥dTflt(k) dTflt(k + 1) · · · dTflt(k + p  1)⇤T (3.44)
Deriving from equations 3.21 and 3.22, the coe cient matrices  , H11, H21, H31, Hd1,
H1, H2, H3, and Hd are as follows:
  =
266666664
CA
CA2
...
CAp
377777775 ; Hi1 =
2666666666664
CBi
CABi
CA2Bi
...
CAp 1Bi
3777777777775
, i = 1, 2, 3, d
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The inequality expression over the prediction horizon propagates to,
E5   E2 ¯(k) + E3Z(k) + E1U(k) + E4X(k) + EdD(k)
  E41u(k   1)  E42 (k   1)  E43z(k   1)  E4ddflt(k   1) (3.45)
where
Ei = (E¯4H¯i + E¯i), i = 2, 3, d
E4 = E¯4 ¯
E4i = E¯4H¯i1, i = 1, 2, 3, d
E5 = [E5 E5 · · · E5]T
and
E¯1 =
2666666666664
 E1 0 · 0
0
. . . · ...
... · · · ·  E1
...
...
...
...
0 · · · ·  E1
3777777777775
E¯i = diag{Ei, · · · , Ei}, i = 2, 3, d
E¯4 = diag{ E4, · · · , E4}
H¯j =
264 [0]ny
Hj(1 : (p  1)ny, :)
375 , j = 1, 2, 3, d, 11, 21, 31, d1
 ¯ =
264 C
 (1 : (p  1)ny, :)
375
3.4.4 Objective Function, Constraints, & Targets
The optimization problem at each decision period consists of determining the
sequence of control actions {u(k), · · · , u(k+m  1)}, { (k), · · · ,  (k+ p  1)}, and
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{z(k), · · · , z(k + p  1)} that minimize the value of the objective function J ,
min
{[u(k+i)]m 1i=0 ,[ (k+i)]p 1i=0 ,[z(k+i)]p 1i=0 }
J (3.46)
subject to process constraints, where:
J ,
pX
i=1
||y(k + i)  yr(k + i)||2Qy +
m 1X
i=0
|| u(k + i)||2Q u +
mX
i=0
||u(k + i)  ur(k + i)||2Qu
+
p 1X
i=0
|| (k + i)   r||2Q  +
p 1X
i=0
||z(k + i)  zr||2Qz (3.47)
(·)r denotes a reference signal and ||(·)||Q⇤ ,
p
(·)TQ⇤(·) is the vector 2-norm weighted
by the penalty matrix Q⇤: Qy is control error penalty weight; Q u is the move size
penalty weight; Qu penalizes deviations of u(k + i) from ur(k + i); Q  penalizes
deviations of  (k + i) from  r; and Qz penalizes deviations of z(k + i) from zr. The
process constraints corresponding to the quadratic cost function in equation 3.47 are
captured in equations 3.23 and,
ymin  y(k + i)  ymax , 1  i  p (3.48)
umin  u(k + i)  umax , 0  i  m  1 (3.49)
 umin   u(k + i)   umax , 0  i  m  1 (3.50)
where ymin and ymax are the upper and lower bounds on the controlled variable
trajectory, umin and umax are the bounds on the manipulated variables, and  umin
and  umax are the bounds on the manipulated variable move sizes.
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Intervention Objective Function
Corresponding to Fig. 3.1 and equation 3.47, the decision system developed here
focuses on the general problem of minimizing equation 3.51,
J , ||CPD(k + i)  CPDr(k + i)||2Qcpd + ||Craving(k + i)  Cravingr(k + i)||2Qcrav
+ || uc(k + i)||2Q uc + || ub(k + i)||2Q ub + || uc(k + i)||
2
Q ul
+ ||uc(k + i)||2Quc + ||ub(k + i)||2Qub + ||ul(k + i)||
2
Qul
+ · · · (3.51)
where Qcpd is the objective function penalty weight for the CPD tracking error and
Qcrav is that for the Craving tracking error; Q uc , Q ub , and Q ul are move suppres-
sion weights for the three treatment components; Quc , Qub , and Qul are the penalty
weights for use of the individual treatment components. Note, equation 3.51 assumes
the treatment component set points are 0 for all times, and omits terms for the
auxiliary variables and capacities for brevity.
Intervention Constraints
Directly related to the constraints described in equations 3.1 through 3.32 are the
following minimum and maximum manipulated variable bounds:
0  uc(k)  1 (3.52)
0  ub(k)  2 (3.53)
0  ul(k)  20 (3.54)
In terms of move size constraints, there is no limitation on the degree to which
counseling and lozenge dose can be adjusted from one day to another, beyond those
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implied by equations 3.52 and 3.54:
 1   uc(k)  1 (3.55)
 20   ul(k)  20 (3.56)
A patient cannot jump directly from zero to two 150 mg doses of bupropion per
day, instead, they must increase by one dose at a time. However, a patient at the
maximum bupropion dose can reduce their dose to any level (Lexicomp, 2014). These
dosing factors translate directly to the following move size constraint:
 2   ub(k)  1 (3.57)
However, ub = 2 can be assigned only after ub = 1 for at least three days (Lexi-
comp, 2014). Capturing the fact that going from one to two bupropion doses can
occur after a minimum of three days but at any time after that would require the
decision-making computations account for a “days-since-last-ub-change” component.
Incorporating a time-dependent constraint of this nature involves a significantly more
complex task than the computational intensity associated with constraints that are
non-time-varying. Instead, the three day ramp up period is incorporated as a switch-
ing time restriction. Specifically,
0   ub(k)  0, k 6= t1sw + nTsw
 2   ub(k)  1, k = t1sw + nTsw, n = 0, 1, 2, ... (3.58)
where t1sw is the first decision period at which ub dose can be adjusted. Tsw is the
switching time. i = 2 and Tsw = 4 are primarily considered in the following and cor-
respond to possible ub adjustments in the week pre-TQD that closely reflects current
clinical practice in terms of bupropion dosing (McCarthy et al., 2008b). Additional
details on switching time considerations within the context of HMPC-based decision
frameworks for health behavior therapeutics can be found in Dong et al. (2014).
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The following logical bounds constitute the constraint in equation 3.48 in the
day-to-day decision-making considered here:
0  CPD(k + 1)  1 (3.59)
0  Craving(k + 1)  1 (3.60)
To reflect the fact that the total amount of counseling is limited, a capacity con-
struct is employed (Nandola and Rivera, 2013). Drawing from equation 3.18, the
controller calculates the total amount of counseling assigned from the beginning of
the intervention through the current day as:
WIPc(k + 1) =
kX
i=0
uc(k   i) (3.61)
With this construct, counseling can be assigned on any day, but it can be limited to
only a certain number of sessions over the entire duration of the intervention. For a
maximum of five counseling sessions,
0  WIPc(k + 1)  5 (3.62)
To facilitate dosing that takes advantage of a synergistic e↵ect between bupropion
and lozenge, an additional linear inequality is defined to ensure that lozenge doses
are only assigned when ub(k) 6= 0; this constraint is represented logically as:
 m = 1 ; m 2 {3, 4, 5} (3.63)
5X
m=3
 m(k) = 1 (3.64)
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Intervention Targets
Intuitively, TQD corresponds to the time at which the CPD and Craving targets
change; mathematically:
CPDtarget(k) = CPDbase , t < TQD
= 0 , t   TQD (3.65)
Cravingtarget(k) = Cravingbase , t < TQD
= 0 , t   TQD (3.66)
where CPDbase and Cravingbase are the pre-TQD levels of CPD and Craving. Equa-
tion 3.65 reflects that the intervention essentially seeks to switch smoking from “on”
pre-TQD to “o↵” as of TQD. As TQD is assumed to be defined by a clinician or a
patient at least two weeks prior to actual initiation of the quit attempt (Tobacco Use
and Dependence Guideline Panel, 2008; McCarthy et al., 2008b; Lexicomp, 2014),
the reference vector Yr in equation 3.47 is essentially a function of TQD, and is re-
calculated at each decision time to reflect the set point change in equations 3.65 and
3.66.
3.4.5 Solving the Optimization Problem
Drawing from equations 3.40 and 3.45, the optimization problem described in
equations 3.46 and 3.47 can be rewritten in vector form as,
min
{U(k), ¯(k),Z(k)}
J , ||Y(k + 1)  Yr||2bQy + ||RuU(k) Ru0u(k   1)||2bQ u
+ ||U(k)  Ur||2bQu + || ¯(k)   ¯r||2bQ  + ||Z(k)  Zr||2bQz (3.67)
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subject to equation 3.45 and,
Ymin  Y(k + 1)  Ymax (3.68)
Umin  U(k)  Umax (3.69)
 Umin   U(k)   Umax (3.70)
where
Yr =
⇥
yTr (k + 1) y
T
r (k + 2) · · · yTr (k + p)
⇤T
(3.71)
Ur =
⇥
uTr (k) u
T
r (k + 1) · · · uTr (k +m  1)
⇤T
(3.72)
 ¯r =
⇥
 Tr (k)  
T
r (k + 1) · · ·  Tr (k + p  1)
⇤T
(3.73)
Zr =
⇥
zTr (k) z
T
r (k + 1) · · · zTr (k + p  1)
⇤T
(3.74)
are the reference vectors and
Ru =
2666666666664
I 0 0 · · · 0 0
 I I 0 · · · ... ...
0  I I . . . ... ...
...
...
. . . . . .
...
...
0 0 · · · · · ·  I I
3777777777775
, Ru0 =
266666664
I
0
...
0
377777775
bQy, bQ u, bQu, bQ , and bQz in equation 3.67 correspond to the penalty weights for the
control error, move suppression, treatment components, discrete auxiliary variables,
and continuous auxiliary variables, respectively; bQ⇤ indicates a square matrix with
the respective penalty weights in the diagonal.
The task at each decision period becomes to determine U(k),  ¯(k), and Z(k) by
solving the problem in equation 3.67 subject to the constraints in equation 3.45 and
3.68 through 3.70. In this HMPC framework, this optimization problem consists of a
mixed integer quadratic program (MIQP). Specifically, the standard MIQP consists
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of,
min
⇠
J , 1
2
⇠TH⇠ + GT ⇠ (3.75)
S⇠  b (3.76)
where ⇠ is the vector of decision variables, i.e.,
⇠ =
266664
U(k)T
 ¯(k)T
Z(k)T
377775 (3.77)
H and G are the coe cient matrices for the quadratic and linear terms in the objec-
tive function, respectively. These terms are obtained after substituting the prediction
equation Y(k + 1) (equation 3.40) into the objective function in vector form (equa-
tion 3.67) and rearranging to group the quadratic and linear terms. Specifically,
H = 2
266664
HT1 bQyH1 + bQ u + bQQ HT1 bQyH2 HT1 bQyH3
HT2 bQyH1 HT2 bQyH2 + bQ  HT2 bQyH3
HT3 bQyH1 HT3 bQyH2 HT3 bQyH3 + bQz
377775 (3.78)
G = 2[g1 g2 g3]T (3.79)
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where
g1 = X(k)
T T bQyH1   YTr bQyH1   UTr bQu +D(k)THTd bQyH1
  u(k   1)T (RTu0 bQ uRu +HT11 bQyH1)   (k   1)THT21 bQyH1   z(k   1)THT31 bQyH1
  dflt(k   1)THTd1 bQyH1
g2 = X(k)
T T bQyH2   YTr bQyH2    ¯Tr bQ  +D(k)THTd bQyH2
  u(k   1)THT11 bQyH2    (k   1)THT21 bQyH2   z(k   1)THT31 bQyH2
  dflt(k   1)THTd1 bQyH2
g3 = X(k)
T T bQyH3   YTr bQyH3   ZTr bQz +D(k)THTd bQyH3
  u(k   1)THT11 bQyH3    (k   1)THT21 bQyH3   z(k   1)THT31 bQyH3
  dflt(k   1)THTd1 bQyH3
S and b in equation 3.76 are the coe cient matrices for the linear constraints. Specif-
ically,
S = [s1 s2   s2]T ; (3.80)
where
s1 = [E1 E2 E3]; s2 =
266664
H1 H2 H3
Im(nu) [0]m(nu)xp(n ) [0]m(nu)xp(nz)
Ru [0]m(nu)xp(n ) [0]m(nu)xp(nz)
377775
(3.81)
125
and
b =
2666666666666666664
E5   E4X(k)  EdD(k) + E41u(k   1) + E42 (k   1) + E43z(k   1) + E4ddflt(k   1)
Ymax    X(k) +HdD(k) H11u(k   1) H21 (k   1) H31z(k   1) Hd1dflt(k   1)
Umax
 Umax +Ru0u(k   1)
 Ymin X(k) +HdD(k) H11u(k   1) H21 (k   1) H31z(k   1) Hd1dflt(k   1)
 Umin
  Umin  Ru0u(k   1)
3777777777777777775
(3.82)
Well-established commercially available programs can solve this MIQP. The sim-
ulations presented in Chapter 4 rely on the TOMLAB-CPLEX solver described in
Holmstrom et al. (2009).
Output Constraint Relaxation
As previously described, the trajectory of the CPD target is meant to reflect the
intent to switch from a state of smoking “on” to smoking “o↵” (see equation 3.65).
Because of this, the for CPD target during the quit attempt is equal to zero cigarettes
per day, which is also the physically realizable bound of CPD. In other words,
ytarget(k) = ymin = 0 for k   TQD. As the behavior change process is represented
as a linear system here, dosing prior to or around TQD can lead to predicted CPD
trajectories that violate the ymin constraint. Consequently, early simulations of the
intervention frequently resulted in infeasible solutions to the optimization problem
according to the TOMLAB-CPLEX solver. The proof-of-concept nature of this work
motivated incorporation of constraint-relaxing capabilities, ultimately allowing valu-
able analysis of the intervention through simulation with often minor relaxation of
the ymin constraint. Three relaxation approaches were explored.
Initially, a relaxation approach was considered where the window over which a
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constraint is enforced is shortened in order to obtain feasibility (Scokaert and Clarke,
1994). Here, this entailed altering the constraint in equation 3.48 to,
 1  y(k + i)  ymax, 1  i  p✏ (3.83)
ymin  y(k + i)  ymax, p✏ + 1  i  p (3.84)
as necessary. Equation 3.83 reflects that the constraint corresponding to the lower
bound on the controlled variables is removed for the first p✏ time points in the predic-
tion horizon; the lower bound constraint is enforced for the duration of the prediction
horizon, per equation 3.84. (Note, both bounds could be relaxed in this manner.
Equations 3.83 and 3.84 only indicate relaxation of the lower bound as ymax =1 in
this intervention already, per equations 3.59 and 3.60.) Equations 3.83 and 3.84 would
only be implemented when the TOMLAB-CPLEX solver indicated an infeasible so-
lution under the conditions of the hard constraint in equation 3.48; when relaxation
was required, the bounds in equations 3.83 and 3.84 were incorporated in an itera-
tive manner such that the smallest p✏ that gave feasible solutions in the optimization
problem was found.
Alternatively, relaxation was considered in which a slack variable, ✏, was added to
b in equation 3.76, where ✏ is a column vector with the same number of rows as in b.
An informal implementation of this slack variable approach was briefly implemented
in a loop around the decision computations such that ✏ = 0 initially, and was increased
by an operator-defined increment (e.g.,  ✏ = 0.1) in an iterative manner until an ✏
value that gave a feasible solution to the optimization problem was found.
A more formal implementation of the slack variable concept was determined to
be a more appropriate relaxation method. In this more formal approach, the values
of the elements in the column vector ✏ are found optimally (Camacho and Bordons,
1995; Zheng and Morari, 1995). Specifically, the optimization problem described by
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equations 3.75 and 3.76 is now,
min
⇠⇤
J , 1
2
⇠⇤T
264H 0
0 bQ✏
375 ⇠⇤ +
264G
0
375
T
⇠⇤ (3.85)
[S   1]
264⇠
✏
375  b (3.86)
where ⇠, H, G, S and b are still described by equations 3.77, 3.78, 3.79, 3.80 and 3.82,
respectively; the vector of decision variables, ⇠⇤, is now,
⇠⇤ =
264⇠
✏
375 =
266666664
U(k)T
 ¯(k)T
Z(k)T
✏
377777775 (3.87)
and bQ✏ is a diagonal matrix of weights penalizing the degree of constraint relaxation.
The bQ✏ matrix results from inclusion of a constraint relaxation term in the objec-
tive function (which is how this relaxation method is more flexible and optimal than
some alternative approaches):
min
{U(k), ¯(k),Z(k),✏}
J , ||Y(k + 1)  Yr||2bQy + ||RuU(k) Ru0u(k   1)||2bQ u
+ ||U(k)  Ur||2bQu + || ¯(k)   ¯r||2bQ  + ||Z(k)  Zr||2bQz + ||✏||2bQ✏
(3.88)
The values in the diagonal of bQ✏ influence how easily solutions to the optimization
problems can diverge from the specified hard constraint. Simulations of the interven-
tion here defined bQ✏ as:
bQ✏ = Q✏ I (3.89)
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where Q✏ is a single value chosen by the user. Mitigation of unnecessary relaxation
motivates choice of the largest Q✏ that provides feasible solutions for an acceptable
computing time, theoretically. Practically, one should choose Q✏   max(Qy, Q u,
Qu, Q , Qz). Unless otherwise specified, Q✏ = 1e5 in this dissertation.
The constraint-relaxation method described by equations 3.85 through 3.88 re-
flects that here, the slack variable is calculated during every decision period, but is
constant over the prediction horizon considered in those computations. Furthermore,
as the lower bound on the controlled variables were the sources of infeasibility errors
from the TOMLAB-CPLEX routines, the rows of ✏ corresponding to the ymin rows of
equation 3.82 were optimally determined, while the other elements of ✏ are set to 0.
3.5 Three-Degree-of-Freedom (3DoF) Tuning Capabilities
The formulation described in Section 3.4 that is to be incorporated into the gen-
eral structure in Fig. 3.1 relies on p, m, and the control error, move suppression,
and treatment component penalty weights to influence the character of the manipu-
lated variable assignments, controlled variable performance, and overall robustness.
However, the e↵ect of adjustments to these parameters on individual controlled and
manipulated variables is di cult to disentangle.
3DoF tuning capabilities o↵er a more intuitive way to tune the controller in an at-
tempt to obtain favorable outcome responses and manipulated variable adjustments.
More straightforward tuning capabilities could facilitate a more clinician-friendly
HMPC-based intervention. Portions of Chapter 4 examine an intervention formu-
lation with 3DoF features. Specifically, the more basic HMPC structure depicted in
Fig. 3.1 is expanded to consider the intervention framework depicted in Fig. 3.5.
In this figure, the CPD target, Craving target, and Stress disturbance signals
pass through filters that influence tuning. Detailed below, first order filters that
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Figure 3.5: Block Diagram of the Decision Framework for an Adaptive, Smoking
Cessation Intervention that Employs an HMPC Algorithmic Structure with 3DoF
Tuning Functionality.
adhere to the structure in equation 3.91 are considered. ↵cpdr and ↵
crav
r influence
the speed at which the intervention tracks the CPD and Craving targets (↵⇤r = 0
corresponds to the most aggressive tracking of the target for a given set of penalty
weights and constraints, where ⇤ indicates CPD or Craving). ↵Sd (✏ [0, 1)) a↵ects
the character of set point tracking by influencing the speed at which a Stress dis-
turbance is rejected (↵Sd = 0 corresponds to the most aggressive Stress disturbance
rejection case). The fa terms influence the speed at which unmeasured disturbances
are rejected.
3.5.1 Reference Trajectories
The ↵r parameter is intended to facilitate tuning of controlled variable responses
independently (Nandola and Rivera, 2013).
In the 3DoF structure, the reference signal(s) incorporated into decision compu-
tations (see equation 3.71 and the related equation development) consist of a filtered
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representation of the intervention targets, per equations 3.90:
yr(k + i)
ytarget(k + i)
= f(q 1,↵jr), 1  j  nj, 1  i  p (3.90)
where f(q 1,↵jr) is a discrete-time filter for reference signal j in the set of nj targets
(nj = ny); q 1 is the backshift operator (Lee and Yu, 1994; Nandola and Rivera, 2013).
As the intervention targets in the cessation intervention are steps (equations 3.65 and
3.66), f(q 1,↵jr) takes the form of a Type-I filter:
f(q 1,↵j⇤) =
↵⇤   1
↵⇤q 1   1 , 0  ↵
j
⇤ < 1, 1  j  nj (3.91)
where ⇤ denotes r and nj is still the number of reference signals when the Type-I filter
corresponds to equation 3.90. The denominator of the filter in equation 3.91 indicates
that filtering the ytarget signal influences the speed at which the target is tracked, as
the signal is processed by a filter that features a pole on the real axis, the location
of which is between 0 and -1. The parameter ↵jr individually detunes the speed at
which the intervention target corresponding to reference (equivalently, outcome) j is
tracked: ↵jr = 0 corresponds to the no-detuning case, in which the j
th target signal
exactly equals the corresponding yr values in equations 3.71 at all time points. In
di↵erence equation form, equation 3.91 in the context of the reference signal filter
expands to,
yr(k + i) = (1  ↵r) ytarget(k + i) + ↵ryr(k + i  1) (3.92)
Equation 3.92 highlights that ↵r generally influences the fraction of the set point
signal used in the optimization problem at time k + i that is the actual intervention
target at that time.
Note that Fig. 3.5 only depicts filtering action for the CPD and Craving refer-
ences. Because the WIPT construct is incorporated in order to discourage aggregate
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over-dosing, its target remains constant—equal to 0—over all time points. Conse-
quently, an ↵wipTr tuning knob should play no e↵ective role in dosing decisions, and
therefore this target signal is omitted from the block diagram, and no filter is asso-
ciated with WIPT . Similarly, the set points for the decision variables are also set to
0 for every time point (equations 3.72 through 3.74 are vectors of 0’s), and therefore
no filters are associated with these set points.
3.5.2 Measured Disturbances
Equation 3.93 corresponds to the filter that facilitates independent adjustment of
the speed at which the jthd disturbance is rejected.
dflt(k + i)
d(k + i)
= f(q 1,↵jdd ), 1  jd  nd, 1  i  p (3.93)
where nd is the number of measured disturbances and d(k+i) consists of measured dis-
turbance signal forecasts. Intuitively, a disturbance on the behavior change system
on the time scale of interest is unlikely to be approximately represented as a ramp that
significantly and continuously increases. Consequently, f(q 1,↵jdd ) in these analyses
similarly employs the Type-I structure in equation 3.91. By extension,
dflt(k + i) = (1  ↵d) d(k + i) + ↵ddflt(k + i  1) (3.94)
Filtering the Quit disturbance signal via an ↵Qd parameter would greatly a↵ect
performance since significant and immediate changes in both CPD and Craving
are induced by the Quit step. However, detuning that slows the rejection of Quit
is operationally undesirable. Given that the Quit step is the signal representing
the fundamental reason why such an intervention is being designed, and is directly
and inherently related to the CPD and Craving target changes and corresponding
dynamics, slowing the rate at which the full value of Quit signal is delivered to
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the controller is incongruous with the purpose of the intervention. Furthermore,
filtering the Quit signal would also suggest that the anticipation of the Quit step
should also be filtered, and the ability to forecast initiation of the upcoming quit
attempt from the very first decision period is particularly advantageous; such Quit
may facilitate aggressive pre-TQD dosing, which is more in line with current clinical
practice. In other words, filtering Quit and providing an anticipated but filtered Quit
signal unnecessarily diminishes the value of anticipating this measured disturbance.
Filtering the Quit signal is also unnecessary from a practical point of view. As Quit
initially brings CPD to its set point in the nominal case, filtering the Quit signal
would lead to decision-making that essentially does not take advantage of the fact
that Quit supports pursuit of the CPD target for a period of time, leading to more
and unnecessary dosing around TQD. Due to these considerations, ↵Qd is omitted from
Fig. 3.5 and ↵Qd = 0 in the decision computations.
Anticipation of the Stress disturbance entails assuming that Stress will equal its
most recent measured value for the duration of the prediction horizon, i.e., assumes
{Stress(k+1), · · · , Stress(k+p 1)} = Stress(k). Consequently, calculation of the
filtered Stress disturbance signal per equation 3.93 reflects d(k + i) = Stress(k) for
0  i  p  1.
3.5.3 Unmeasured Disturbances
As G and b in equations 3.75 and 3.76 are both functions of X(k) (see equa-
tions 3.79 and 3.82), an estimate for X(k) must be calculated at each decision period.
These estimates are obtained via a state observer. To be able to tune for measured
disturbance rejection and for unmeasured disturbance rejection independently, a two
step estimation procedure is employed:
1. Estimation of X(k): An estimate of X(k) is obtained per equations 3.95 and
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3.96:
X(k|k   1) = AX(k   1|k   1) + B1 u(k   1) + B2  (k   1)
+ B3 z(k   1) + Bd d(k   1) (3.95)
X(k|k) = X(k|k   1) +Kf (y(k)  CX(k|k   1)). (3.96)
Equation 3.95 is the prediction of X(k) per the model (under the assumption of
no white noise; see equation 3.35). Equation 3.96 involves a a correction when
the e↵ect of unmeasured disturbance is incorporated into the estimate, where
the (y(k)  CX(k|k  1)) term is the prediction error calculated with unfiltered
d signals; Kf is a filter gain. Conceptually, Kf is a weight telling the controller
how much to trust the model versus the measurement. Formulaically, Kf defines
the speed and character of unmeasured disturbance rejection (Nandola and
Rivera, 2013).
2. Estimation of Xflt(k): Xflt(k) represents an estimation of the augmented states
using a filtered form of the measured disturbance signal:
Xflt(k|k   1) = AXflt(k   1|k   1) + B1 u(k   1) + B2  (k   1)
+ B3 z(k   1) + Bd dflt(k   1) (3.97)
Xflt(k|k) = Xflt(k|k   1) +Kf (y(k)  CX(k|k   1)). (3.98)
The first term in equation 3.98 consists of the prediction obtained using the
filtered measured disturbance while the second term is the prediction error,
as before. The result is an estimate of the augmented states in which the
e↵ects of detuning the measured disturbance rejection via the ↵d parameter(s) is
decoupled from detuning the unmeasured disturbance rejection viaKf (Nandola
and Rivera, 2013).
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Ideally, an optimal Kf value would be determined. Doing so would require ac-
curate matrices of the process noise and measurement noise covariances (Franklin
et al., 1998; Nandola and Rivera, 2013). However, these covariances are di cult
to determine in this behavioral health problem setting. Instead, the filter gain is
parameterized according to:
Kf =
266664
0
Fb
Fa
377775 (3.99)
where
Fa = diag{(fa) + 1, . . . (fa)ny}, 0 < (fa)j  1 (3.100)
Fb = diag{(fb) + 1, . . . (fb)ny} (3.101)
(fb)j =
(fa)2j
(1 + ↵j(fa)j)
, 1  j  ny. (3.102)
↵j = 0 or = 1 for rejection of step and ramp disturbances, respectively, in the jth
controlled variable. The speed of unmeasured disturbance rejection is proportional to
value of the tuning parameter (fa)j; (fa)j = 1 corresponds to the no-detuning case,
where very aggressive control action is taken to reject the influence of unmeasured
disturbances on the jth controlled variable (Lee and Yu, 1994; Nandola and Rivera,
2013).
CPD and Craving are considered here to be the only signals that can be corrupted
by unmeasured disturbances and the e↵ects of plant-model mismatch, therefore, anal-
ysis of unmeasured disturbance rejection here considers f cpda and f
crav
a parameters
only.
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Chapter 4
EVALUATING INTERVENTION PERFORMANCE
4.1 Overview
The objective of an HMPC-based smoking intervention is generally to promote
successful cessation, and specifically to meet targets for the controlled variables; on
this basis, performance requirements for the controller can be defined. These require-
ments would seek to balance the desire for intervention e cacy with a concern for
dosing and resource-use demands. Ultimately, a clinician would determine what is ac-
ceptable performance. In this chapter, the intervention algorithm is assessed through
simulation in two broad sets of analyses:
1. Nominal Performance — First, controller performance is evaluated when there
is no model uncertainty and minimal plant-model mismatch (Morari and Zafiriou,
1989). In other words, the dose-, Quit-, and Stress-response models provided
to the controller are those describing the particular patient who is the “plant”
in the control loop. Nominal performance is first examined for an HMPC-
framework that does not feature 3DoF tuning capabilities; similar analyses are
later pursued for a formulation with 3DoF features. Nominal performance anal-
ysis in the following sections assumes nominal stability of the system (which can
be observed via simulation).
2. Robust Performance — The controller is also evaluated for robust performance,
i.e., performance in the presence of uncertainties (Morari and Zafiriou, 1989).
Deriving formal robustness margins for constrained predictive control is a sig-
nificant undertaking (Rossiter, 2003) and lies outside the scope of this work. In
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this chapter, uncertainties in the model are simulated via model perturbations.
Initially, unmodeled exogenous disturbances are incorporated in the form of
measurement noise. Plant-model mismatch is then incorporated in the form of
di↵erent parametric uncertainties in the open-loop models of the representative
patient. Next, the intervention is evaluated when the plant consists of models
estimated for single subjects from the placebo group in the McCarthy et al.
(2008b) study who are not the subject upon which the representative patient is
based. The assessment of robust performance includes robust stability.
4.2 Evaluating the Intervention: Time Frame & Conditions of Interest
The potential clinical utility of an HMPC-based adaptive smoking cessation inter-
vention is illustrated through simulation. Simulink, MATLAB’s graphical simulation
environment (The MathWorks, 2014g), facilitates such performance, robustness, and
tuning analyses, and a clinician-friendly tuning strategy is ultimately defined. These
analyses focus on the following conditions.
4.2.1 Time Frame
Intervention performance is primarily examined for a 50 day time span: control
action is first determined on day 0 and TQD is day 15.
Implementing the intervention approximately two weeks pre-TQD reflects the rec-
ommendation that patients pick a TQD two weeks prior to initiation of the actual
quit attempt (Tobacco Use and Dependence Guideline Panel, 2008). Calculating po-
tential control actions for days or weeks pre-TQD o↵ers a number of opportunities.
If suitable, nonzero dosage levels can be assigned in anticipation of TQD. Fixed in-
tervention protocols that feature such pre-TQD dosing have been shown to be helpful
for treatments featuring counseling and bupropion (Tobacco Use and Dependence
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Guideline Panel, 2008; McCarthy et al., 2008b; U.S. Department of Health and Hu-
man Services and Centers for Disease Control and Prevention, 2014; Lexicomp, 2014)
and is being explored for fixed interventions employing nicotine replacement therapies
(Bullen et al., 2006; Carpenter et al., 2013).
After TQD, analysis focuses on the first five weeks of the quit attempt. Approxi-
mately 70% of quit attempts fail within one month of initiation of the attempt (Meyer
et al., 2003), suggesting intervention evaluation on this time scale is appropriate. Fur-
thermore, habituation is more probable over long time periods (e.g., where a lozenge
has di↵erential e↵ects if delivered one week vs. ten weeks post-TQD; Mart´ın et al.,
2014). It is also hypothesized that the overall long-term cessation process involves
discrete stages characterized by distinct individual processes (DiClemente et al., 1991;
Prochaska and DiClemente, 1983; Velicer et al., 1998). These factors suggest it may
not be reasonable to assume that the models describing dynamics over the weeks
following TQD, such as those in equations 3.5 through 3.9 and Table 3.2, will be
representative of the dynamics that would be observed on the order of months post-
TQD. Consequently, a quit attempt is defined here as having been unsuccessful if a
patient has not significantly reduced smoking levels by day 50.
4.2.2 Disturbances
The Quit disturbance is described by equation 3.11 with TQD = 15, unless oth-
erwise specified.
Stress also acts as a measurable and anticipatable disturbance. A patient can
experience stress on a variety of time scales (Ehlert and Straub, 1998; Shi↵man and
Waters, 2004), impacting smoking behavior through a number of pathways (Shi↵man
and Waters, 2004). In the following, Stress is represented in two ways—as a step
of magnitude 3 and as stochastic signal. These signal types are intended to reflect
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Figure 4.1: A Time Series Realization of the Stochastic Signal that Represents
Stress (see Equation 4.1).
that stressors and their e↵ects may be acute or chronic in nature (Ehlert and Straub,
1998; Shi↵man and Waters, 2004). Day-to-day changes in the stochastic Stress signal
are assumed to be autocorrelated (DeLongis et al., 1988). Specifically, the stochastic
Stress signal is represented by a normally distributed pseudorandom sequence (N ⇠
(0, 0.5)) filtered according to the first order autoregressive model in equation 4.1
(The MathWorks, 2014b),
Stress(t) =
1.67
(0.67 q 1 + 1)
a(t) (4.1)
where Stress(t) and a(t) are discrete signals and q 1 is the time-domain backshift
operator. Fig. 4.1 features a realization of this stochastic stress disturbance.
4.3 Performance Metrics
Visual examination of simulated CPD and Craving responses and the correspond-
ing dosing profiles facilitate assessment of the intervention formulation and di↵erent
tuning conditions. However, quantitative metrics that are used here to help evaluate
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nominal and robust performance include:
• Rise time, tyr – Length of time after TQD required for the response of controlled
variable y to first reach within 5% of its target level.
• O↵set, eyti – Deviation between controlled variable y and its target at time ti
(in units of y).
• Total Cigs – Total number of cigarettes smoked over a specified time interval
(generally for t   TQD, below).
• Tot(u⇤) – Total number of doses of intervention component u⇤ assigned over a
specified time interval.
• Mean, µx – Average value of x over the time interval of interest; x may represent
a controlled or manipulated variable.
• Maximum value, max(x) – Maximum value of the sequence of variable x be-
tween two specified time points; x may represent a controlled or manipulated
variable.
• Minimum value, min(x) – Minimum value of the sequence of variable x between
two specified time points; x may represent a controlled or manipulated variable.
• Variance, var(x) – Variance of the sequence of variable x between two specified
time points; x may represent a controlled or manipulated variable.
• Cumulative deviation from target, Jye – Metric reflecting the cumulative devia-
tion between controlled variable y and its target level between times t1 and t2;
calculated according to (Nandola and Rivera, 2013):
Jye =
t2X
k=t1
(y(k)  ytarget(k))T (y(k)  ytarget(k)) (4.2)
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where ytarget(k) is the user-defined target for y at time k (which is equivalent
to the reference trajectory provided to the controller in the no-3DoF and ↵yr =
0 cases). This metric is intended to quantify total deviation of a controlled
variable from its target; as the simulations examined in this section enforce
saturation in CPD and Craving levels such that these controlled variables can
never assume negative values, the values of Jye and of Tot(y) are directly related.
• Cumulative intervention energy, Ju⇤I – Metric reflecting the cumulative energy
required of manipulated variable u⇤ between times t1 and t2; calculated accord-
ing to (Nandola and Rivera, 2013):
JuI =
t2X
k=t1
(u(k))T (u(k)) (4.3)
• Total relaxation required, ✏T – The total amount of constraint relaxation re-
quired for a given scenario and specified Q✏, defined as the sum of all values of
the slack calculated at each decision period, summed across all decision periods.
✏T should o↵er insight into the amount of relaxation necessary to obtain feasible
solutions to the optimization computations associated with each control move.
While these metrics o↵er quantified insight into intervention performance, each one
is not examined for each scenario below, and most of the following discussion focuses
on general characteristics of performance.
4.4 Nominal Performance
The goal of the simulations that follow in this section is to identify how the
penalty weights can be adjusted to give favorable CPD and Craving performance
and desirable dosing schedules. Unless otherwise specified, the following parameters
are kept constant: p = 30 days, m = 7 days, Qcpd = 10, Q u⇤ = Qu⇤ = Q  = Qz = 0
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(where ⇤ indicates counseling, bupropion, or lozenge here), Q✏ = 1e5, and T = 1 day.
To avoid unnecessary dosing, WIPT (see equation 3.19) is assigned a set point of zero
for all time points. Initially, the bupropion move size constraint in equation 3.58 is
implemented, which allows decreases in ub over time, where Tsw = 4 and t1sw = 2.
In several cases it is assumed Stress does not fluctuate beyond some baseline level,
mathematically represented as Stress = 0.
The following sections incorporate increasing degrees of penalty weighting and tun-
ing complexity. The scenarios of focus for nominal performance analysis are described
in Table 4.1 and referred to by scenario number in the remainder of Section 4.4.
Table 4.1: Scenarios Considered in Section 4.4.
Scenario QwipT ↵
⇤
r ↵
S
d Stress  ub constraint equation
1 0 0 0 0 3.57
2   0 0 0 0 3.57
3   0 0 0 Step 3.57
4   0 0 0 Stochastic 3.57
5   0 0 0 Stochastic 4.4
6 1   0 0 0 4.4
7 1 0   0 Step 4.4
8 1 0   0 Stochastic 4.4
9 1   0   0 Stochastic 4.4
4.4.1 Tuning via Objective Function Penalty Weights
Within a standard HMPC framework (Fig. 3.1), the character of the control ac-
tion and controlled variable responses is determined by the objective function penalty
weights for a given set of targets, constraints, and manipulated variables. In this con-
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text, Qcpd and Qcrav, penalty weights on the CPD and Craving errors, respectively,
directly promote dosing that pursues intervention targets. QwipT penalizes deviations
of WIPT from its set point, which when set to 0 reflects a concern for the total dos-
ing demands for a given day. Qu⇤ penalizes deviations of manipulated variable u⇤
(where u⇤ denotes uc, ub, or ul) from its set point. Q u⇤ can suppress dosing changes.
Altering the values of these penalty weights relative to one another can facilitate a
practical desire to prioritize intervention goals, influence the time-varying nature of
controlled variable o↵sets, and adjust the character of dosing schedules.
Scenario 1
If the only nonzero objective function penalty weights are those for CPD and Craving
set point tracking, adjustment of the manipulated variables is aggressive, limited only
by the availability of discrete-valued dosage levels and hard constraints. In other
words, with QwipT = Qu⇤ = Q u⇤ = 0, dosing for the purposes of smoking abstinence
and Craving reduction tracking will be aggressive.
Mathematically, the relative values of Qcpd and Qcrav determine which outcome
target is prioritized during day-to-day decision making. Fig. 4.2 depicts three sets of
responses where Qcpd = 10 and Qcrav is an order of magnitude smaller than, equal
to, and an order of magnitude larger than Qcpd (Fig. 4.2a, Fig. 4.2b, and Fig. 4.2c,
respectively). The performance metrics corresponding to these figures (as well as
Qcrav = {5, 20, 50}), are found in Table 4.2.
As seen in Fig. 4.2, various values of Qcrav relative to Qcpd lead to CPD and
Craving responses with relatively good set point tracking and similar general features.
The patient is able to quit relatively successfully, reflected by the only minor degrees
of lapse, which occur according to various trends. Each penalty weight combination
features some CPD o↵set at day 50, although this o↵set appears to be due to lapse
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(a) Scenario 1: Outcome and Manipulated Variable Responses Where QwipT = 0, Qcpd = 10,
and Qcrav = 1.
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(b) Scenario 1: Outcome and Manipulated Variable Responses where QwipT = 0, Qcpd = 10,
and Qcrav = 10.
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(c) Scenario 1: Outcome and Manipulated Variable Responses where QwipT = 0, Qcpd = 10,
and Qcrav = 100.
Figure 4.2: Scenario 1: Outcome and Manipulated Variable Responses where
QwipT = 0, Qcpd = 10 for Various Qcrav values.
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Table 4.2: Scenario 1: Performance Metrics for the Intervention with Various
Penalty Weight Values (Stress = 0).
Figure: 4.2a 4.2b 4.2c
Parameters Qcpd 10 10 10 10 10 10
Qcrav 1 5 10 20 50 100
QwipT 0 0 0 0 0 0
Performance, t   TQD tcpdr 0 0 0 0 0 0
tcravr 9 11 12 12 12 7
ecpd50 0.53 0.78 0.42 0.53 0.53 0.46
ecrav50 0.10 0.72 0.00 0.10 0.10 0.00
Total Cigs 16.33 16.94 7.65 11.95 17.66 9.86
Days CPD=0 11 11 20 14 14 18
max(cpd) 2.77 2.57 1.90 0.89 1.30 1.90
max(crav) 23.70 23.70 23.70 23.70 23.70 20.67
max(WIPT ) 20 19 19 19 19 20
J cpde 19.06 21.58 6.34 7.65 16.32 11.62
J crave 2574.94 2202.51 2173.27 2167.42 2166.47 1674.79
JwipTe 7212 7498 6045 6833 7913 8396
var(cpd) 0.33 0.39 0.13 0.11 0.22 0.25
var(crav) 56.21 47.38 47.09 47.23 47.69 38.67
var(WIPT ) 39.58 34.41 25.28 30.92 34.75 39.88
JucI 1 1 1 1 1 1
JubI 76 70 97 79 61 61
JulI 6304 6593 5048 5948 7082 7527
var(uc) 0.03 0.03 0.03 0.03 0.03 0.03
var(ub) 0.49 0.32 0.37 0.35 0.28 0.28
var(ul) 33.37 29.79 21.03 27.26 30.00 35.48
✏T 0.28 1.48 1.51 3.37 5.75 35.33
147
events occurring just prior to day 50 specifically, after substantial periods of no or
negligible smoking.
A scenario with Qcpd non-trivially greater than Qcrav intuitively seems like it
should provide optimal performance in terms of supporting cessation success most
directly. However, post-TQD deviations in CPD, Craving, and WIPT from target
levels appear to be greater when Qcpd   Qcrav for this nominal case; Fig. 4.3 indicates
that cumulative post-TQD outcome errors approach minimal levels when Qcpd and
Qcrav are on the same order of magnitude. Specifically, these plots suggest that
the total amount of post-TQD smoking does not significantly improve when Qcrav
increases in value beyond Qcpd; Qcpd = Qcrav = 10 also corresponds to low relative
values of both J crave and J
wipT
e , and larger Qcrav values similarly do not systematically
improve the performance in both metrics.
Examining outcome variable responses and dosing schedules specifically, Fig. 4.2
suggest that when both weights equal 10, CPD features very minor instances of lapse
during the first weeks of quitting and only a few subsequent days where more than
one whole cigarette is smoked. Furthermore, the magnitudes of the total amount of
smoking during the quit attempt (Total Cigs, also reflected in J cpde ) and CPD o↵set
on day 50 are smallest for the equal weight case. Similarly, the total number of days
the patient does not smoke for this weight combination, 20 days, is nearly double
that for the Qcrav ⌧ Qcpd cases and more than 25% greater than the Qcrav = 20 and
50 cases. This, and the low variance in the CPD sequence post-TQD, suggest that
significantly disparate penalty weights on the CPD and Craving set point tracking
goals can lead to performance degradation.
Craving consistently increases above baseline levels around TQD despite the inter-
vention. The similarity of the Craving inverse response, tcravr values, and max(crav)
values across the various penalty weight combinations are likely a consequence of the
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Figure 4.3: Scenario 1: Metrics of Post-TQD Intervention Performance for QwipT =
0, Qcpd = 10, and Varying Levels of Qcrav, Relative to the Qcrav = 0.1 Case.
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lower bound on CPD (see equation 3.59) and the interrelationship between CPD and
Craving. As Quit drives CPD to its lower limit—and equivalently, its set point—the
controller avoids dosing around TQD that would drive CPD below its lower bound,
even though such control action would also bring max(crav). Fig. 4.2c supports
this assertion: here, the peak in Craving on TQD, 20.67 points, is lower than the
other scenarios, all 23.70 points; however, the value of ✏T for this case relative to
the equivalent simulations suggests that to achieve the lower Craving maximum as
well as feasible solutions for the Qcrav = 100 problem, significant relaxation of the
hard constraint bounds is required—likely corresponding to significant relaxation of
physically realizable CPD level.
Fig. 4.2 suggests that the various combinations of penalty weights generally as-
sign unit counseling around TQD and rely heavily on bupropion and lozenge dosing
to achieve set point tracking, often trading o↵ between use of lozenges and imple-
mentation of a second bupropion dose as time goes on. The dosing around TQD
is relatively limited, with ub and ul being gradually assigned until becoming very
aggressive approximately one week after TQD (for the cases with limited constraint
relaxation). These ub moves contrast current clinical practice, which prescribe the
maximum bupropion dose four days prior to TQD (Tobacco Use and Dependence
Guideline Panel, 2008; Lexicomp, 2014). This relative delay in aggressive dosing re-
flects the fact that the nominal patient is initially above to achieve the CPD = 0
target without the aid of any treatment components; the manipulated variables are
then assigned in a manner that addresses the resumption of smoking—gradual depar-
ture from target CPD levels—that would otherwise occur.
In terms of overall dosing requirements for this favorable penalty weight combi-
nation, the intervention relies on greater magnitudes of and greater adjustments to
lozenge dosage and less on bupropion dosage when Qcpd 6= Qcrav 6= 10 (see JubI , JulI ,
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and var(ul) in Table 4.2). Specifically, Fig. 4.2b employs an initial dose of bupropion
just after TQD and employs the second bupropion dose more than the other cases in
Fig. 4.2, which also corresponds to lower peak and steady-state ul levels in the first
three weeks of the quit attempt.
Scenario 2
As alluded to previously, assigning Qu⇤ > 0 values and u
ref
⇤ = 0 would serve to dis-
courage assignment of nonzero treatment dosages, and assigning Q u⇤ > 0 for move
suppression would serve to discourage changes of these manipulated variables. Math-
ematically, this approach treats each manipulated variable separately and a concern
for total dosing or over-dosing would require careful selection of synergistic combi-
nations of Qcpd, Qcrav, Quc , Qub , Qul , Q uc , Q ub , and Q ul values. Relatedly, the
concern is primarily in managing dosing in aggregate, and managing such a concern
via individual manipulated variable penalty weights restricts dosing flexibility in an
unintuitive manner and to an unnecessary degree. Instead, a construct accounting
for total dosing over a given period of time is defined and given a set point.
Fig. 4.4 features J⇤e values (where ⇤ indicates CPD or Craving) corresponding to
various QwipT levels and Qcpd = Qcrav = 10, scaled relative to the corresponding J
⇤
e
values where QwipT = 0. Fig. 4.5 features controlled variable responses and the cor-
responding dosing schedules when QwipT assumes values orders of magnitude smaller
than or equal to Qcpd = Qcrav = 10. The corresponding performance metrics are
found in Table 4.3.
These figures suggest that increasing QwipT > 1 in this scenario quickly degrades
CPD performance significantly, as well as Craving performance. This could be
expected, as moving WIPT toward its set point of no dosing becomes a greater
priority relative to the CPD and Craving targets, which leads to less dosing—a
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Figure 4.4: Scenario 2: Metrics of Post-TQD Intervention Performance for Varying
QwipT Values and Qcpd = Qcrav = 10, Scaled Relative to the QwipT = 0 Case.
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direct consequence of which is increased post-TQD smoking and craving levels. This
is particularly apparent in Fig. 4.5c. In this case, the maximum daily lozenge dose is
6 lozenges, and only 41 ub doses are assigned, versus more than 50 for the QwipT = 0.1
andQwipT = 1 cases. Such dosing suppression leads to significantly worse performance
compared to the other cases in Table 4.3.
Compared to the scenario where QwipT = 0 (Fig. 4.2b), the QwipT = 0.1 and
QwipT = 1 cases feature better CPD performance according to some metrics. Notably,
the highestmax(cpd), J cpde , and J
crav
e magnitudes are smaller. That said, there are six
fewer cigarette-free days with these two penalty values. In terms of dosing, a WIPT
penalty weight two orders of magnitude lower than the CPD and Craving penalty
weights does not su ciently smooth the ul dosing profile, as quantified through the
var(ul) value, and still requires high amounts of lozenge consistently. Interestingly,
a QwipT value that is approximately one order of magnitude smaller than or equal to
Qcpd and Qcrav appears to fall within a window of QwipT values that decreases the total
dosing demands by approximately 25% compared to smaller magnitudes of theWIPT
penalty weight, yet negatively a↵ect total post-TQD CPD and Craving set point
deviations only marginally. The QwipT = 1 case appears to retain the suppressed
total dosing and less variant ul adjustments while still achieving greater CPD set
point tracking during the quit attempt. These features are achieved simultaneously
by the controller’s reliance on additional counseling and maximum bupropion dosages
as compared to the QwipT = 0 case. Fig. 4.2a also highlights that with QwipT = 1
here, the intervention relies more consistently on ub doses, which is more in congruent
with current clinical practice (Lexicomp, 2014).
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(a) Scenario 2: Outcome and Manipulated Variable Responses where Qcpd = Qcrav = 10
and QwipT = 0.1.
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(b) Scenario 2: Outcome and Manipulated Variable Responses where Qcpd = Qcrav = 10
and QwipT = 1.
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(c) Scenario 2: Outcome and Manipulated Variable Responses where Qcpd = Qcrav = 10
and QwipT = 10.
Figure 4.5: Scenario 2: Outcome and Manipulated Variable Responses where Qcpd =
Qcrav = 10 and Various QwipT Values.
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Table 4.3: Scenario 2: Performance Metrics for the Intervention with Various
Penalty Weight Values, QwipT 6= 0 (Stress = 0).
Figure: 4.5a 4.5b 4.5c
Parameters Qcpd 10 10 10 10
Qcrav 10 10 10 10
QwipT 0.1 1 5 10
Performance, t   TQD tcpdr 0 0 0 0
tcravr 12 13 17 16
ecpd50 0.53 0.06 0.19 1.07
ecrav50 0.10 2.72 4.20 5.91
Total Cigs 9.02 5.55 22.70 29.52
Days CPD=0 14 14 10 6
max(cpd) 0.80 0.91 2.15 2.84
max(crav) 23.70 23.70 23.70 23.70
max(WIPT ) 19 15 7 8
J cpde 4.90 2.26 28.21 41.66
J crave 2170.04 2248.06 2822.83 2864.20
JwipTe 35 119 576 693
var(cpd) 0.08 0.04 0.40 0.50
var(crav) 46.87 41.48 41.70 34.50
var(WIPT ) 0.03 0.25 2.21 2.65
JucI 1 2 5 5
JubI 88 109 61 67
JulI 5457 2173 404 171
var(uc) 0.03 0.05 0.12 0.12
var(ub) 0.37 0.35 0.41 0.58
var(ul) 25.74 9.67 3.61 2.48
✏T 2.28 1.49 2.46 1.81
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Scenario 3
Nominal performance is first examined where Stress beyond some baseline level takes
the form of a step change of magnitude three. Given the risk for relapse posed by
a disturbance of this nature, performance is evaluated when the step disturbance
occurs two weeks into the quit attempt, i.e., Stress(t) = 0, t < 24 and = 3, t   29.
Fig. 4.6 features plots with Qcpd = 10 and combinations of Qcrav and QwipT . The
corresponding performance metrics are found in Table 4.4.
Poor performance results when QwipT is on the same order of magnitude as that of
the penalty weight(s) for CPD and/or Craving set point tracking. Specifically, the
control action for the Qcrav = QwipT = 1 (Fig. 4.6b) and Qcpd = Qcrav = QwipT = 10
cases is e↵ectively unable to reject the Stress disturbance, where approximately 3 and
5 cigarettes are smoked on day 50, respectively. Such poor performance is confirmed
by similarly high Craving levels at day 50, large Total Cigs, max(cpd), max(crav),
J cpde , and J
crav
e values, and relatively small number of cigarette-free days for these
cases. Conversely, the scenarios where QwipT = 0 feature e↵ective disturbance re-
jection; e.g., ecpd50 = 0.00 and e
crav
50 < 1 for Fig. 4.6a. That said, even aggressive
dosing—where ul dosing is sustained at maximum levels—features post-TQD days
where more than 2 cigarettes are smoked.
The Qcpd = Qcrav = 10 with QwipT = 1 case appears to balance step disturbance
rejection and peak daily ul requirements e↵ectively in the nominal performance case.
While it does feature consecutive days of post-TQD smoking, there are 17 cigarette-
free days (the greatest number of smoke-free days of the comparable cases in Table 4.4)
and the maximum lapse is only 1.85 cigarettes. As a whole, these tuning weights to-
gether o↵er better overall set point tracking despite the step Stress disturbance, as
compared to the QwipT = 0 case shown. This is quantified by J
cpd
e , which is nearly
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(a) Scenario 3: Outcome and Manipulated Variable Responses in the Presence of a Step
Change in the Stress Disturbance of Magnitude Three on Day 29 where Qcpd = 10, Qcrav =
10, and QwipT = 0.
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(b) Scenario 3: Outcome and Manipulated Variable Responses in the Presence of a Step
Change in the Stress Disturbance of Magnitude Three on Day 29 where Qcpd = 10, Qcrav =
1, and QwipT = 1.
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(c) Scenario 3: Outcome and Manipulated Variable Responses in the Presence of a Step
Change in the Stress Disturbance of Magnitude Three on Day 29 where Qcpd = 10, Qcrav =
10, and QwipT = 1.
Figure 4.6: Scenario 3: Outcome and Manipulated Variable Responses in the Pres-
ence of a Step Change in the Stress Disturbance of Magnitude Three on Day 29
where Qcpd = 10 for Various Combinations of Qcrav and QwipT values.
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Table 4.4: Scenario 3: Performance Metrics for the Intervention in the Presence of
a Step Change in the Stress Disturbance of Magnitude Three on Day 29 for Several
Combinations of Controlled Variable Penalty Weights.
Figure: 4.6a 4.6b 4.6c
Parameters Qcpd 10 10 10 10 10
Qcrav 1 10 1 10 10
QwipT 0 0 1 1 10
Performance, t   TQD tcpdr 0 0 0 0 0
tcravr 9 12 13
ecpd50 0.05 0 2.19 0.57 4.56
ecrav50 0.93 0.76 6.81 2.62 11.31
Total Cigs 21.56 17.92 61.89 13.25 92.91
Days CPD=0 12 16 2 17 5
max(cpd) 2.77 2.49 3.52 1.85 4.71
max(crav) 23.7 23.7 23.7 23.7 23.7
max(WIPT ) 23 23 12 18 9
J cpde 26.67 24.81 143.95 13.65 351.51
J crave 2582.44 2189.08 3580.69 2241.94 4309.14
JwipTe 11883 11369 2475 5632 1319
var(cpd) 0.39 0.45 1.07 0.25 3.19
var(crav) 55.68 45.75 29.34 41.34 22.88
var(WIPT ) 60.43 55.08 16.65 24.89 11.11
JucI 3 3 5 5 5
JubI 106 118 115 109 85
JulI 10097 9502 1619 4420 804
var(uc) 0.08 0.08 0.12 0.12 0.12
var(ub) 0.54 0.32 0.52 0.35 0.68
var(ul) 44.02 41.77 12.25 18.81 7.42
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50% smaller than the nearest comparable J cpde values in Table 4.4. This favorable
performance is achieved through increased reliance on uc and early use of ub. Relat-
edly, this case features less reliance on ul dosing and less dramatic changes in daily ul
dosing (see JulI , max(ul), and var(ul)); this less intense lozenge dosing may increase
chances of overall adherence (Piper et al., 2009).
Scenario 4
Intuitively, a Stress disturbance in the form of a deterministic step signal that re-
mains at a constant level for at least three weeks seems unlikely in real world set-
tings. As noted in Shi↵man and Waters (2004), instances of lapse can more di-
rectly be attributed to rapidly changing stress levels than to slowly time-varying and
chronic stressors. This motivates assessment of controller performance when CPD
and Craving are subjected to a Stress disturbance that is stochastic in nature. For
comparative purposes, one realization of an autocorrelated, stochastic stress distur-
bance is considered initially, the character of which is described by equation 4.1.
Fig. 4.7 features intervention responses where Qcpd = 10 and varying combinations of
Qcrav and QwipT . The corresponding performance metrics in Table 4.5 o↵er insight
into how varying the penalty weights influences how sensitive control action is to the
stochastic stress disturbance, i.e., how aggressive the controller is in terms of rejecting
this Stress influence, and how that relates to intervention outcomes.
Comparing the performances of the controllers when there is and is not stochastic
Stress present where Qcpd = Qcrav = 10 and QwipT = 1 (see Fig. 4.5b versus 4.7d)
indicates that control action, particularly that related to ul, is sensitive enough to
the stochastic disturbance that the patient is still able to achieve relatively successful
cessation outcomes. Specifically, there is no CPD o↵set on day 50 and an additional
smoke-free day in the presence of stochastic Stress compared to the Stress = 0
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Table 4.5: Scenario 4: Performance Metrics for the Intervention with Various
Penalty Weight Values for a Single Realization of a Stochastic Stress Signal (Sto.,
ex) and Averaged Over 50 Realizations of the Stochastic Signal (Sto., 50).
Stress form Sto., ex Sto., ex Sto., ex Sto., ex Sto., ex Sto., ex Sto., 50 Sto., 50
Figure: 4.7a 4.7b 4.7c 4.7d
Parameters Qcpd 10 10 10 10 10 10 10 10
Qcrav 0.1 1 10 10 1 10 10 10
QwipT 0 0 0 0.1 1 10 0.1 1
Performance, t   TQD tcpdr 0 0 0 0 0 0 0.16 0.04
tcravr 11 13 11 13 13 20 9.86 13.02
ecpd50 0 1.13 1.16 1.13 0 0.44 0.24 0.14
ecrav50 1.17 1.35 1.84 1.34 1.8 4.32 2.1 2.97
Total Cigs 15.03 14.88 23.54 19.79 15.98 40.51 15.41 8.26
Days CPD=0 19 15 10 13 15 3 14.94 18.22
max(cpd) 2.9 2.9 2.9 2.9 2.9 3.26 1.8 1.79
max(crav) 22.88 22.88 22.88 22.88 22.88 22.88 23.17 22.99
max(WIPT ) 22 21 22 21 17 8 20.24 15.48
J cpde 22.63 18.75 31.87 24.36 24.06 72.23 21.1 8.99
J crave 2564.99 2549.3 2523.96 2521.18 2635.57 3280.32 2207.87 2326.25
JwipTe 5525 6577 8226 7742 3358 339 6289.78 2639.6
var(cpd) 0.47 0.36 0.47 0.38 0.48 0.76 0.33 0.19
var(crav) 53.73 54 54.47 54.6 49.9 40.16 45.56 41.7
var(WIPT ) 35.28 39.11 47.57 44.39 22.6 3.4 33.2 16.38
JucI 2 1 2 1 3 5 1.06 2.52
JubI 79 85 58 67 97 58 86.8 103.06
JulI 4489 5497 7127 6710 2417 137 5233.3 1856.34
var(uc) 0.05 0.03 0.05 0.03 0.08 0.12 0.03 0.07
var(ub) 0.5 0.52 0.39 0.45 0.54 0.51 0.34 0.43
var(ul) 29.36 31.97 39.32 36.66 19.06 2.01 27.38 13.41
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(a) Scenario 4: Outcome and Manipulated Variable Responses where Qcpd = 10, Qcrav = 1,
and QwipT = 0.
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(b) Scenario 4: Outcome and Manipulated Variable Responses where Qcpd = 10, Qcrav = 10,
and QwipT = 0.
166
0 5 10 15 20 25 30 35 40 45 50
0
5
10
Patient−Reported Cigarettes Smoked / Day (CPD)
0 5 10 15 20 25 30 35 40 45 50
0
10
20
Patient−Reported Average Daily Craving Level (Craving)
0 5 10 15 20 25 30 35 40 45 50
0
1
2
Bupropion Dose
0 5 10 15 20 25 30 35 40 45 50
0
1
Counseling Dose
0 5 10 15 20 25 30 35 40 45 50
0
10
20
Lozenge Dose
0 5 10 15 20 25 30 35 40 45 50
0
10
20
Total Number of Treatment Doses
0 5 10 15 20 25 30 35 40 45 50
0
1
Disturbance Signal(s)
Day
Qu
it
−2
0
2
St
re
ss
(c) Scenario 4: Outcome and Manipulated Variable Responses where Qcpd = 10, Qcrav = 10,
and QwipT = 0.1.
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(d) Scenario 4: Outcome and Manipulated Variable Responses where Qcpd = 10, Qcrav = 10,
and QwipT = 1.
Figure 4.7: Scenario 4: Outcome and Manipulated Variable Responses where Qcpd =
10 and Qcrav and QwipT Values Vary. Stress is Present in the Form of a Single
Stochastic Realization.
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case. This performance, though, comes at the expense of dosing requirements as
documented in the aggregate dosing metric JwipTe , which is more than 28 times greater
in the stochastic stress case, and dosing variances (var(WIPT ), var(ul)).
Contrasting the scenarios depicted in Fig. 4.6 where Stress is a step disturbance,
the controller trades o↵ between ub and ul doses in the presence of the stochastic
disturbance. As current clinical practice consists of two daily bupropion doses consis-
tently for weeks or months after initially stepping up to two daily doses, decreases in ub
assignments (such as those seen in each scenario in Fig. 4.7) may appear operationally
unadvisable to clinicians, regardless of predicted CPD and Craving performances.
One potential method for discouraging such dosage changes would be to penalize
changes in ub via the move size penalty Q ub . Fig. 4.8a depicts the responses and
dosing for the case where Qcpd = Qcrav = 10, QwipT = 1 and Q ub = 100. This
figure suggests that a large bupropion move size penalty could facilitate an e↵ective
intervention that does not require decreases in ub dosage at any point. As previously
described, complex tuning via set point tracking and move suppression weights in the
objective function is an unintuitive way to obtain desirable performance characteris-
tics (Nandola and Rivera, 2013). Furthermore, penalizing ub moves serves to suppress
both increases and decreases in ub, which may unnecessarily prevent implementation
of e cacious bupropion doses.
Scenario 5
Given the lack of a reliable, systematic way to choose Q ub values that penalize
 ub(k) < 0 but not  ub(k) > 0, this move size concern is addressed in an alterna-
tive manner. Specifically, the move size constraint in equation 3.57 is replaced by
equation 4.4.
0   ub(k)  1 (4.4)
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Equation 4.4 states that once ub has increased in dose, it cannot subsequently de-
crease. Fig. 4.8b depicts the dosing and controlled variable responses with this up-
dated constraint. It indicates adjustment of this constraint does not necessarily de-
grade performance significantly. For example, Total Cigs is only slightly smaller for
this Stress realization in the simulation employing the updated formulation, versus
the Q ub = 100 case (although this comparable performance is at the expense of
overall dosing requirements, JwipTe equal to 3116 versus 2660).
Figures 4.7 and 4.8 examine nominal performance for one realization of the stochas-
tic Stress disturbance. To get a more general picture of the performance subject to
Stress, Table 4.5 also contains performance metrics for two tuning weight combina-
tions as averaged across the dosing and responses for 50 realizations of the stochastic
disturbance. The first set of 50 realizations was obtained for Qcpd = Qcrav = 10 and
QwipT = 0.1; the second adjusts QwipT to equal 1. As one would expect, the realiza-
tions with QwipT = 1 leads to less total dosing on average, represented by an average
JwipTe that is nearly 2.5 times smaller than that for the QwipT = 0.1 case. Similarly, the
QwipT = 0.1 case leads to average total dosing variation approximately twice that of
the QwipT = 1 (var(WIPT ) = 32.7 versus 16.4). Together, this suggests that increas-
ing the WIPT objective function penalty weight by an order to magnitude leads to
a much less demanding dosing regimen overall. Interestingly, this larger QwipT value
also corresponds here to improved performances on average, as quantified by lower
J cpde , max(cpd), Total Cigs, and Days CPD=0 metrics. These seemingly incongruous
average dosing and CPD performance metrics may be due in part to simulation re-
laxation. ✏T is nearly 50% larger for the QwipT = 1 case, indicating that more hard
constraint relaxation was required for feasible dosing optimizations on average. This
may be partially related to more pre-TQD dosing that was assigned more frequently
in the QwipT = 1 case, which would lead to CPD values below 0 on TQD due to the
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(a) Scenario 4: Outcome and Manipulated Variable Responses where Qcpd = Qcrav = 10,
QwipT = 1, Q ub > 0, and the  ub Constraint is Described by Equation 3.57.
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(b) Scenario 5: Outcome and Manipulated Variable Responses where Qcpd = Qcrav = 10,
QwipT = 1, Q ub = 0, and the  ub Constraint is Described by Equation 4.4.
Figure 4.8: Outcome and Manipulated Variable Responses whereQcpd = Qcrav = 10,
QwipT = 1, and a Means to Suppress Decreases in ub Over Time.
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Quit disturbance. Pre-TQD dosing indicates that the controller takes action to keep
CPD and Craving levels at average baseline values, essentially avoiding conditions
immediately prior to TQD that make abstinence early in the quit attempt more di -
cult; as more of this pre-TQD dosing occurs in with QwipT = 1, the controller appears
to take this action prior to TQD in order to require less dosing at future points in
the prediction horizon.
4.4.2 Tuning via 3DoF Tuning Parameters
The focus of Section 4.4.2 remains to be nominal performance, but in the con-
text of the intervention architecture depicted in Fig. 3.5. Under nominal conditions,
adjustment of f cpda and f
crav
a o↵er little meaningful e↵ect on the manipulated vari-
able assignments or controlled variables responses. Therefore, f cpda = f
crav
a = 1 in
the simulations immediately following; detuning via fa tuning parameters will not be
described until robustness is considered in subsequent sections.
Scenario 6
Section 4.4.1 illustrated that without 3DoF functionality, more than marginal alter-
ations in performance—as quantified by the summed total of CPD and Craving
post-TQD—require orders of magnitude of Qcpd and Qcrav adjustment. This finding
suggests that tuning via ↵cpdr or ↵
crav
r independently would need to be aggressive in
order to to nontrivially a↵ect the controlled variable o↵set magnitudes, as summed
across the quit attempt time frame considered here (for a given set of penalty weights
and in the absence of additional tuning parameters). Fig. 4.9 depicts relative J cpde ,
J crave , and J
wipT
e values as a function of ↵cpdr and ↵
crav
r and confirms these expectations.
Examining the ↵cpdr and ↵
crav
r axes in Fig. 4.9a indicates that even large, inde-
pendent adjustments of either ↵⇤r parameter does not lead to large changes in total
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post-TQD smoking. However, this figure reflects that simultaneous adjustment of
the ↵⇤r parameters such that ↵
cpd
r > 0.5 and ↵
crav
r > 0.6 leads to much greater mag-
nitudes of smoking during the first 5 weeks of a quit attempt. For example, when
↵cpdr = ↵
crav
r = 0.8, the patient smokes more than twice as many cigarettes than the
no-3DoF tuning case over the same time period (Total Cigs in Table 4.6), with the
peak lapse event having a magnitude more than double that of the no-tuning case
(max(cpd)). Negligible changes in the summed total of post-TQD Craving are ob-
served for cases where ↵cravr  0.6. However, Fig. 4.9b indicates that even as ↵cravr
increases beyond 0.6, total post-TQD Craving increases marginally compared to the
scenario with very aggressive tracking of the Craving target. As would be expected,
Fig. 4.9c, the total amount of post-TQD dosing reflects aggressive pursuit of the CPD
and Craving targets in the absence of significant detuning. Specifically, the values of
JwipTe are marginally a↵ected by ↵cravr  0.6, although even more extreme detuning
of the Craving target tracking has little influence on the peak level of total daily
dosing.
Altogether, Fig. 4.9 indicates that detuning the intervention targets for the pur-
poses of lowering total dosing requirements should focus on ↵cpdr < 0.6 and ↵
crav
r > 0.6,
and that the engineer or practitioner should be most concerned with the CPD out-
come when altering these parameters. Examining this ↵⇤r window, the average dosing
metrics in Table 4.6 suggest an ↵cravr ⇡ 0.8 may correspond to more appealing dosing.
Specifically, the ↵cravr = 0.8 and ↵
cpd
r = 0, 0.4, or 0.6 cases require additional bupro-
pion doses, 20 to 33 fewer lozenges, and less intense lozenge adjustments (var(ul))
compared to the other tuning combinations. These tuning cases also correspond to
an additional cigarette-free day and a 24% smaller peak lapse event.
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Figure 4.9: Scenario 6: Nominal, Stress = 0, Post-TQD Intervention Performance
Metrics for Qcpd = Qcrav = 10, QwipT = 1 and Varied ↵
cpd
r and ↵
crav
r Parameters
Relative to the ↵cpdr = ↵
crav
r = 0 Case.
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Table 4.6: Scenario 6: Performance Metrics for the Intervention When Qcpd =
Qcrav = 10, QwipT = 1 for Various Levels of Detuning via ↵
cpd
r and ↵
crav
r (Stress = 0).
Parameters ↵cpdr 0.2 0.4 0.8 0 0 0 0.2 0.4 0.6 0.8
↵cravr 0 0 0 0.2 0.4 0.8 0.2 0.4 0.6 0.8
Performance, t   TQD tcpdr 0 0 0 0 0 0 0 0 0 0
tcravr 13 13 13 13 13 13 13 13 16
ecpd50 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06
ecrav50 2.72 2.72 2.72 2.72 2.72 2.72 2.72 2.72 2.72 2.72
Total Cigs 5.55 5.55 5.9 5.55 5.55 5.45 5.55 5.55 5.55 11.42
Days CPD=0 14 14 14 14 14 15 14 14 14 10
max(cpd) 0.91 0.91 1.19 0.91 0.91 0.69 0.91 0.91 0.91 2.1
max(crav) 23.7 23.7 23.7 23.7 23.7 23.7 23.7 23.7 23.7 23.7
max(WIPT ) 15 15 15 15 15 15 15 15 15 14
J cpde 2.26 2.26 2.9 2.26 2.26 2 2.26 2.26 2.26 11.89
J crave 2248 2248 2258 2248 2248 2319 2248 2248 2248 2322
JwipTe 3080 3080 2992 3080 3080 2512 3080 3080 3080 3010
var(cpd) 0.04 0.04 0.06 0.04 0.04 0.03 0.04 0.04 0.04 0.24
var(crav) 41.48 41.48 41.01 41.48 41.48 40.43 41.48 41.48 41.48 40.42
var(WIPT ) 12.71 12.71 12.14 12.71 12.71 10.43 12.71 12.71 12.71 11.69
JucI 2 2 2 2 2 2 2 2 2 2
JubI 109 109 109 109 109 118 109 109 109 100
JulI 2173 2173 2097 2173 2173 1654 2173 2173 2173 2150
var(uc) 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05
var(ub) 0.35 0.35 0.35 0.35 0.35 0.32 0.35 0.35 0.35 0.37
var(ul) 9.67 9.67 9.11 9.67 9.67 7.43 9.67 9.67 9.67 8.6
Scenario 7
In the presence of a measured disturbance, tuning should first adjust ↵d parameters
prior to ↵⇤r parameter adjustment, as the manner in which controller targets are
obtained and maintained is a function of the disturbance rejection capabilities of the
controller. As before, the Stress disturbance takes in the form of a step of magnitude
three two weeks into the quit attempt, and in the form of a stochastic signal beginning
on day 1. Initially, independent tuning of the ↵Sd parameter is examined.
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(a) Scenario 7: Outcome and Manipulated Variable Responses where Qcpd = Qcrav = 10,
QwipT = 1, ↵
cpd
r = ↵cravr = 0, and ↵
S
d = 0.2.
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(b) Scenario 7: Outcome and Manipulated Variable Responses where Qcpd = Qcrav = 10,
QwipT = 1, ↵
cpd
r = ↵cravr = 0, and ↵
S
d = 0.8.
Figure 4.10: Scenario 7: Outcome and Manipulated Variable Responses where
Qcpd = Qcrav = 10, QwipT = 1, ↵
cpd
r = ↵
crav
r = 0, and Various ↵
S
d Values.
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Table 4.7: Scenario 7: Performance Metrics for the Intervention Under a Selection
of 3DoF Tuning Conditions Where ↵Sd > 0 and Stress Takes the Form of a Step of
Magnitude Three on Day 29.
Figure: 4.10a 4.10a
Parameters ↵cpdr 0 0 0
↵cravr 0 0 0
↵Sd 0 0.2 0.8
Performance, t   TQD tcpdr 0 0 0
tcravr 13 13 13
ecpd50 0.21 0.15 0.38
ecrav50 2.31 2.21 2.31
Total Cigs 15.46 17.77 31.64
Days CPD=0 12 11 10
max(cpd) 1.65 1.73 3.54
max(crav) 23.7 23.7 23.7
max(WIPT ) 18 17 18
J cpde 13.2 18.29 60.84
J crave 2249.22 2273.38 2426.15
JwipTe 6367 6161 6274
var(cpd) 0.19 0.27 0.94
var(crav) 41.29 40.55 38
var(WIPT ) 27.56 25.85 27
JucI 5 5 5
JubI 109 109 109
JulI 4979 4803 4929
var(uc) 0.12 0.12 0.12
var(ub) 0.35 0.35 0.35
var(ul) 19.68 18.36 19.49
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Table 4.7 and Fig. 4.10 suggest that for a measured and anticipated step dis-
turbance of this character, disturbance rejection capabilities are most significantly
degraded with large ↵Sd values (in the absence of additional detuning). That said, the
CPD and Craving o↵sets 21 days after the step disturbance are only 0.38 cigarettes
and 2.31 points, respectively, when ↵Sd = 0.8. This CPD o↵set is only 77% larger
than that for the ↵Sd = 0 case and less than 0.4 cigarettes greater than the lowest e
cpd
50
value in Table 4.7, while this Craving o↵set is approximately equal to that for the
↵Sd = 0 case and less than 1 point larger than the smallest e
crav
50 magnitude. However,
significantly slowing rejection of the step disturbance leads to fewer cigarette-free days
(2 fewer days for ↵Sd = 0.8).
Overall, though, post-TQD CPD and Craving responses are negatively a↵ected
as ↵Sd increases; Total Cigs, J
cpd
e , J
crav
e , max(cpd), var(cpd), and var(crav) values
in Table 4.7 are all more than double for the large detuning case. Interestingly,
such degraded performance occurs despite relatively similar total dosing demands,
as reflected in JwipTe and manipulated variable variance metrics. The ↵Sd = 0.4 case
appears to be more responsive to the disturbance initially, assigning two uc doses
within five days of the step, and relatively fast changes in ul assignment over a similar
time period. Altogether, these simulations suggest that detuning via ↵Sd may not o↵er
an acceptable trade o↵ between dosing and performance degradation in the presence
of a step disturbance of this nature.
Scenario 8
Fig. 4.11 depicts the average cumulative energy metrics J cpde , J
crav
e , and J
wipT
e from
25 realizations of the stochastic disturbance signal (scaled to the average J⇤e values
for the ↵Sd = 0 case) where the intervention is detuned by increasing values of ↵
S
d .
When Stress takes the form of the stochastic signal described in Section 4.2.2,
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Table 4.8: Scenario 8: Performance Metrics for the Intervention Under a Selection
of 3DoF Tuning Conditions Where Stress Takes the Form of a Stochastic Signal.
The Reported Metrics are Averaged Across 25 Realizations of the Disturbance.
Parameters ↵cpdr 0 0 0 0.65 0.8 0 0 0.65
↵cravr 0 0 0 0 0 0.65 0.8 0.65
↵Sd 0 0.4 0.8 0.2 0.2 0.2 0.2 0.2
Performance, t   TQD tcpdr 0.2 0 0.1 0.2 0 0.2 0.1 0.3
tcravr 12.2 12 12.8 13.35 13.3 13.1 14.3 13.4
ecpd50 0.11 0.09 0.15 0.13 0.04 0.14 0.09 0.16
ecrav50 2.88 2.67 2.58 2.8 2.67 2.95 2.84 3.18
Total Cigs 8.3 8.87 8.54 7.85 9.23 6.11 8.16 7.12
Days CPD=0 18.84 18.6 18.48 16.55 16.3 19.7 14.5 18.4
max(cpd) 1.79 1.75 1.52 1.69 1.65 1.4 1.65 1.22
max(crav) 23.26 23.29 23.88 23.96 23.6 23.42 23.83 24.1
max(WIPT ) 15.36 15.36 15.36 16.15 16.1 15.4 13.6 14.3
J cpde 9.25 9.25 7.73 7.8 9.17 6.44 8.04 5.97
J crave 2334.79 2363 2299.95 2356.53 2378.65 2243.01 2472.43 2311.92
JwipTe 2547.36 2783 2941.12 2823 2831.2 2399.2 2288.2 2472.5
var(cpd) 0.2 0.19 0.16 0.17 0.18 0.14 0.17 0.12
var(crav) 41.77 42.7 41.83 42.06 42.64 39.95 42.48 40.55
var(WIPT ) 16.49 14.46 14.25 16.44 15.42 13.84 12.62 13.75
JucI 2.6 2.32 2.24 2.3 2.3 2.4 2.2 2.6
JubI 102.88 105.04 106.84 108.25 102.7 110.2 110.2 104.8
JulI 1788.6 1949.92 2074.44 1999.35 2023.7 1622.8 1518.4 1704.4
var(uc) 0.07 0.06 0.06 0.06 0.06 0.06 0.06 0.07
var(ub) 0.41 0.41 0.36 0.39 0.4 0.38 0.43 0.38
var(ul) 13.92 11.17 11.17 13.67 12.43 11.24 9.43 11.29
Fig. 4.11 and Table 4.8 suggests that the CPD intervention target is much more
sensitive to detuning via ↵Sd than is the Craving target. This is consistent with
earlier findings suggesting that overall dosing decisions are heavily biased toward the
CPD target, which is equivalently the lower bound on CPD. Specifically, relatively
minor adjustments to ↵Sd or large adjustments to ↵
S
d—i.e., ↵
S
d  0.2, > 0.5—actually
improves performance in terms of total smoking during the quit attempt compared
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Figure 4.11: Scenario 8: Post-TQD Intervention Performance Metrics (as Averaged
Over 25 Stochastic Disturbance Realizations) as Quantified by Total Deviations from
Set Points (J⇤e , where ⇤ Indicates CPD, Craving, or WIPT ) in the Presence of
Stochastic Stress for Increasing ↵Sd Values, Scaled Relative to J
⇤
e for the ↵
S
d = 0 Case.
to the most aggressive case. Meanwhile, these ↵Sd ranges have little e↵ect on the
summed total of post-TQD Craving.
Improvement in smoking abstinence success with relatively minor detuning (0 <
↵Sd  0.2) may result from the autocorrelated nature of the stochastic disturbance
signal. As dosing decisions are based in a measured disturbance’s forecasted e↵ect, a
first order filter on the measured disturbance means dosing decisions are based in a
filtered representation of Stress. According to equation 3.94, this representation of
Stress is a function of both the most recent measured value of Stress and the filtered
representation of Stress at the previous time point, Stressflt(k   1). This suggests
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that for ↵Sd > 0, dosing decisions account for a relationship between Stress(k) and
Stress(k   1). As the stochastic Stress disturbance considered here features au-
tocorrelation with a first order lag (see equation 4.1), the filter essentially leads to
dosing decisions that implicitly recognize the autocorrelated nature of Stress, and
can therefore anticipate and dose more e↵ectively. As equation 4.1 indicates relatively
modest autocorrelation of the stochastic disturbance signal specifically, more e↵ective
tracking of the CPD target during the quit attempt overall is understandable for a
small window of minor detuning, such as that for 0 < ↵Sd  0.2 (see Fig. 4.11).
Increased total dosing is likely responsible for improvements in total post-TQD
smoking levels observed for ↵Sd > 0.5 (see the scaled J
cpd
e and J
wipT
e averages in
Fig. 4.11). Interestingly, Fig. 4.11 suggests that the tuning parameter window 0.2 <
↵Sd  0.5 corresponds to no improvement of, or even degraded, performance in terms
of total smoking during the quit attempt. This may define a tuning window where
the filter serves to suppress increases in dosing that would otherwise occur, but at
the expense of set point tracking.
Examining the average dosing demands specifically, decreasing the speed of Stress
rejection appears to mitigate the intensity of daily dosing adjustments, as expected.
This is reflected by the averaged var(JwipTe ), var(ub), and var(ul) values in Table 4.8,
which trend downward with increasing ↵Sd values. Also suggested by previous tuning
scenarios, particularly favorable tuning scenarios may be those that elicit increased
use of ub. Per Table 4.8, ↵Sd = 0.2 employs the greatest number of bupropion doses
over the quit attempt on average, 59, assigning ub levels more consistently than the
other tuning scenarios with comparable total dosing. On average, this tuning scenario
and resulting average bupropion dosing led to the smallest peak instance of lapse and
least sporadic lapse trends versus the comparable scenarios in Table 4.8, as well as
large numbers of smoke-free days on average.
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Scenario 9
Given the promising e↵ects of ↵Sd = 0.2, nominal performance with stochastic Stress
is examined where ↵Sd fixed to 0.2, and varied levels of filtering of the CPD and
Craving targets: recalling that previous adjustment of ↵cpdr and ↵
crav
r suggested that
↵cpdr < 0.6 and ↵
crav
r > 0.6 lead to reduced total dosing demands (see Fig. 4.9) and
that ↵cpdr and ↵
crav
r values below 0.8 have relatively minor e↵ects on post-TQD CPD
and Craving performances (see Fig. 4.9a and 4.9b), Table 4.8 documents nominal
performance metrics for relatively large ↵cravr values. These metrics consist of values
averaged across 50 realizations of the stochastic Stress signal. Fig. 4.12 features the
associated responses and dosing demands for individual Stress realizations.
As expected, relatively extreme detuning of tracking of the Craving target, ↵cravr =
0.8 corresponds to the least aggressive dosing documented in Table 4.8. This is re-
flected in the relatively low values of the ub variance, ul variance, J
wipT
e , and J
ul
I values.
This, though, comes at the expense of performance, highlighted by this scenario’s five
fewer cigarette-free days on average—likely indicating an undesirable trade-o↵. Con-
sidering the ↵cpdr = ↵
crav
r = 0.65 and ↵
cpd
r = 0, ↵
crav
r = 0.65 cases, the former requires
smaller peak daily dosing (max(wipT ) = 14.3 versus 15.4) and peak lapse levels
(max(cpd) = 1.22 cigarettes versus 1.40) on average; however, the latter features
approximately 1.5 additional cigarette-free days while requiring fewer total doses on
average. In such cases where the performance and dosing trade o↵ is relatively subtle,
the appropriateness of one tuning strategy over another may be clarified through a
clinician’s assessment of a patient’s likelihood to adhere to high daily dosing demands
or total daily dosing commands.
Altogether, Table 4.8 suggests that detuning via 3DoF functionality where ↵cpdr =
0, ↵cravr = 0.65, and ↵
S
d = 0.2 corresponds to favorable intervention performance in
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(a) Scenario 9: Outcome and ManipulatedVariable Responses when a Stochastic Stress
Disturbance is Present and Qcpd = Qcrav = 10, QwipT = 1, ↵
S
d = 0.2, ↵
cpd
r = 0, and
↵cravr = 0.65.
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(b) Scenario 9: Outcome and Manipulated Variable Responses when a Stochastic Stress
Disturbance is Present and Qcpd = Qcrav = 10, QwipT = 1, ↵
S
d = 0.2, ↵
cpd
r = 0, and
↵cravr = 0.8.
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(c) Scenario 9: Outcome and Manipulated Variable Responses when a Stochastic Stress
Disturbance is Present and Qcpd = Qcrav = 10, QwipT = 1, ↵
S
d = 0.2, and ↵
cpd
r = ↵
cpd
r =
0.65.
Figure 4.12: Scenario 9: Outcome and Manipulated Variable Responses when a
Stochastic Stress Disturbance is Present and Qcpd = Qcrav = 10, QwipT = 1, and
↵Sd = 0.2 for Various Combinations of ↵
cpd
r and ↵
crav
r Values.
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terms of CPD and Craving set point tracking in the presence of stochastic stress on
average, which is achieved through reasonable dosing demands in terms of total dosing
requirements, maximum daily dosing levels, and intensity of daily dosage adjustments.
4.5 Robust Performance
The previous section focused on nominal performance, i.e., when all relevant dis-
turbances are measured and P (s) ⇡ P˜ (s). These analyses helped gain insight into the
mechanics of the decision-making generally, and the sensitivity of the outcomes and
dosing to certain constraints, penalty weights, and 3DoF tuning parameters. How-
ever, as previously discussed, one of the defining features of health behaviors and
treatment e↵ectiveness is patient-to-patient variability, which can enter at a multi-
tude of biological, psychological, and environmental levels (Collins, 2006; Hamburg
and Collins, 2010; Hekler et al., 2013a; Kendall, 2006; Piasecki, 2006). Consequently,
a critical component of this work is concerned with how e↵ective the intervention
may be in the presence of imperfect patient information. In other words, robust per-
formance in this context considers how sensitive the performance of the intervention
algorithm is to unmodeled perturbations (Morari and Zafiriou, 1989).
This section continues to consider the same general intervention formulation as
that discussed up to this point, where the nominal models describe the represen-
tative patient (equations 3.5 through 3.8 and Table 3.2). However, three types of
unmodeled perturbations are considered. Section 4.5.1 incorporates an unmeasured,
stochastic influence into the measured outcomes, representing an unmeasured distur-
bance or measurement noise. This sort of variance is particularly apparent in the
Craving signals observed in the McCarthy et al. (2008b) clinical trial (McCarthy
et al., 2006). Section 4.5.2 incorporates plant-model mismatch in the form of para-
metric uncertainty in a subset of parameters from the representative patient’s self-
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regulation (Quit-path) and dose-response models. Section 4.5.3 incorporates plant-
model mismatch by applying the intervention formulation to patients other than the
representative one around whom the intervention was primarily designed. Specifically,
the simulations employ Craving(z 1)/Quit(z 1) and CPD(z 1)/Quit(z 1) models
estimated for other single subjects from the PNc group in the McCarthy et al. (2008b)
study. These subjects’ observed Craving and CPD dynamics diverge from those of
the representative patient. As the orders of these alternative patient models vary,
Section 4.5.3 can be seen as a focused study of certain types of non-parametric un-
certainty (Morari and Zafiriou, 1989).
In the presence of nontrivial, unmeasured, and unmodeled perturbations, altering
the controller tuning parameters f cpda and f
crav
a can significantly influence the nature
of manipulated variable adjustments and controlled variable responses (see Fig. 3.5).
Specifically, the speeds at which unmeasured disturbances are rejected are directly
proportional to these values, where f ⇤a = 1 (where ⇤ refers to CPD or Craving) cor-
responds to the most aggressive rejection of unmeasured disturbances (Nandola and
Rivera, 2013). In the following sections, these parameters will be tuned independently
and in combination to examine how a clinician could influence the character of dosage
assignments and intervention target tracking in the presence of unmeasured patient-
to-patient variability. For simplicity, the following remain constant in the sections be-
low unless otherwise specified: Qcpd = Qcrav = 10, QwipT = 1, ↵
cpd
r = ↵
crav
r = ↵
S
d = 0,
and Stress = 0.
4.5.1 Unmeasured, Stochastic Perturbations
Even with future advances in measurement methods (e.g., wearable technologies;
Lopez-Meyer et al., 2013), it will not be possible to perfectly measure or predict the
e↵ect of all time-varying factors that influence a smoker’s behavior or the e↵ect of
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accurate self-reporting (such as recall bias; Raphael, 1987). Consequently, examining
the robust performance of an HMPC-based cessation intervention in the context of
unmodeled variance in outcome measurements is critical. In this section, the inter-
vention performance is evaluated when the self-reported controlled variable signals
are subject to measurement noise.
Significant variance is characteristic of day-to-day measurements of Craving, the
level of which generally increases upon initiation of the quit attempt (McCarthy et al.,
2006). To reflect this, the following simulations subject the measured Craving signal
to a normally distributed pseudorandom sequence, the variance of which increases as
of TQD. Specifically, for t < TQD, N ⇠ (0, 8.95), and for t   TQD, N ⇠ (0, 11.90).
The initial level of variance in Craving is based o↵ of the pre-TQD variance estimated
for the subject in the McCarthy et al. (2008b) clinical trial after whom the nominal,
representative patient was patterned. The post-TQD Craving variance is based o↵
of the the ratio between post-TQD and pre-TQD Craving variance for individual
subjects from the PNc group in the McCarthy et al. (2008b) study who had su cient
enough data to estimate a discrete-time model; in other words, this representative
subject’s post-TQD Craving variance is nearly 30% greater than the pre-TQD period,
which is reflective of the increased level of the variance generally observed in the PNc
treatment condition. Fig. 4.13 depicts one realization of the stochastic signal added
to the simulated, non-perturbed Craving responses over time. A pseudorandom
sequence of the character N ⇠ (0, 4.55) is added to simulated, non-perturbed CPD
signals for the pre-TQD time period. This is based on the pre-TQD CPD variance
for the clinical trial subject who acted as the basis for the representative patient; for
simplicity and more straightforward performance evaluation, it is assumed that CPD
is accurately reported for t   TQD. (Anecdotal evidence suggests significant variance
in CPD post-TQD is rare.)
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Figure 4.13: A Time Series realization of the Stochastic Signal that is Incorporated
as a Measured Disturbance into the Simulated, Un-perturbed Craving Measurements
(where TQD is Day 15).
Fig. 4.14a depicts the dosing and corresponding outcome responses for one re-
alization of unmodeled measurement noise on Craving and pre-TQD CPD levels
(f cpda = f
crav
a = 1). Fig. 4.14a depicts considerable reduction in both CPD and
Craving levels, also reflected in the relatively low o↵set values on day 50, 0.12
cigarettes and 4.58 points, respectively. These reductions suggest that the controller
can assign e↵ective dosing despite the presence of unmeasured, stochastic perturba-
tions. Interestingly, the general shape of the controlled variable responses in Fig. 4.14a
look similar to noise-free cases under similar conditions, per Fig. 4.5b (which did not
have a 0   ub  1 constraint). Similar uc and ub doses are assigned in both cases,
with the noisy case employing more aggressive dosage adjustments in an attempt to
reject the variation in Craving (var(WIP T ) is 12.71 versus 0.25 in the noise-free
case). That said, the influence of the noise is clear in both outcomes. Craving ap-
proaches 50% of the baseline level four times after day 25. Due to the interrelated
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(a) Dosing and Responses when Craving and CPD are Subject to Unmodeled, Stochastic
Measurement Noise; f cpda = f crava = 1.
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(b) Dosing and Responses when Craving and CPD are Subject to Unmodeled, Stochastic
Measurement Noise; f cpda = 0.8 and f crava = 0.4.
Figure 4.14: Dosing and Responses when Craving and CPD are Subject to Un-
modeled, Stochastic Measurement Noise for Various Combinations of f cpda and f
crav
a
Values. (See Subsection 4.5.1.)
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nature of CPD and Craving, the dosing decisions based o↵ of the noisy Craving
signal a↵ect the CPD outcome as well, with approximately double the number of to-
tal cigarettes smoked after TQD versus the noise-free equivalent, and the maximum
lapse even is 2.60 cigarettes (which was less than 1 cigarette in the case corresponding
to Fig. 4.5b).
Table 4.9: Intervention Performance Metrics When CPD and Craving are Subject
to Measurement Noise for Various Combinations of Detuning via the Observer Gain
Matrix Parameters, Averaged Across 20 Noise Realizations. (See Subsection 4.5.1.)
Parameters f cpda 1 1 1 0.6 0.6 0.6 0.4 0.4 0.4 0.2 0.2 0.2
f crava 1 0.6 0.2 1 0.6 0.2 1 0.6 0.2 1 0.6 0.2
Performance, t   TQD tcpdr 0 0 0 0 0 0 0 0 0 0 0 0
tcravr 8.9 7.95 9.05 8.75 8.85 9.25 8.85 9.35 8.75 9.65 9 9.75
ecpd50 0.17 0.1 0.06 0.35 0.16 0.04 0.17 0.08 0.05 0.24 0.06 0.09
ecrav50 3.7 4.18 2.36 4.23 4.77 4.56 3.43 3.77 3.35 3.42 3.54 3.78
Total Cigs 9.45 6.39 4.77 6.97 4.61 1.35 4.85 2.22 2.09 4.89 2.38 1.35
Days CPD=0 14.6 18.2 19 17.45 19.25 27.8 22 25.7 29.3 22.6 26.65 31.45
max(cpd) 1.75 1.29 1.17 1.3 0.75 0.32 1.04 0.58 0.38 1 0.65 0.48
max(crav) 24.01 21.18 22.71 24.2 24.81 21.59 23.08 24.43 22.57 23.86 24.9 24.38
max(WIPT ) 15.25 16.45 15.25 13.9 14.55 13.8 14.2 13.5 12.55 14.35 14.95 15.15
J cpde 9.36 6 4.46 5.22 2.51 0.66 3.84 1.03 1.44 3.07 1.25 0.82
J crave 2622 2054 2323 2367 2370 2022 2138 2162 1997 2321 2222 2128
JwipTe 2624 3090 2739 2475 3120 2914 2761 2716 2779 2817 3079 3591
var(cpd) 0.19 0.13 0.1 0.11 0.05 0.01 0.08 0.02 0.02 0.07 0.03 0.02
var(crav) 42.95 34.78 40.59 40 40.57 34.6 36.56 38.27 35.57 39.85 39.72 39.63
var(WIPT ) 14.3 15.51 14.35 10.71 12.08 10.59 11.23 10.47 10.76 11.53 12.06 13.65
JucI 2.15 2.45 2.25 2.25 2.15 2.25 2.3 2.25 2.65 2.2 2.3 2.5
JubI 112 110 111 113 109 118 112 117 109 114 113 105
JulI 1766 2131 1883 1629 2177 1918 1896 1804 1906 1926 2144 2664
var(uc) 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.06 0.07 0.06 0.06 0.07
var(ub) 0.4 0.35 0.44 0.34 0.35 0.3 0.31 0.33 0.32 0.33 0.33 0.31
var(ul) 11.33 12.22 10.81 7.84 8.58 7.14 8.63 7.33 7.71 8.81 9.04 10.3
The plots in Fig. 4.14a correspond to the most aggressive possible dosing for
the penalty weight combination, i.e., no detuning is present as specified by f cpda =
f crava = 1. Fig. 4.15 contains a surface plot of the J
y
e values relative to the f
cpd
a =
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f crava = 1 case, averaged across 20 realizations of the noise, as a function of the
tuning parameters in the observer. A selection of the corresponding performance
metrics are found in Table 4.9. The average, scaled variance of the WIPT construct
is also depicted. Fig. 4.15c reflects that detuning via the observer gain has a more
complex e↵ect on the total dosing levels than has been observed up to this point.
That said, Fig. 4.15a indicates that filtering conditions that suppress tracking of
the Craving noise leads to more favorable tracking of the CPD target post-TQD.
Fig. 4.15d suggests that adjusting the f cpda parameter has a greater e↵ect on the
intensity with which the treatments are adjusted, which appears to correspond to
specific dosing combinations and sequences that facilitate more consistent tracking
of the CPD target. The decreased amount of dosing adjustments and the improved
tracking of the CPD target suggests clinical implementation of an intervention of this
sort would benefit from a tuning scenario in which f cpda < 1 and f
crav
a < 1. Fig. 4.14b
depicts an example, where f cpda = 0.8 and f
crav
a = 0.4. Comparing this figure to
Fig. 4.14a indicates that the detuning makes dosage adjustments less sensitive to
the Craving noise, particularly adjustments in ul, as expected. This more patient-
friendly dosing also leads to improved CPD performance versus the f cpda = f
crav
a = 1
case, reflected in the lower amounts of total smoking and lower peak lapse events
during the quit attempt. In other words, CPD performance is also less sensitive to
noise in Craving when the controller is detuned in order to discourage aggressive
noise rejection.
4.5.2 Plant-Model Mismatch due to Parametric Uncertainty
This section considers robust performance in the presence of plant-model mis-
match due to parametric uncertainty. (Note, the remaining analyses do not incorpo-
rate unmodeled noise in the CPD and Craving measurements.) Specifically, param-
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Figure 4.15: Surface Plots of Intervention Performance Metrics for Di↵erent Levels
of Detuning via f ya , as Averaged Across 20 Realizations of Noise and Scaled Relative
to the f cpda = f
crav
a = 1 Values. (See Subsection 4.5.1.)
eters from the self-regulation models—the open-loop Quit-path models—are altered
to indicate that the plant resumes smoking more quickly and/or experiences greater
peak Craving levels than is captured in the nominal models; parameters in the open-
loop dose-response models are also altered to represent uncertainties that lead to less
e↵ective treatment components. As exogenous, unmeasured disturbances and plant-
model mismatch factor in to control decisions in an equivalent manner, this section
also briefly examines how adjusting the tuning parameters in the observer gain matrix
a↵ect the sensitivity of control action to this mismatch. As the dose-response models
draw from literature and theory more than data, and as these analyses are limited to
simulation, the focus of this section is on evaluating the e↵ects of these uncertainties
generally, and therefore each source of uncertainty is introduced and examined inde-
pendently. Tables 4.10 and 4.11 contain the performance metrics for various levels
of parametric uncertainty for the mismatch cases examined; Figures 4.16 and 4.17
depict the dosing demands and responses for a subset of these cases.
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Uncertainty in the Quit-Path Models
Analyzed in Chapter 2, the responses of CPD and Craving to initiation of a quit
attempt—when represented by the closed-loop transfer functions in equations 2.35
and 2.36 and the corresponding structures in equations 2.30 through 2.32—are sen-
sitive to moderate to large changes in the Kd and K1 values. Specifically, decreases
in the Kd magnitude leads to smaller decreases in CPD on TQD, indicating an in-
ability of the patient to fully quit on their own at any point. This also leads to
smaller peak Craving magnitudes. Increasing the magnitude of K1 serves to increase
the speed at which smoking is fully resumed, increase the CPD overshoot seen af-
ter TQD during relapse, and increase peak Craving levels. Table 4.10 contains the
performance metrics for the following cases in which Kd and K1 are altered indepen-
dently: the magnitude of Kd is 30% and 60% smaller than baseline smoking levels
and the magnitude of K1 increases by 50% and 100%. Fig. 4.16a and Fig. 4.16c depict
the dosing demands and responses for the latter of each of these mismatch scenarios
(f cpda = f
crav
a = 1); the open-loop CPD and Craving responses of the uncertainty
models are also depicted (dashed grey).
Compared to the equivalent nominal performance case, Fig. 4.16a reflects that
uncertainty in Kd primarily influences dosing in the first two weeks of a quit attempt;
early aggressive ul dosing serves to bring CPD down to target levels, with dosing
between days 20 and 30 more hesitant than the corresponding nominal performance
case (e.g., Fig. 4.5b). This is due to the lower peak in Craving on TQD that results
from decreased Kd magnitudes, meaning less aggressive dosing is required over this
time interval to bring Craving toward its target. Fig. 4.16a and Table 4.10 suggest
that intervention performance is not significantly degraded by decreased Kd magni-
tudes; while smoking abstinence is not achieved until after TQD (reflected in the
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(a) Dosing and Responses (Solid Blue) in the Presence of Plant-Model Mismatch where
the Kd in the Plant Models is 40% of the Representative Subject’s Baseline CPD Level;
f cpda = f crava = 1. Open-loop Responses of CPD and Craving to Quit are Also Depicted
(Dashed Grey).
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(b) Dosing and Responses (Solid Blue) in the Presence of Plant-Model Mismatch where
the Kd in the Plant Models is 40% of the Representative Subject’s Baseline CPD Level;
f cpda = f crava = 0.3. Open-Loop Responses of CPD and Craving to Quit are Also Depicted
(Dashed Grey).
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(c) Dosing and Responses (Solid Blue) in the Presence of Plant-Model Mismatch where
the K1 in the Plant Models is 100% Greater than that for the Representative Subject;
f cpda = f crava = 1. Open-loop Responses of CPD and Craving to Quit are also Depicted
(Dashed Grey).
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(d) Dosing and Responses (Solid Blue) in the Presence of Plant-Model Mismatch where
the K1 in the Plant Models is 100% Greater than that for the Representative Subject;
f cpda = f crava = 0.3. Open-Loop Responses of CPD and Craving to Quit are Also Depicted
(Dashed Grey).
Figure 4.16: Dosing and Responses (Solid Blue) in the Presence of Plant-Model
Mismatch Introduced into Individual Parameters in Equations 2.35 and 2.36. Open-
Loop Responses of CPD and Craving to Quit are Also Depicted (Dashed Grey).
(See Subsection 4.5.2.)
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Table 4.10: Intervention Performance Metrics in the Presence of Uncertainty in Two
Parameters of the Quit-Path Nominal Models, Where the Specified Uncertainty in
the Parameter is Relative to the Value of the Parameter in the Representative Subject
Models (See Subsection 4.5.2).
Uncertain parameter Kd Kd Kd Kd K1 K1 K1 K1
Degree of uncertainty 70% 70% 40% 40% 150% 150% 200% 200%
Tuning parameter f cpda 1 0.3 1 0.3 1 0.3 1 0.3
f crava 1 0.3 1 0.3 1 0.3 1 0.3
Performance, t   TQD tcpdr 3 2 3 3 0 0 0 0
tcravr 11 9 4 7 12 10 10 8
ecpd50 0.08 0.04 0.00 0.24 0.23 0.01 0.06 0.10
ecrav50 2.42 2.35 1.68 2.31 3.07 2.50 2.12 2.47
Total Cigs 8.45 7.15 17.32 15.39 4.35 3.87 8.67 6.23
Days CPD=0 16 22 12 19 16 24 9 20
max(cpd) 2.90 2.90 5.55 5.55 1.09 1.05 1.59 1.57
max(crav) 21.51 21.51 19.32 19.32 27.34 27.34 30.99 30.99
max(WIPT ) 10 10 16 11 14 17 17 15
J cpde 17.13 16.41 63.27 63.07 2.71 2.63 8.32 5.31
J crave 1409.42 1363.07 848.63 931.81 2536.92 2271.14 2709.35 2659.33
JwipTe 1840 1805 2568 1850 1794 2546 2911 2332
var(cpd) 0.43 0.43 1.57 1.61 0.06 0.06 0.18 0.12
var(crav) 25.62 26.18 16.44 17.92 47.18 45.94 53.90 54.60
var(WIPT ) 6.86 5.48 8.45 7.90 12.14 14.03 13.16 12.15
JucI 3 3 3 3 3 3 2 3
JubI 118 127 100 127 118 109 118 109
JulI 1121 1069 1780 1120 1162 1782 2044 1608
var(uc) 0.08 0.08 0.08 0.08 0.08 0.08 0.05 0.08
var(ub) 0.32 0.28 0.37 0.28 0.32 0.35 0.32 0.35
var(ul) 4.87 3.96 5.90 6.29 11.33 12.50 11.15 10.94
nonzero tcpdr values), lapses after day 20 appear manageable even when the Kd mag-
nitude is only 40% of the baseline CPD level, and there may be improved Craving
performance overall (e.g., lower tcravr values than in previous scenarios). Good—even
improved—CPD performance can also be obtained with f cpda < 1 and/or f
crav
a < 1
(e.g., Fig. 4.16b). In this case, slowing the speed at which the mismatch is rejected
leads to a suppression of aggressive changes in ul early in the quit attempt. Although
this leads to a slightly increased post-TQD period on nontrivial smoking, it also leads
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to earlier implementation of the second ub dose, which helps bring CPD to target
levels relatively quickly and bring down Craving quickly as well.
Examining the cases considered here with uncertainty in K1 (see equations 2.30,
2.35, and 2.36) suggests that the intervention can be e cacious overall despite the
mismatch, but at the expense of some post-TQD lapse events and aggressive dosing
early within the quit attempt (when f cpda = f
crav
a = 1). This is seen with Fig. 4.16c.
However, even relatively aggressive detuning via the observer gain has relatively minor
e↵ects on that performance and the corresponding dosing demands, as apparent in
Fig. 4.16d.
Altogether, longer-term intervention e cacy appears to be relatively robust to un-
certainty in the degree to which a patient can quit on their own on TQD (i.e., smaller
values of Kd relative to baseline CPD levels) and the K1 parameter (which primarily
a↵ects the open-loop increase in Craving), however uncertainty in the latter scenario
is managed at the expense of aggressive dosing of all treatment components early in
the intervention, which is not well-handled by decreases in f ⇤a values. Practically, this
suggests that intervention performance may be most sensitive to uncertainty inK1, as
the aggressive dosing assigned by the intervention in this case is less patient-friendly
than would be preferred; this likely increases the probability of non-adherence, ulti-
mately leading to degraded performance.
Uncertainty in the Dose-Response Models
Table 4.11 contains the performance metrics for the cases in which there is uncertainty
in one parameter in the dose-response models; specifically, 20% and 40% reductions in
the gain of each open-loop, discrete-time dose-response model. Generally, with f cpda =
f crava = 1, each scenario with these independent uncertainties does lead to CPD and
Craving values that are at or near target levels by day 50, and CPD remains within
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5 cigarettes of its target over the entire time period. Uncertainty in the counseling
models appears to have the least e↵ect on dosing and outcome performance, as could
be expected given the limited use of counseling overall. The e↵ect of uncertainty
in the gain of the lozenge model appears to be most consequential to the lozenge
assignments, generally leading to increased amounts of lozenge assignment at most
time points compared to most previous cases. Intervention dosing and e cacy appears
to be most sensitive to uncertainty in the e↵ect of bupropion. Decreasing the f ⇤a values
under these uncertainty conditions appears to have some minor e↵ect on ul dosing
but relatively small changes in performance. As seen in Fig. 4.17a, for f ⇤a = 1, the
lower gain in the bupropion dose-response model leads to increased counseling and
generally a sustained increase in daily lozenge dose and adjustment frequency; this
still leads to larger amounts lapse and fewer cigarette-free days (see Table 4.11). For
the independent, 40% mismatch in the gains of the counseling and lozenge dose-
response gains, detuning such that f cpda = f
crav
a = 0.3 leads to more patient-friendly
dosing in that the frequency of ul adjustment is decreased overall. However, for the
equivalent mismatch in bupropion dose-response models, total amount of lozenges
assigned decreased slightly, bringing in the maximum bupropion dose earlier (see
Fig. 4.17b).
While the outcome targets are obtained in these simulations, they each incor-
porate only one distinct source of parameter uncertainty. It may suggest that the
character of dosing schedules and lapse events will be more sensitive to a conflu-
ence of uncertainties of multiple dose-response models, as opposed to the Quit-path
models.
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(a) Dosing and Responses where the Gain Values in the Bupropion-Response Models for the
Plant are 40% of the Corresponding Gain Values for the Nominal Models; f cpda = f crava = 1.
Open-loop Responses of CPD and Craving to Quit are Also Depicted (Dashed Grey).
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(b) Dosing and Responses where the Gain Values in the Bupropion-Response Models for the
Plant are 40% of the Corresponding Gain Values for the Nominal Models; f cpda = f crava =
0.3. Open-Loop Responses of CPD and Craving to Quit are Also Depicted (Dashed Grey).
Figure 4.17: Dosing and Responses where the Gain Values in the Bupropion-
Response Models for the Plant are 40% of the Corresponding Gain Values for the
Nominal Models. Open-Loop Responses of CPD and Craving to Quit are Also
Depicted (Dashed Grey). (See Subsection 4.5.2.)
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Table 4.11: Intervention Performance Metrics in the Presence of Uncertainty in
the Gain Parameters of the Discrete-Time Dose-Response Models, Where the De-
gree of Uncertainty is Relative to the Gain for the Equivalent Nominal Model (See
Subsection 4.5.2).
Dose-response model Counseling Counseling Counseling Bupropion Bupropion Bupropion Lozenge Lozenge Lozenge
Degree of uncertainty 80% 60% 60% 80% 60% 60% 80% 60% 60%
Tuning parameters f cpda 1 1 0.3 1 1 0.3 1 1 0.3
f crava 1 1 0.3 1 1 0.3 1 1 0.3
Performance, t   TQD tcpdr 0 0 0 0 0 0 0 0 0
tcravr 12 15 12 15 14 13 13 13 12
ecpd50 0.15 0.01 0.06 0.04 0.12 0.78 0.10 0.11 0.12
ecrav50 2.85 2.63 2.71 1.64 1.53 2.83 2.78 3.18 2.86
Total Cigs 7.19 4.31 6.28 6.62 16.43 15.14 7.10 5.46 6.99
Days CPD=0 10.00 16.00 24.00 12.00 11.00 13.00 11.00 15.00 12.00
max(cpd) 0.92 0.99 1.54 1.24 2.15 1.42 0.90 1.08 0.88
max(crav) 23.70 23.70 23.70 23.70 23.70 23.70 23.70 23.70 23.70
max(WIPT ) 14.00 15.00 16.00 16.00 17.00 13.00 15.00 18.00 19.00
J cpde 3.31 2.66 6.17 4.20 16.33 13.78 3.24 3.05 2.88
J crave 2322.52 2339.46 2075.02 2226.66 2249.13 2074.67 2447.69 2534.90 2279.65
JwipTe 2984.00 2820.00 3884.00 3453.00 3934.00 3329.00 3733.00 3380.00 5318.00
var(cpd) 0.05 0.06 0.14 0.09 0.25 0.21 0.05 0.06 0.04
var(crav) 41.22 41.74 39.42 43.34 43.58 38.45 42.73 42.29 38.05
var(WIPT ) 9.97 10.09 11.51 16.88 17.39 10.25 14.37 18.32 17.23
JucI 2.00 3.00 3.00 3.00 4.00 5.00 2.00 3.00 2.00
JubI 118.00 118.00 100.00 109.00 109.00 118.00 109.00 109.00 118.00
JulI 2014.00 1885.00 2865.00 2548.00 2901.00 2292.00 2712.00 2501.00 4073.00
var(uc) 0.05 0.08 0.08 0.08 0.10 0.12 0.05 0.08 0.05
var(ub) 0.32 0.32 0.37 0.35 0.35 0.32 0.35 0.35 0.32
var(ul) 6.34 6.99 8.03 14.08 13.82 6.77 9.82 15.72 11.79
4.5.3 Plant-Model Mismatch due to Non-Parametric Uncertainty in the Open-Loop
Cessation Models
Section 4.5.2 examined uncertainty in two individual parameters of the open-loop
Quit disturbance models. Now, uncertainty in the Quit-path disturbance models is
non-parametric. Specifically, black-box, SISO, discrete-time models of various lag
orders were estimated for four subjects from the PNc group in the McCarthy et al.
(2008b) study, other than that after whom the representative patient is based. Con-
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Table 4.12: Structures and Parameter Estimates of the Alternate Patients Consid-
ered, Estimated as SISO ARX Models from Four Single Subject Data Sets in the PNc
Group of the McCarthy et al. (2008b) Study (See Subsection 4.5.3).
Subject Outcome Baseline [na, nb, nk] {a1, . . . , ana} {b1, . . . , bnb}
1 CPD 10.6 [8 4 2] {-0.470, -0.1978, 0.043, {-3.5019, -2.9119, 2.3128, 2.4737}
0.033, -0.239, 0.082, 0.077, 0.080}
1 Craving 25.6 [8 8 1] {-0.364, 0.080, -0.109, -0.176, {4.460, -10.567, 13.038, -2.965,
-0.224, -0.034, -0.133, -0.181} -0.123, 0.109, -2.046, -2.998}
2 CPD 30.0 [1 3 1] -0.583 {2.169, 10.420, -7.749}
2 Craving 17.2 [3 1 1] {-0.472, 0.185, -0.011} -20.140
3 CPD 24.2 [1 3 1] -0.201 {3.160, 2.860}
3 Craving 30.8 [1 2 1] 0.133 {2.172, -26.130, 26.190}
4 CPD 20.3 [1 2 1] -0.158 {-20.330, 3.316}
4 Craving 23.8 [4 2 1] {-0.507, -0.204, 0.091, -0.194} {1.955, -5.174}
sidering these alternate models as the plant’s open-loop cessation dynamics facilitates
analysis of robust performance where plant-model mismatch resulting from a conflu-
ence of parameter uncertainties and unmodeled complexities, such as nonlinearities
that are likely characteristic of patient-to-patient variability. Generally, these analy-
ses also help assess how appropriate the representative patient is as a basis for design
of an intervention of this nature.
Table 4.12 contains the orders of the ARX structures, parameter estimates, and
average pre-TQD levels of Craving and CPD for the four subjects. These sets of dy-
namics are examined here as they represent several classes of experimentally-observed
dynamic patterns. Subject 1 nearly quits on their own initially, but eventually re-
sumes smoking to a degree, and also features more complex Craving dynamics. Sub-
ject 2 nearly abstains on their own, but increased Craving levels are sustained for
several weeks into the quit attempt. Subject 3 is less successful than the represen-
tative patient in their independent quit attempt, unable to reduce smoking for more
than one day (not on TQD), which corresponds to a sustained increase in Craving.
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Table 4.13: Intervention Performance Metrics in the Presence of Uncertainty in
the Gain Parameters of the Discrete-Time Dose-Response Models, Where the De-
gree of Uncertainty is Relative to the Gain for the Equivalent Nominal Model (See
Subsection 4.5.3).
Subject 1 1 2 2 2 3 3 4 4 4
Tuning parameters ↵cpdr 0 0 0 0.8 0 0 0 0 0.8 0
↵cravr 0 0 0 0.8 0 0 0 0 0.8 0
f cpda 1 0.2 1 1 0.2 1 0.1 1 1 0.2
f crava 1 0.2 1 1 0.2 1 0.1 1 1 0.2
Performance, t   TQD tcpdr 2 2 2 2 2 2 2 1 1 1
ecpd50 0.00 0.00 0.00 0.00 0.00 13.52 13.52 0.00 0.00 0.00
ecrav50 4.70 2.38 16.32 16.86 12.67 15.05 15.05 2.21 2.45 0.00
Total Cigs 16.96 16.96 40.23 40.23 39.12 402.44 402.15 20.33 20.33 20.33
Days CPD=0 34 34 32 32 34 1 1 35 35 35
max(cpd) 10.60 10.60 30.00 30.00 30.00 25.63 25.63 20.33 20.33 20.33
max(crav) 28.68 28.68 31.05 31.05 17.99 32.58 32.58 24.38 24.38 24.38
max(WIPT ) 22.00 22.00 18.00 17.00 21.00 22.00 22.00 6.00 3.00 22.00
J cpde 152.82 152.82 997.26 997.26 983.14 5286.42 5274.37 413.15 413.15 413.15
J crave 2242.77 2312.65 7744.45 7951.02 3889.60 6345.40 6327.91 1660.81 1908.47 1182.94
JwipTe 8865.00 10546.00 4508.00 4068.00 5678.00 15529.00 15550.00 87.00 63.00 1836.00
var(cpd) 4.14 4.14 27.21 27.21 26.88 22.50 22.34 11.48 11.48 11.48
var(crav) 33.20 38.70 59.73 54.85 10.20 47.35 47.31 34.48 29.86 31.55
var(WIPT ) 26.12 34.33 33.79 30.84 23.56 35.68 35.14 0.88 0.33 21.34
JucI 5 5 3 3 4 5 5 3 2 4
JubI 118 100 115 115 109 127 127 34 34 34
JulI 7192 8916 3293 2920 4462 13199 13216 29 12 1423
var(uc) 0.12 0.12 0.08 0.08 0.10 0.12 0.12 0.08 0.05 0.10
var(ub) 0.32 0.37 0.52 0.52 0.35 0.28 0.28 0.05 0.05 0.05
var(ul) 18.03 23.31 26.88 24.71 21.17 21.91 21.33 0.76 0.29 19.05
Subject 4 essentially quits smoking on their own and features a significant reduction
in Craving. Figures 4.18 through 4.21 depict the dosing demands and outcome re-
sponses for a subset of tuning combinations considered. The open-loop step responses
of these alternate subject models are depicted as the dashed grey responses in their
respective intervention simulations. Note, there is no mismatch in the dose-response
models in these simulations (other than that due to the causality issue in the dose-
response models for the lozenge, see Fig. 3.4). The nominal Quit-path models remain
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to be those describing the self-regulatory dynamics for the representative patient
per equations 2.35 and 2.36, although the Kd parameter in the nominal models (see
equation 2.31) is set to each subject’s respective baseline CPD level. The alternate
subjects’ set points and controlled variable lower limit constraints are adjusted to
the respective average pre-TQD baseline levels appropriately. Table 4.13 contains the
performance metrics for a selection of simulations considered in these analyses.
Subject 1
Subject 1’s baseline CPD level is slightly larger than that of the representative pa-
tient; Subject 1’s baseline Craving is approximately 50% larger than that of the repre-
sentative patient. Fig. 4.18a depicts the dosing and responses where f cpda = f
crav
a = 1.
Aggressive dosing is seen early on in each manipulated variable, which quickly brings
down the peak and overall level of Craving. The intervention reduces uc and ul dosing
within days of TQD, as maximum dosing levels are not needed to support tracking
of the CPD target. However, high lozenge dosing is implemented and sustained as
of day 34 in an attempt to mitigate the high Craving levels that would otherwise be
observed.
As Subject 1 is able to track the CPD target with less treatment than the nominal
case, Fig. 4.18a reflects relative poor balance between the general goals of avoiding
over-dosing and mitigating Craving as a risk factor. However, detuning has a limited
e↵ect. Adjusting either the ↵cpdr or f
cpd
a parameter has little e↵ect as relatively little
e↵ort is required to quickly reach the CPD target, regardless of whether the controller
is tuned to pursue this target aggressively or otherwise. Detuning via the ↵cravr or
f crava parameters only balances the Craving and dosing trade-o↵ for a period of time.
This is apparent with Fig. 4.18b. As the 3DoF tuning parameters slow the rate at
which a target is tracked and mismatch rejected, detuning a↵ects dosing for only a
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(a) Subject 1: Dosing and Responses (Solid Blue) Where f cpda = f crava = 1. Open-Loop
Responses of CPD and Craving to Quit are Also Depicted (Dashed Grey).
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(b) Subject 1: Dosing and Responses (Solid Blue) where f cpda = 1, f crava = 0.2. Open-Loop
Responses of CPD and Craving to Quit are Also Depicted (Dashed Grey).
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(c) Subject 1: Dosing and Responses (Solid Blue) where f cpda = 1, f crava = 0.2 and a
Stochastic Stress Disturbance is Present. Open-Loop Responses of CPD and Craving to
Quit are Also Depicted (Dashed Grey).
Figure 4.18: Subject 1: Dosing and Responses (Solid Blue) for Select Observer
Gain Tuning Levels. Open-Loop Responses of CPD and Craving to Quit are Also
Depicted (Dashed Grey).
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period of time in the first few weeks of TQD, and high dosing levels are assigned after
longer periods of time to decrease the Craving o↵set that would otherwise remain
large. Fig. 4.18c illustrates that similar lozenge levels are assigned after several days
when a stochastic Stress disturbance is present. Even despite the presence of this
disturbance, the intervention is able to support a successful quit attempt in terms of
CPD, but does lead to slightly higher Craving o↵set.
Altogether, Fig. 4.18 indicates that intervention performance is relatively robust
to this sort of mismatch in terms of the CPD and Craving outcomes, but at the
expense of the WIPT target. Specifically, it appears that the extent of aggressive
dosing is sensitive to the baseline Craving level.
Subject 2
Subject 2’s baseline CPD level is more than three times that of the representative
subject. Although the Craving baseline levels are similar, the open-loop response of
Craving to Quit consists of a sustained increase in Craving of approximately 50%.
Fig. 4.19a depicts the dosing and responses where f cpda = f
crav
a = 1. The inter-
vention is hesitant just after TQD, as seen in most nominal performance simulations,
which serves to avoid large amounts of relaxation of the lower bound on CPD early
in the quit attempt. An aggressive lozenge regimen begins on day 20 in order to re-
duce Subject 2’s very high Craving levels. Interestingly, the intervention ultimately
decreases lozenge dosing starting approximately 18 days after TQD, which corre-
sponds to a gradual increase in Craving, although the CPD target is still tracked.
This unintuitive control action is the result of a number of factors. Notably, this
can be partially attributed to a trade o↵ in the objective function between dosing
and constraint relaxation, as large dosing would move CPD far beyond the bound
according to the nominal models. Also, CPD features a larger baseline level than
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(a) Subject 2: Dosing and Responses (Solid Blue) where f cpda = f crava = 1. Open-Loop
Responses of CPD and Craving to Quit are Also Depicted (Dashed Grey).
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(b) Subject 2: Dosing and Responses (Solid Blue) where f cpda = 1 and f crava = 0.2. Open-
Loop Responses of CPD and Craving to Quit are also Depicted (Dashed Grey).
Figure 4.19: Subject 2: Dosing and Responses (Solid Blue) for Select Observer
Gain Tuning Levels. Open-Loop Responses of CPD and Craving to Quit are Also
Depicted (Dashed Grey).
217
Craving, but the CPD and Craving targets are penalized equally in the objective
function. This means that successful tracking of the CPD target leads to lower min-
imum J values than would perfect tracking of the Craving target. This assertion
is supported by the contrasting dosing assignments after day 35 for Subjects 1 and
2 when f cpda = f
crav
a = 1 (see Fig. 4.18a and Fig. 4.19a, respectively). The baseline
Craving level is larger than the baseline CPD level for Subject 1, meaning tracking
the Craving target is “harder” than tracking the CPD target, hence the consistently
aggressive dosing after day 35 for Subject 1 as tracking the Craving target perfectly
will reduce J values more than perfect tracking of Subject 1’s CPD target.
Independently decreasing the f cpda value leads to more consistently aggressive
lozenge dosing for longer periods of time as of day 20 (not shown), a result of the
increased priority of aggressively tracking the Craving target. Detuning via indepen-
dent decreases in f crava actually improves Craving performance early on. As dosing
decisions focus on tracking of the CPD target when f cpda = 1 and f
crav
a < 1, the inter-
vention aggressively doses early in order to suppress the nearly 30 cigarette resumption
that the nominal model predicts would otherwise occur; this has a simultaneous ef-
fect of reducing the peak Craving levels. Both aspects of these independent detuning
scenarios are observed in Fig. 4.19b, where f cpda = f
crav
a = 0.2. As before, though,
detuning e↵ects are most distinct for the first few weeks immediately following TQD
only, reflected in the similar Craving o↵sets on day 50 for Fig. 4.19a and Fig. 4.19b.
Subject 3
Subject 3’s baseline CPD and Craving levels are both significantly higher than those
for the representative subject. This, and the fact that Subject 3’s open-loop Quit-
response models indicate only one day of decreased CPD levels during the quit at-
tempt and no decrease in Craving levels, leads to aggressive dosing in all components
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Figure 4.20: Subject 3: Dosing and Responses (Solid Blue) where f cpda = f
crav
a = 1.
Open-Loop Responses of CPD and Craving to Quit are Also Depicted (Dashed
Grey).
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early on. Depicted in Fig. 4.20, this aggressive dosing is generally sustained for the
duration of the quit attempt. Such dosing does move both CPD and Craving to
approximately 50% of the baseline levels as of day 17, but the patient still features
nontrivial smoking for most of the quit attempt, and Craving remains at approx-
imately 18 points as of day 50. Detuning via any of the tuning parameters may
suppress aggressive dosing early on, but at the expense of the CPD and Craving
outcomes, and ultimately still leads to an unsuccessful quit attempt.
Subject 4
While Subject 3 represents a relatively extreme level of mismatch, Subject 4 represents
an alternative mismatch extreme in that the patient can successfully reduce smoking
and Craving on their own over time. Subject 4’s baseline CPD and Craving levels
are both larger than those for the representative subject. As seen in Fig. 4.21, the
intervention adapts appropriately to the patient’s early and consistently successful
attempt to quit smoking: counseling is only briefly assigned just after TQD, only one
bupropion dose is assigned, and few lozenges are assigned. This minor dosing serves
to bring Craving to trivial levels by day 21, which still corresponds to successful
tracking of the CPD target. Altogether, Fig. 4.21 highlights the appealing resource
use aspect of this approach, as the dosing depicted in the plots is less than that
generally assigned by current clinical recommendations, yet successful outcomes are
still achieved and maintained. Because of the success of the patient’s open-loop quit
attempt, the intervention does not necessarily benefit from detuning. Even extreme
detuning pursued by significantly increasing ↵cpdr and ↵
crav
r corresponds to little change
in dosing demands compared to the ↵cpdr = ↵
crav
r = 0 case; the level of Craving for the
detuned scenario where ↵⇤r > 0 is actually slightly higher beginning around day 17 to
day compared to the Craving observed for the ↵cpdr = ↵
crav
r = 0 case. Adjusting f
cpd
a
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Figure 4.21: Subject 4: Dosing and Responses (Solid Blue) where f cpda = f
crav
a = 1.
Open-Loop Responses of CPD and Craving to Quit are Also Depicted (Dashed
Grey).
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or f crava independently or simultaneously actually leads to more aggressive dosing
overall, particularly within the first 10 days of the quit attempt. As an example,
independently detuning such that f cpda = 0 and f
crav
a = 0.2 leads the intervention
to assign the maximum ub dose as of day 20 as well as some lozenge. This occurs
as f crava < 1 leads the observer to trust the nominal Craving models more than
the Craving measurement, and the nominal Craving models suggest Craving will
remain high after TQD in the absence of relatively aggressive dosing.
4.5.4 Summary
The scenarios presented in this section indicate that the performance of this inter-
vention approach can be robust in the presence of a variety of noise and uncertainty
conditions. Similarly, the e↵ective adaptation that balances tracking of intervention
targets with resource use considerations suggest that the character of the representa-
tive patient’s cessation dynamics o↵er good initial nominal models.
While aggressive dosing often leads to tracking of the intervention targets, the
3DoF tuning capabilities can o↵er clinicians a flexible way to obtain dosing schedules
suited to individual patient circumstances. The simulated results appear to indicate
that patients for whom adherence is an issue may benefit most from a detuned sce-
nario, as detuning generally leads to lower peak lozenge demands and more subtle
lozenge dosing adjustments in particular. Specifically, decreasing the tuning parame-
ters in the observer gain matrix o↵er improved dosing and potentially improved out-
comes for tuning conditions including the following: when significant noise is present
in Craving measurements, where decreasing f cpda specifically leads to improved dosing
and even CPD dynamics (see Fig. 4.15d and Fig. 4.15a); when aggressive bupropion
dosing is more favorable than high lozenge levels; and when there is a benefit to ag-
gressive dosing early in the intervention over later in the intervention or vice-versa,
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as detuning in the presence of mismatch can manage a trade-o↵ between aggressive
tracking of the CPD target early in the quit attempt, versus aggressive tracking of
the Craving target as time goes on. Detuning appears to negatively influence dosing
assignments when the patient receiving the intervention features open-loop cessation
dynamics that independently lower CPD and Craving levels.
That said, robust performance appears to be most sensitive to uncertainty in the
e↵ectiveness of bupropion (see Section 4.5.2) and the steady-state levels of CPD
and Craving in the open-loop. Diverging open-loop steady-state levels can bias
the intervention toward aggressive dosing that tracks one target over another weeks
after TQD, based on how much tracking one set point contributes to reduction of
the objective function values at the decision points. In other words, the controller
formulation evaluated in this section is particularly sensitive to the relative steady-
state levels of the Quit-path processes in the open-loop. High steady-state Craving
levels in the open-loop relative to that patient’s steady-state CPD levels in the open
loop, and to that of the nominal patient’s Craving levels appear to have a significant
e↵ect; this scenario tends to assign large amounts of all treatment components even
weeks after TQD, regardless of success in CPD target tracking. As detuning only
slows the speed at which the targets are tracked or mismatch rejected, doing so in this
case still leads to high dosing at the end of the time period examined. This suggests
that future research may benefit from development of a formulaic method to determine
a more advantageous ratio of Qcpd to Qcrav as a function of the relative baseline levels.
However, this issue speaks more to the need for accurate dose-response models as
Section 4.5.3 does not employ dose-response models other than those describing the
representative, yet treatment e↵ects are likely a function of levels of addiction and
other factors; this concept of dosing e↵ects being a function of addiction level is even
addressed in current clinical practice as 4 mg nicotine lozenges—as opposed to 2 mg
223
lozenges—are assigned to heavier smokers (Rennard et al., 2014).
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Chapter 5
CONCLUSIONS & FUTURE WORK
5.1 Summary
This dissertation has explored the usefulness of applying process modeling and
control concepts from engineering into the study of cigarette smoking behavior change
and the development of an adaptive smoking intervention. Toward this goal, two dis-
tinct but related aspects of this research were presented: (1) the use of dynamical
systems modeling and system identification methods to describe behavior change dur-
ing a smoking cessation intervention (Chapter 2), and (2) the formulation (Chapter 3)
and evaluation (Chapter 4) of a decision framework based in Hybrid Model Predictive
Control (HMPC) that adapts treatment components to meet the changing needs of
a patient.
5.1.1 Modeling Smoking Cessation Behavior Change
Two hypothesized mechanisms of change that are central to the study of cause and
e↵ect in behavioral and social science settings were cast as dynamical systems in this
research. Specifically, dynamical systems models were developed to describe behavior
change according to statistical mediation and self-regulatory mechanisms. As was
illustrated in Chapter 2, these models examine relationships between time-varying
behaviors as input-output systems; system identification methods o↵er a means to
utilize behavioral ILD to describe these dynamic behaviors with low order di↵erential
equation models. The major contributions of this modeling work include:
• Demonstration that an engineering modeling approach can be used to e↵ectively
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understand dynamic behavioral phenomena: The work described in Chapter 2
illustrates that linear time-invariant models in continuous-time ODE form and
prediction-error identification methods o↵er a means for obtaining clinically-
meaningful models of behavior change. This modeling paradigm can provide
significant insight into tobacco-use behaviors in particular. Models were esti-
mated using both treatment group average and single subject data sets. This
suggests this modeling methodology can be used to investigate broad research
questions within behavioral science.
• Development of a dynamical systems representation of statistical mediation:
The dynamic mediation models presented here stem from a connection to production-
inventory systems and are not necessarily limited to the study of cigarette smok-
ing. These models represent each path in a mediated behavioral system as an
independent input-output process, which together describe mediated behavior
change as a parallel-cascade system.
• Estimation and interpretation of dynamic mediation models that describe cessation-
induced changes in CPD as a Craving-mediated process: Using ILD collected in
the McCarthy et al. (2008b) clinical trial, treatment group average continuous-
time ODEs were estimated. Estimation of each set of expressions consists of esti-
mated low-order transfer functions and high goodness-of-fit values. These mod-
els attribute the large, immediate drop in CPD on TQD to the non-mediated
path and the relatively small and slow resumption of smoking after TQD to
changes in Craving. Comparing the parameter estimates across the groups
suggests counseling and bupropion independently and in combination a↵ect the
cessation process, generally influencing the net change in Craving, the degree
to which CPD decreases on TQD, and the magnitude and speed at which CPD
226
increases after TQD. Ultimately, these models suggest an interrelationship be-
tween Craving and CPD cannot be fully described by one mediation model
structure.
• Reverse-engineering of models describing a self-regulating psychological pro-
cess: Through secondary analysis of ILD, empirical closed-loop models were
estimated and validated to represent self-regulation within behavior change.
Models of this nature have historically been di cult to precisely quantify with
traditional behavioral science analytical methods, and this mechanism was pre-
viously described largely in conceptual terms in behavioral science and sub-
stance use literature (Carver and Scheier, 1998; Solomon, 1977; Solomon and
Corbit, 1974; Velicer et al., 1992).
• Development of models describing smoking cessation behavior change as a self-
regulatory process: A specific self-regulation system was proposed and modeled
in this work. This feedback process represents Craving as the controlled vari-
able, CPD as the input variable to the process where Craving is the output.
CPD itself is the result of an excitatory Quit disturbance as well as the output
of a biological or psychological Craving self-regulator.
• Estimation and interpretation of models quantifying self-regulation within day-
to-day changes in Craving and CPD during a quit attempt: Continuous-time
ODE models were estimated using data from the McCarthy et al. (2008b) study
through a two step closed-loop identification problem. They suggest that on
average, the Craving set point is the average Craving level pre-TQD and that
the self-regulator acts as a proportional-with-filter controller.
Altogether, this dissertation makes the case for the usefulness and relevance of dy-
namical systems modeling and system identification techniques for better under-
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standing dynamic health behaviors generally, and specifically for providing clinically-
meaningful insight into the nature of cigarette smoking behavior change.
5.1.2 Adaptive Intervention Design & Evaluation
Adaptive smoking cessation interventions seek to explicitly address the chronic,
relapsing nature of tobacco dependence by adjusting treatment component dosages
to the changing needs of a specific patient. A control systems engineering paradigm
for designing such interventions o↵ers a means for systematic treatment optimization
and personalization. In Chapter 3, an adaptive intervention algorithm employing
an HMPC framework was developed. This intervention was evaluated extensively
through simulation, as described in Chapter 4. Ultimately, this work o↵ers a proof-
of-concept for the potential clinical application of an engineering approach to the
design of cigarette smoking treatments. The major contributions of this intervention
design work include:
• Identification of the major requirements of a clinically-relevant adaptive ces-
sation intervention and establishment of a connection to control systems en-
gineering ideas: Connections between specific clinical considerations and con-
trol systems engineering ideas were outlined; these clinical circumstances and
demands manifest in a control systems framework as controlled variables, con-
troller structure, constraints, manipulated variable constraints, and more.
• Development of a mathematical representation of the nominal model: A set of
open-loop Quit-response, Stress-response, and dose-response models were ob-
tained to represent a hypothetical patient unable to quit smoking on their own.
The discrete-valued nature of treatment component dosages were represented
as linear inequality constraints via continuous and discrete auxiliary variables
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incorporated into the MLD model framework. Discrete-time, state-space repre-
sentations of these models were then presented.
• Formulation of an HMPC-based adaptive cessation intervention: The general
requirements, goals, and constraints of a clinically-relevant control-based in-
terventions were translated into mathematical form and incorporated into the
HMPC framework. The result is an intervention algorithm that determines
daily adjustments to counseling, bupropion, and nicotine replacement lozenge
dosages in order to move controlled variables to their target levels while reject-
ing the influence of a measured Stress disturbance and accounting for an array
of hard constraints. 3DoF tuning capabilities were also incorporated.
• Demonstration that good therapeutic performance can be obtained in the nom-
inal case: Diverse simulations indicate that an HMPC-based intervention can
promote successful cessation in an individual unable to do so on their own. The
objective function penalty weights and 3DoF tuning parameters o↵er a means
for obtaining dosing profiles and post-TQD CPD and Craving responses of
diverse character.
• Illustration that the therapeutic performance of an HMPC-based smoking ces-
sation intervention can be robust to measurement noise, parametric uncertainty,
and significant plant-model mismatch: Among other findings, simulations that
assessed robust performance suggest that tuning via the observer gain o↵ers
significant improvement in terms of dosing demands and outcomes in the pres-
ence of measurement noise. Additionally, dosing demands appear to be largely
sensitive to a patient’s baseline Craving level, particularly its value relative to
CPD baseline levels and to the nominal patient’s baseline levels.
229
5.1.3 Future Work
A number of opportunities and lines of research exist to move the ideas and
analyses presented in this dissertation toward clinical practice.
Improving Model & Controller Complexity
While not an exhaustive list of opportunities, a number of natural extensions of the
work presented are described below. Significant progress on this work can likely build
on existing work in a relatively straightforward manner and in the absence of novel
experimentation.
Given the nonlinear nature of physiological phenomena and the diverse manner
in which inter-individual variability can enter determinants of human behaviors, in-
corporating additional complexity into the models presented here may result in ex-
pressions representative of dynamics observed over a wider range of circumstances
or time scales. For example, slowly time-varying or static variables, such as demo-
graphic variables, likely play a nontrivial role within an individual’s cessation process.
The systematic e↵ect of such factors could be incorporated into future self-regulation
models. As an example, a linear parameter-varying form of the closed-loop models
presented in Chapter 2 could be developed in which a scheduling parameter may
represent an individual’s socioeconomic status, for example (Novara et al., 2011).
Furthermore, the dynamic psychological component of the cessation process is
intuitively nonlinear as there is physical and logical lower bound on both CPD and
Craving. In other words, the fact that CPD and Craving cannot realistically as-
sume negative values indicates that the open-loop behavior change process actually
consists of a saturated system (Widanage et al., 2004). While such saturation was
incorporated into simulations of the patient-reported responses, this factor was not
230
incorporated into the nominal models. Future e↵orts may benefit from incorporat-
ing this nonlinearity into the open-loop models that act as the basis for intervention
design.
Formulaically, the intervention developed here can be altered in a straightforward
manner to include additional or alternate treatment components, controlled variables,
and disturbances. For example, self-e cacy and negative a↵ect are thought to play
significant roles in the cessation process (Gwaltney et al., 2009; Piper and Curtin,
2006; Shi↵man and Waters, 2004) and could be incorporated as additional controlled
variables. Similarly, an alternate set of treatment components could be employed.
For example, nicotine replacement patches are the most commonly used treatment
product (Reynolds, 2011). Future work may want to consider combination therapy
consisting of a nicotine replacement patch in lieu of bupropion as the former is more
widely available. Reformulating the intervention to alter the combination of ma-
nipulated and/or controlled variables would be relatively straightforward. However,
without additional experimentation, the open-loop models around which an HMPC-
based intervention is designed will be limited by the quality of the dynamical systems
models.
Incorporating Within-Day Decision-Making
Design of the intervention in Chapter 3 with daily measurements and adaptation is
motivated by a number of factors. First, the models in Chapter 2 indicate relevant
behavioral phenomena occur on the daily time scale. Additionally, dosages of many
existing treatment components can only realistically be adjusted from day-to-day (or
even more infrequently), and their e↵ects are more appropriately described by a daily
time scale; counseling, bupropion, and nicotine replacement patches fall into this
category. Furthermore, daily measurement and adaptation requirements should be
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manageable from a logistical perspective.
However, a controller involving within-day measurement and treatment adapta-
tion may improve how e↵ective lozenge assignments are in terms of preventing spe-
cific instances of smoking. An intervention algorithm of this sort may also be able
to mitigate issues of plant-model mismatch for the ul and Stress e↵ects, which were
introduced to the controller formulation in Chapter 3 in order to maintain a causal
controller (see Section 3.3.2). That said, simply extending the HMPC formulation
described in Chapter 3 such that sampling and control action decisions occur on a
minutely or hourly basis would result in an unnecessarily complex intervention al-
gorithm with tractability issues. Specifically, a single overarching control algorithm
that is meant to determine counseling, bupropion, and lozenge control action multiple
times within a day would mean the prediction horizon value (p) employed in Chap-
ter 4 translates to a p in this hypothetical scenario that is an order of magnitude
larger. These large prediction and move horizons would also include spans of time
where measurement and adaptation is not feasible (e.g., while a patient is sleeping).
Furthermore, this more complex controller would also require switching time con-
straints such that counseling and bupropion control action could not be implemented
more than once daily (or even less in the case of bupropion). Instead, a hierarchi-
cal control scheme can o↵er a means to manage the multi-timescale nature of the
cessation process, dosing frequency, and speed of treatment e↵ects in a conceptually
and computationally simpler manner (Barcelli, 2012; Brdys et al., 2008; Scattolini
and Colaneri, 2007; Van Henten and Bontsema, 2009). A survey of the various forms
a hierarchical control scheme can take is outside the scope of this chapter; Barcelli
(2012) and Scattolini and Colaneri (2007) o↵er good overviews of this class of control
framework.
In the context of an adaptive smoking intervention, a decision framework that
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(a) Block Diagram for the Upper, Slow Level of the Hierarchical Control Scheme. P s
Encompasses the Fast Level of the Control Scheme Depicted in Fig. 5.1b.
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(b) Block Diagram for the Within-Day, Fast Level of the Hierarchical Control Scheme. This
Subsystem Constitutes the Process Block in the Block Diagram of the Slow Level of the
Control Scheme, i.e., P s in Fig. 5.1a.
Figure 5.1: Block diagram of a Potential Hierarchical Control Scheme for an Adap-
tive Intervention that Features Combined Within-Day and Between-Day Dosing.
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features within-day decision making may take the form of the block diagrams in
Fig. 5.1. Generally, this framework considers a “slow” level that operates on a daily
time scale and a “fast” level that operates on a within-day time scale (e.g., minutes,
half hours, multi-hour, etc.). The slow controller defines dosing for the treatment
components whose dosages can only be delivered on a daily basis and/or whose e↵ects
are observed more on a multi-day time scale. It also determines the total number
of lozenges to be taken during the following day, and this value acts as a terminal
constraint on the fast time scale.
More specifically, P s in Fig. 5.1a represents the behavior change system from
the higher level (the “slow” level, indicated with the s superscript). On this slow
level, Quit, uc, and ub are the same signals as defined in Chapters 3 and 4. CPD,
Craving, and Stress represent total daily smoking level, average daily craving level,
and average daily stress level, as before, but are no longer patient-reported. Instead,
they are constructed from smoking, craving, and stress levels that are reported by
the patient multiple times within a given day; this is why Stress is an output of P s
in Fig. 5.1a, but it will not act as a controlled variable. The slow controller, Cs, is
provided with the intervention targets and values of Quit, Craving, and Stress each
day to determine adjustments to uc, ub, the number of lozenges to be taken in the
day (ultc, which will act as a terminal constraint in the within-day controller), and
the CPD and Craving set points (rfcpd and r
f
crav, respectively). (These set points
will likely equal the CPD and Craving targets defined for the slow level—i.e., =
baseline levels, t < TQD, and = 0, t   TQD—but this may not necessarily be true
if the intervention target is not full cessation or if detuning tracking of the targets is
desired.)
On the fast level, depicted in Fig. 5.1b, patient-reported smoking, craving, and
stress levels are obtained at some time interval, e.g., every two hours; CPDf , Cravingf ,
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and Stressf are measurements of the total number of cigarettes smoked since the last
report, average craving level since the last report, and average stress level since the
last report, respectively. On this control level, the manipulated variable is ufloz, i.e.,
the number of lozenges to be taken consecutively between now and next sampling
instance. CPDf , Cravingf , and the total number of lozenges taken since the be-
ginning of the day—count(ufloz)—are the controlled variables. uc and ub are defined
by Cs, are constant values on this level, and act as feedforward signals; Stressf is
also a feedforward signal. The fast controller Cf determines adjustments to ufloz such
that CPDf tracks rfcpd, Craving
f tracks rfcrav, and count(u
f
loz) equals ultc by the end
of the day; the values of rfcpd, r
f
crav, and ultc were defined by C
s. Dose-response and
Stressf -response mechanisms of the behavior change phenomena that occurs on this
time scale are represented by the plant models, P f . Pcntr is a function counting the
total number of lozenges taken since the beginning of the day. Pconvert translates
the patient-reported CPDf , Cravingf , and Stressf levels into CPD, Craving, and
Stress constructs (which are used by Cs).
A hierarchical control scheme of this sort could be formulated and evaluated com-
putationally based on the programs and routines employed in this dissertation. How-
ever, additional experimentation would be required in order to estimate high-fidelity
models of P s and P f .
Possible Future Experimentation
This dissertation alluded to a number of questions future experiments may seek to
answer. These potential experimental avenues include modeling the natural evolution
of craving and smoking levels within a day, between-day dynamics, the self-regulatory
system depicted in Fig. 2.7 (regardless of any treatments), validating the novel inter-
vention, and more.
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More specifically, future research would significantly benefit from a pilot-type
study intended to examine the ideas and findings discussed in this dissertation; in
other words, a study conducted prior to a large experiment designed with system iden-
tification experimental methods or randomized-controlled structures in mind would
be useful. In such a study, modern EMA methods and intensive data collection tools
should be employed, as the capabilities of mobile and wearable technologies today are
far beyond those commonly available when the McCarthy et al. (2008b) study was
conducted. Such a pilot study could explore how modern smartphone and mHealth
tools can be used to better understand the influence of contextual factors, obtain bet-
ter single subject models, and more. Furthermore, an initial exploratory study that
implements an intervention similar to that described in Chapter 3 could provide in-
sight in to the form a larger randomized, placebo-controlled clinical trial should take,
and more generally about the feasibility of an adaptive intervention of this nature.
Ultimately, if the ideas and findings presented in this dissertation are to move
toward widespread clinical practice, novel, large-scale clinical studies should have two
major goals: (1) estimation and validation of high-fidelity Quit-, disturbance-, and
dose-response models, and (2) validation of the e cacy of an HMPC-based adaptive
intervention relative to current clinical practice.
A novel clinical trial intended to collect ILD better suited for obtaining high-
fidelity dose-response dynamical models should be designed with experiment-design
methods from system identification in mind. Specifically, input signal design methods
should be used to define a “patient-friendly” sequence of treatment dosages that vary
over time in a persistently exciting manner (Deshpande et al., 2014; Ljung, 1999).
In designing these input signals, one must consider a variety of factors unique to
this problem setting. These factors include switching time, amplitude, move size,
and integer constraints as dictated by the nature of the treatment components being
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examined (Deshpande and Rivera, 2014). For example, the binary nature of uc implies
a counseling input sequence that reflects a random binary signal (RBS) or pseudo-
random binary signal (PRBS) may be appropriate. As major swings in lozenge dosing
assignments may not be practical clinically, or may threaten subject buy-in, total daily
lozenge dosing should likely take the form of a multisine signal. If modeling within-day
dynamics is a goal of this future clinical study, the specific time at which a lozenge is
assigned within a single day may be determined according to an RBS or PRBS signal,
where the total number of lozenges assigned in a given day has been pre-determined
according to the multisine signal defining day-to-day total lozenge dosing. Future
experiments and interventions may want examine nicotine replacement patches in
lieu of bupropion. Compared to bupropion, this form of NRT is more widely used
currently (Reynolds, 2011), is more widely available (Rennard et al., 2014), and its
dosages can be varied over time more freely (Rennard et al., 2014; Tobacco Use and
Dependence Guideline Panel, 2008). While patches are commercially available in 7,
14, and 21 mg of nicotine dosages, not all levels can be assigned to all patients without
potentially inducing nicotine toxicity side e↵ects (Rennard et al., 2014; Tobacco Use
and Dependence Guideline Panel, 2008). Consequently, a patch protocol may also
want to take the form of an RBS or PRBS signal. ILD in this study should be collected
via EMA protocol and would likely draw from the same questionnaires employed in
the McCarthy et al. (2008b) clinical trial. A future study should also be designed to
allow cross-validation such that models estimated from a ILD collected from a portion
of subjects are validated against ILD collected from the remaining subjects.
Once dynamical systems models with greater predictive ability have been esti-
mated and validated, an HMPC-based adaptive intervention could be formulated
with the improved models. A clinical study focusing on the e cacy of such an adap-
tive intervention could be pursued. Ultimately, this sort of intervention would need to
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be examined in a large scale randomized, placebo-controlled study, in which the novel
intervention’s e cacy is compared to that of current clinical practice, particularly in
terms of six month cessation rates.
In conclusion, a number of avenues for future work are apparent that can build
from the ideas and findings presented in this dissertation. These future e↵orts would
continue to pursue a better understanding of smoking cessation behavior change and
an optimized engineering-based smoking intervention. Ultimately, many additional
contributions can be made by future incorporation of dynamical systems and control
ideas into the study and treatment of smoking cessation.
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APPENDIX A
CUSTOM GUI FOR MODEL ESTIMATION & ANALYSIS
255
Figure A.1: Screenshot of the Custom Graphical User Interface Created in MAT-
LAB for Flexible Analysis of Estimated Mediation and Self-Regulation Models Draw-
ing from Group Average and Single Subject ILD from the McCarthy et al. (2008b)
Study.
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